BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 011412
(486 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 204 bits (519), Expect = 9e-53, Method: Compositional matrix adjust.
Identities = 117/304 (38%), Positives = 183/304 (60%), Gaps = 18/304 (5%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
+L++F+ +L++A+ NF +++LG GGFG V+KG + G VAVK L +
Sbjct: 24 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----------RLADGTLVAVKRLKEE 73
Query: 175 GLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 230
QG + ++ EV + VH NL++L G+C+ +RLLVY +M GS+ + L R
Sbjct: 74 RXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
PL W R +IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 193
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
D HV V GT G+ APEY+ TG + ++DV+ +GV+LLE++TG+R+ D R +
Sbjct: 194 YKD-XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 351 N--LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ L++W + L E ++ L+D L+G++ + ++ Q+A C P RP MSEVV
Sbjct: 253 DVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 409 EALK 412
L+
Sbjct: 312 RMLE 315
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 202 bits (514), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 116/304 (38%), Positives = 182/304 (59%), Gaps = 18/304 (5%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
+L++F+ +L++A+ NF +++LG GGFG V+KG + G VAVK L +
Sbjct: 16 QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG----------RLADGXLVAVKRLKEE 65
Query: 175 GLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 230
QG + ++ EV + VH NL++L G+C+ +RLLVY +M GS+ + L R
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
PL W R +IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
D HV V G G+ APEY+ TG + ++DV+ +GV+LLE++TG+R+ D R +
Sbjct: 186 YKD-XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 351 N--LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ L++W + L E ++ L+D L+G++ + ++ Q+A C P RP MSEVV
Sbjct: 245 DVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 409 EALK 412
L+
Sbjct: 304 RMLE 307
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 190 bits (482), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 112/293 (38%), Positives = 169/293 (57%), Gaps = 17/293 (5%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
DL+ AT NF + L+G G FG V+KG + + G VA+K + QG +E+
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRM 239
E+ L H +LV LIG+C E ++ +L+Y++M G+L+ HL+ LP + W R+
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+I +GAA+GL +LH R +I+RD K+ NILLD ++ K++DFG++K G E D+TH+
Sbjct: 143 EICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
V GT GY PEY + G LT +SDVYSFGVVL E+L R ++ ++ P NL EWA
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ +++DP L + +K A CL+ + RP M +V+ L+
Sbjct: 260 -HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 187 bits (474), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 111/293 (37%), Positives = 168/293 (57%), Gaps = 17/293 (5%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
DL+ AT NF + L+G G FG V+KG + + G VA+K + QG +E+
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRM 239
E+ L H +LV LIG+C E ++ +L+Y++M G+L+ HL+ LP + W R+
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+I +GAA+GL +LH R +I+RD K+ NILLD ++ K++DFG++K G E +TH+
Sbjct: 143 EICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
V GT GY PEY + G LT +SDVYSFGVVL E+L R ++ ++ P NL EWA
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ +++DP L + +K A CL+ + RP M +V+ L+
Sbjct: 260 -HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 172 bits (436), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 109/309 (35%), Positives = 169/309 (54%), Gaps = 22/309 (7%)
Query: 114 SRLRKFTFNDLKLATRNF--RPESL----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 167
+R F+F +LK T NF RP S+ +GEGGFG V+KG++ A K + +
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 168 VKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL- 226
+ L +++ E+ + H NLV+L+G+ + D LVY +MP GSL + L
Sbjct: 70 TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 227 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
+ PL W +R KIA GAA G+ FLHE I+RD K++NILLD + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
A+ + +T + +R++GT Y APE + G +T +SD+YSFGVVLLE++TG ++D++R
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
L++ E + ID ++ S + +A+ CL RP +
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 406 EVVEALKPL 414
+V + L+ +
Sbjct: 296 KVQQLLQEM 304
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 171 bits (434), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 109/309 (35%), Positives = 168/309 (54%), Gaps = 22/309 (7%)
Query: 114 SRLRKFTFNDLKLATRNF--RPESL----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 167
+R F+F +LK T NF RP S+ +GEGGFG V+KG++ A K + +
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 168 VKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL- 226
+ L +++ E+ + H NLV+L+G+ + D LVY +MP GSL + L
Sbjct: 70 TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 227 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
+ PL W +R KIA GAA G+ FLHE I+RD K++NILLD + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
A+ + +T + R++GT Y APE + G +T +SD+YSFGVVLLE++TG ++D++R
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
L++ E + ID ++ S + +A+ CL RP +
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 406 EVVEALKPL 414
+V + L+ +
Sbjct: 296 KVQQLLQEM 304
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 169 bits (429), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 108/309 (34%), Positives = 167/309 (54%), Gaps = 22/309 (7%)
Query: 114 SRLRKFTFNDLKLATRNF--RPESL----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 167
+R F+F +LK T NF RP S+ +GEGGFG V+KG++ A K + +
Sbjct: 4 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 63
Query: 168 VKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL- 226
+ L +++ E+ + H NLV+L+G+ + D LVY +MP GSL + L
Sbjct: 64 TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 116
Query: 227 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
+ PL W +R KIA GAA G+ FLHE I+RD K++NILLD + AK+SDFGL
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
A+ + + + R++GT Y APE + G +T +SD+YSFGVVLLE++TG ++D++R
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 232
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
L++ E + ID ++ S + +A+ CL RP +
Sbjct: 233 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 289
Query: 406 EVVEALKPL 414
+V + L+ +
Sbjct: 290 KVQQLLQEM 298
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 162 bits (410), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 95/240 (39%), Positives = 138/240 (57%), Gaps = 19/240 (7%)
Query: 114 SRLRKFTFNDLKLATRNF--RPESL----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 167
+R F+F +LK T NF RP S+ GEGGFG V+KG++ A K + +
Sbjct: 1 TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 60
Query: 168 VKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL- 226
+ L +++ E+ H NLV+L+G+ + D LVY + P GSL + L
Sbjct: 61 TEELK-------QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLS 113
Query: 227 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
+ PL W R KIA GAA G+ FLHE I+RD K++NILLD + AK+SDFGL
Sbjct: 114 CLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 170
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
A+ + + +R++GT Y APE + G +T +SD+YSFGVVLLE++TG ++D++R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 107 bits (267), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 84/303 (27%), Positives = 144/303 (47%), Gaps = 45/303 (14%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-------NHDGLQG 178
LA E +G+GGFG V KG + ++ + VA+K+L + ++
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEK 66
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
+E+ EV + +L H N+VKL Y + + +V EF+P G L + L ++ P+ WS++
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGPEGD 293
+++ L A G+ ++ + P+++RD ++ NI L +A AK++DFGL++
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS---- 179
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
H + ++G + + APE + T ++D YSF ++L +LTG D+ G+
Sbjct: 180 -VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIK 237
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ R G R PRL + C S DPK RP S +V+ L
Sbjct: 238 FINMIREE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKEL 284
Query: 412 KPL 414
L
Sbjct: 285 SEL 287
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 105 bits (262), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 83/303 (27%), Positives = 143/303 (47%), Gaps = 45/303 (14%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-------NHDGLQG 178
LA E +G+GGFG V KG + ++ + VA+K+L + ++
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEK 66
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
+E+ EV + +L H N+VKL Y + + +V EF+P G L + L ++ P+ WS++
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGPEGD 293
+++ L A G+ ++ + P+++RD ++ NI L +A AK++DFG ++
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS---- 179
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
H + ++G + + APE + T ++D YSF ++L +LTG D+ G+
Sbjct: 180 -VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIK 237
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ R G R PRL + C S DPK RP S +V+ L
Sbjct: 238 FINMIREE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKEL 284
Query: 412 KPL 414
L
Sbjct: 285 SEL 287
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 105 bits (261), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 83/303 (27%), Positives = 143/303 (47%), Gaps = 45/303 (14%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-------NHDGLQG 178
LA E +G+GGFG V KG + ++ + VA+K+L + ++
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEK 66
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
+E+ EV + +L H N+VKL Y + + +V EF+P G L + L ++ P+ WS++
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGPEGD 293
+++ L A G+ ++ + P+++RD ++ NI L +A AK++DF L++
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS---- 179
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
H + ++G + + APE + T ++D YSF ++L +LTG D+ G+
Sbjct: 180 -VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIK 237
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ R G R PRL + C S DPK RP S +V+ L
Sbjct: 238 FINMIREE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKEL 284
Query: 412 KPL 414
L
Sbjct: 285 SEL 287
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 101 bits (252), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 131/279 (46%), Gaps = 33/279 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W+ ++ VA+KT+ +G ++++ E + L H
Sbjct: 15 IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C+E LV+EFM G L ++L + + + L +G+A+L E
Sbjct: 63 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ VI+RD N L+ + K+SDFG+ + + D+ ST +A+PE
Sbjct: 123 S---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 178
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
+S+SDV+SFGV++ E+ + + +NR N E +VE + +RL PRL
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 228
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ Q+ HC P+ RP S ++ L +
Sbjct: 229 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 101 bits (251), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W+ ++ VA+KT+ +G ++++ E + L H
Sbjct: 15 IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C+E LV+EFM G L ++L + + + L +G+A+L E
Sbjct: 63 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD N L+ + K+SDFG+ + + D+ ST +A+PE
Sbjct: 123 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 178
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
+S+SDV+SFGV++ E+ + + +NR N E +VE + +RL PRL
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 228
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ Q+ HC P+ RP S ++ L +
Sbjct: 229 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 101 bits (251), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 72/217 (33%), Positives = 110/217 (50%), Gaps = 31/217 (14%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----AEVNF 188
E ++G GGFG V++ WI G VAVK HD + + + E
Sbjct: 12 EEIIGIGGFGKVYRAFWI------------GDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L H N++ L G C+++ LV EF G L L + +P I + A+ A+G
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--DILVNWAVQIARG 117
Query: 249 LAFLHEEAERPVIYRDFKTSNILL-----DADYN---AKLSDFGLAKDGPEGDKTHVSTR 300
+ +LH+EA P+I+RD K+SNIL+ + D + K++DFGLA++ K +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-- 175
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
G Y + APE + + SDV+S+GV+L E+LTG
Sbjct: 176 --GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W+ ++ VA+KT+ +G ++++ E + L H
Sbjct: 13 IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 60
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C+E LV+EFM G L ++L + + + L +G+A+L E
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD N L+ + K+SDFG+ + + D+ ST +A+PE
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 176
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
+S+SDV+SFGV++ E+ + + +NR N E +VE + +RL PRL
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 226
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ Q+ HC P+ RP S ++ L +
Sbjct: 227 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W+ ++ VA+KT+ +G ++++ E + L H
Sbjct: 18 IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C+E LV+EFM G L ++L + + + L +G+A+L E
Sbjct: 66 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD N L+ + K+SDFG+ + + D+ ST +A+PE
Sbjct: 126 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 181
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
+S+SDV+SFGV++ E+ + + +NR N E +VE + +RL PRL
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 231
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ Q+ HC P+ RP S ++ L +
Sbjct: 232 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W+ ++ VA+KT+ +G +++ E + L H
Sbjct: 35 IGSGQFGLVHLGYWLNKD-----------KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHP 82
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C+E LV+EFM G L ++L + + + L +G+A+L E
Sbjct: 83 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD N L+ + K+SDFG+ + + D+ ST +A+PE
Sbjct: 143 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 198
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
+S+SDV+SFGV++ E+ + + +NR N E +VE + +RL PRL
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 248
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ Q+ HC P+ RP S ++ L +
Sbjct: 249 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 99.8 bits (247), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 42/291 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ E ++G G FG V K W ++ VA+K + + + K ++ E+
Sbjct: 9 KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 54
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---MKIALG 244
L + H N+VKL G C+ + LV E+ GSL N + + PLP+ M L
Sbjct: 55 QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQ 111
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMG 303
++G+A+LH + +I+RD K N+LL A K+ DFG A D +TH+ T G
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHM-TNNKG 166
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
+ + APE + + + DV+S+G++L E++T R+ D+ G + WA H G R
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGTR 223
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ + +E L C S+DP RP M E+V+ + L
Sbjct: 224 PPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 262
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 42/291 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ E ++G G FG V K W ++ VA+K + + + K ++ E+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 53
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---MKIALG 244
L + H N+VKL G C+ + LV E+ GSL N + + PLP+ M L
Sbjct: 54 QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQ 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMG 303
++G+A+LH + +I+RD K N+LL A K+ DFG A D +TH+ T G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHM-TNNKG 165
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
+ + APE + + + DV+S+G++L E++T R+ D+ G + WA H G R
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGTR 222
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ + +E L C S+DP RP M E+V+ + L
Sbjct: 223 PPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 261
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 99.0 bits (245), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W+ ++ VA+KT+ +G ++++ E + L H
Sbjct: 16 IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C+E LV EFM G L ++L + + + L +G+A+L E
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD N L+ + K+SDFG+ + + D+ ST +A+PE
Sbjct: 124 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 179
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
+S+SDV+SFGV++ E+ + + +NR N E +VE + +RL PRL
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 229
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ Q+ HC P+ RP S ++ L +
Sbjct: 230 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 75/204 (36%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V + P GTG VAVK L D G Q W E++ L L H
Sbjct: 22 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
+++K G C + ++ LV E++P GSL ++L R S+ L + + A +G+A+LH
Sbjct: 77 HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEY 312
+ I+R+ N+LLD D K+ DFGLAK PEG + + V + APE
Sbjct: 135 SQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLT 336
+ SDV+SFGV L E+LT
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 98.2 bits (243), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 77/205 (37%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
LGEG FG V + P GTG VAVK L D H+ W E++ L L H
Sbjct: 39 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 196 NLVKLIGYCIEDD---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
+++K G C ED LV E++P GSL ++L R S+ L + + A +G+A+L
Sbjct: 94 HIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYL 150
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPE 311
H + I+RD N+LLD D K+ DFGLAK PEG + + V + APE
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLT 336
+ SDV+SFGV L E+LT
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 98.2 bits (243), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 75/204 (36%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V + P GTG VAVK L D G Q W E++ L L H
Sbjct: 22 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
+++K G C + ++ LV E++P GSL ++L R S+ L + + A +G+A+LH
Sbjct: 77 HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEY 312
+ I+R+ N+LLD D K+ DFGLAK PEG + + V + APE
Sbjct: 135 AQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLT 336
+ SDV+SFGV L E+LT
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 97.4 bits (241), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 37 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ F
Sbjct: 91 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 148
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E D H T + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 38 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ F
Sbjct: 92 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 149
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E D H T + A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 35 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ F
Sbjct: 89 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 146
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E D H T + A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 37 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ F
Sbjct: 91 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 148
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E D H T + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 96 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N++ L+G C+ + L+V +M G L N + + + L AKG+ FL
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPE 311
A + ++RD N +LD + K++DFGLA+D E D H T + A E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLT 336
+ T T++SDV+SFGV+L E++T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 38 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ F
Sbjct: 92 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 149
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E D H T + A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 42 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ F
Sbjct: 96 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 153
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E D H T + A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMT 237
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 96.7 bits (239), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E +P K + VAVK L L K++ E L +L H +
Sbjct: 23 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 240
+VK G C + D ++V+E+M G L N R P L S +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M + PE +M T+ SDV+SFGV+L E+ T
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E P + + VAVKTL K++ E L +L H +
Sbjct: 21 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 243
+VK G C+E D ++V+E+M G L N R P L S + IA
Sbjct: 77 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A G+ +L A + ++RD T N L+ + K+ DFG+++D D V M
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ PE +M T+ SDV+S GVVL E+ T
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 94.7 bits (234), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 81/297 (27%), Positives = 134/297 (45%), Gaps = 34/297 (11%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 180
+D+ + + + +G G FG V + E +G+ VAVK L +
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 181 -EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSI 237
E+L EV + L H N+V +G + +V E++ RGSL L + L
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
R+ +A AKG+ +LH P+++RD K+ N+L+D Y K+ DFGL++ +
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLX 195
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
S GT + APE + +SDVYSFGV+L E+ T ++ P V A
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAV 251
Query: 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+R R ++P++ A + C + +P RP + +++ L+PL
Sbjct: 252 GFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRPL 296
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 73/206 (35%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
LGEG FG V E P TG VAVK+L + H L E+ L +L H
Sbjct: 29 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 196 NLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C ED + L+ EF+P GSL+ +L + + ++K A+ KG+ +L
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST---RVMGTYGYAAP 310
R ++RD N+L+++++ K+ DFGL K E DK + R + Y AP
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWY-AP 198
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT 336
E +M SDV+SFGV L E+LT
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 73/206 (35%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
LGEG FG V E P TG VAVK+L + H L E+ L +L H
Sbjct: 17 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 196 NLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C ED + L+ EF+P GSL+ +L + + ++K A+ KG+ +L
Sbjct: 72 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 130
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST---RVMGTYGYAAP 310
R ++RD N+L+++++ K+ DFGL K E DK + R + Y AP
Sbjct: 131 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWY-AP 186
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT 336
E +M SDV+SFGV L E+LT
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V E P++ TG VAVK L H + +++ E+ L L H N
Sbjct: 21 LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 197 LVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+VK G C +R L+ EF+P GSL +L + + ++ KG+ +L
Sbjct: 76 IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEY 312
+ I+RD T NIL++ + K+ DFGL K P+ DK + G + APE
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLT 336
+ + SDV+SFGVVL E+ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
N + R+ + LG+G FG V E P++ TG VAVK L H + ++
Sbjct: 21 NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ E+ L L H N+VK G C +R L+ E++P GSL ++L + + +
Sbjct: 76 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK
Sbjct: 136 QYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 191
Query: 300 RVMGT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ G + APE + + SDV+SFGVVL E+ T
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
N + R+ + LG+G FG V E P++ TG VAVK L H + ++
Sbjct: 21 NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ E+ L L H N+VK G C +R L+ E++P GSL ++L + + +
Sbjct: 76 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK
Sbjct: 136 QYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 191
Query: 300 RVMGT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ G + APE + + SDV+SFGVVL E+ T
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V E P++ TG VAVK L H + +++ E+ L L H N
Sbjct: 17 LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 197 LVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+VK G C +R L+ E++P GSL ++L + + ++ KG+ +L
Sbjct: 72 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEY 312
+ I+RD T NIL++ + K+ DFGL K P+ DK + G + APE
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 187
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLT 336
+ + SDV+SFGVVL E+ T
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 13 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 67
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 68 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 128 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 183
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 10 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 64
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 65 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 125 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 180
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 11 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 65
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 66 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 126 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 181
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 9 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 64 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 179
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 176
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 152 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 207
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 12 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 66
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 67 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 127 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 182
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 36 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 90 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 176
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEP 176
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 4 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 58
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 59 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 119 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 174
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 81/298 (27%), Positives = 137/298 (45%), Gaps = 36/298 (12%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 180
+D+ + + + +G G FG V + E +G+ VAVK L +
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 181 -EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSI 237
E+L EV + L H N+V +G + +V E++ RGSL L + L
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
R+ +A AKG+ +LH P+++R+ K+ N+L+D Y K+ DFGL++ T +
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFL 194
Query: 298 STR-VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
S++ GT + APE + +SDVYSFGV+L E+ T ++ P V A
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAA 250
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+R R ++P++ A + C + +P RP + +++ L+PL
Sbjct: 251 VGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRPL 296
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 7 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 62 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+R+ T NIL++ + K+ DFGL K P+ DK + +
Sbjct: 122 SQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEP 177
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 178 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 74/204 (36%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V + P GTG VAVK L G Q W E+ L L H
Sbjct: 17 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 71
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VK G C + ++ LV E++P GSL ++L R + L + + A +G+A+LH
Sbjct: 72 HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLH 129
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEY 312
+ I+R N+LLD D K+ DFGLAK PEG + + V + APE
Sbjct: 130 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLT 336
+ SDV+SFGV L E+LT
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+ R+ + LG+G FG V E P++ TG VAVK L H + +++
Sbjct: 9 QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 64 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ DK +
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEP 179
Query: 303 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
G + APE + + SDV+SFGVVL E+ T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 37 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 91 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 36 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 90 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 74/204 (36%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V + P GTG VAVK L G Q W E+ L L H
Sbjct: 16 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 70
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VK G C + ++ LV E++P GSL ++L R + L + + A +G+A+LH
Sbjct: 71 HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLH 128
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEY 312
+ I+R N+LLD D K+ DFGLAK PEG + + V + APE
Sbjct: 129 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLT 336
+ SDV+SFGV L E+LT
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 32 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 37 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 91 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 56 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 167
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT 251
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 35 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 89 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 146
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 55 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 166
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMT 250
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 29 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 83 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 140
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT 224
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 92.0 bits (227), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVH 194
++G G FGCV+ G + +N G + AVK+LN G ++L E + D H
Sbjct: 34 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 251
N++ L+G C+ + L+V +M G L N F R+ +++ I G AKG+ +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 145
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
L A + ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T T++SDV+SFGV+L E++T
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT 229
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 129/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 44 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 93
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 94 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA + +H ++ G+ + APE +
Sbjct: 153 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 269 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 298
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 129/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 16 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 65
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 66 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA + +H ++ G+ + APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 241 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 270
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 87/324 (26%), Positives = 142/324 (43%), Gaps = 44/324 (13%)
Query: 119 FTFNDLKLATRNF---------RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
FTF D A R F + E ++G G FG V G ++ G + VA+K
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI------FVAIK 67
Query: 170 TLNHDGLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
TL + + ++L+E + +G H N++ L G + +++ EFM GSL++ L +
Sbjct: 68 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 127
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ + G A G+ +L A+ ++RD NIL++++ K+SDFGL++
Sbjct: 128 NDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 289 GPEGDKTHVSTRVMG---TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 344
+ T +G + APE + TS SDV+S+G+V+ E+++ G R
Sbjct: 185 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 244
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404
N +E + YRL P + QL C +D RP
Sbjct: 245 TNQDVINAIE----------QDYRLPPP-------MDCPSALHQLMLDCWQKDRNHRPKF 287
Query: 405 SEVVEALKPL---PN-LKDMASSS 424
++V L + PN LK MA S
Sbjct: 288 GQIVNTLDKMIRNPNSLKAMAPLS 311
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 129/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 36 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 85
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 86 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA + +H ++ G+ + APE +
Sbjct: 145 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 260
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 261 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 290
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 18 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 74 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 131
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 132 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 189 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 231
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 232 EQVLRFV---MEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 22 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 78 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 136 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 237
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +PK RP E+V LK
Sbjct: 238 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 27 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 83 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 141 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 240
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 241 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 25 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 81 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +PK RP E+V LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 89.4 bits (220), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V+KG W +G VK L V T LQ K EV L H+
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHV 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N++ +GY + Q +V ++ SL +HL + IA A+G+ +LH +
Sbjct: 81 NILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 314
+ +I+RD K++NI L D K+ DFGLA + +H ++ G+ + APE +
Sbjct: 140 S---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 315 --TGHLTSRSDVYSFGVVLLEMLTGR 338
+ + +SDVY+FG+VL E++TG+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V+KG W +G VK L V T LQ K EV L H+
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHV 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N++ +GY Q +V ++ SL +HL + IA A+G+ +LH +
Sbjct: 81 NILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 314
+ +I+RD K++NI L D K+ DFGLA + +H ++ G+ + APE +
Sbjct: 140 S---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 315 --TGHLTSRSDVYSFGVVLLEMLTGR 338
+ + +SDVY+FG+VL E++TG+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 88.6 bits (218), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 190
+G G FG V+KG W + VAVK LN LQ K EV L
Sbjct: 18 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 61
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H+N++ +GY + Q +V ++ SL +HL + IA A+G+
Sbjct: 62 KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 120
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH ++ +I+RD K++NI L D K+ DFGLA +H ++ G+ + AP
Sbjct: 121 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177
Query: 311 EYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
E + + +SDVY+FG+VL E++TG+ N N + + R +L
Sbjct: 178 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 236
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
R P+ +L A CL + RPL +++ +++ L
Sbjct: 237 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 272
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 44 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 93
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 94 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA +H ++ G+ + APE +
Sbjct: 153 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 269 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 298
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLV 193
+LGEG FG V +G +++ + GT L VAVKT+ D + E+L+E + D
Sbjct: 41 ILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 194 HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 243
H N+++L+G CIE + +++ FM G L +L L +P +K +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A G+ +L + R ++RD N +L D ++DFGL+K GD
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E + TS+SDV++FGV + E+ T
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 12/203 (5%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
+LG G FG V+KG W+ E T + VA+K LN G + + E++ E + +
Sbjct: 45 VLGSGAFGTVYKGIWVPEGETVKI------PVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H +LV+L+G C+ +L V + MP G L ++ + + + + AKG+ +L
Sbjct: 99 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
E R +++RD N+L+ + + K++DFGLA+ +K + + + A E +
Sbjct: 158 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
T +SDV+S+GV + E++T
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMT 237
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 21 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 71 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA +H ++ G+ + APE +
Sbjct: 130 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 246 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 275
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 21 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 71 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA +H ++ G+ + APE +
Sbjct: 130 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 246 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 275
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 43 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 92
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 93 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA +H ++ G+ + APE +
Sbjct: 152 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 267
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 268 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 297
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 16 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 65
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY + Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 66 ILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA +H ++ G+ + APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 241 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 270
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 88.2 bits (217), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 12/203 (5%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
+LG G FG V+KG W+ E T + VA+K LN G + + E++ E + +
Sbjct: 22 VLGSGAFGTVYKGIWVPEGETVKI------PVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H +LV+L+G C+ +L V + MP G L ++ + + + + AKG+ +L
Sbjct: 76 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
E R +++RD N+L+ + + K++DFGLA+ +K + + + A E +
Sbjct: 135 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
T +SDV+S+GV + E++T
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMT 214
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 88.2 bits (217), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R+ + S LG+G FG V E P+ TG VAVK L H G +++ E+
Sbjct: 10 RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 189 LGDLVHLNLVKL--IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L L +VK + Y LV E++P G L + L R L S + +
Sbjct: 65 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT-- 304
KG+ +L R ++RD NIL++++ + K++DFGLAK P DK + R G
Sbjct: 125 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 180
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + + +SDV+SFGVVL E+ T
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 88.2 bits (217), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 82/310 (26%), Positives = 141/310 (45%), Gaps = 45/310 (14%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQ 177
F ++ ++A LG+G FG V++G G +P T VA+KT+N ++
Sbjct: 6 FVPDEWEVAREKITMSRELGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMR 61
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL------ 231
E+L E + + + ++V+L+G + L++ E M RG L+++L RSL
Sbjct: 62 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMEN 119
Query: 232 -----PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
P S +++A A G+A+L+ ++RD N ++ D+ K+ DFG+
Sbjct: 120 NPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 176
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+D E D + + + +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 177 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------- 226
Query: 347 NGEHNLVEWARPHLG-ERRRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARP 402
L E +P+ G + R + +EG K +L C +PK RP
Sbjct: 227 -----LAE--QPYQGLSNEQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 276
Query: 403 LMSEVVEALK 412
E++ ++K
Sbjct: 277 SFLEIISSIK 286
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 24 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 80 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 138 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 239
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +PK RP E+V LK
Sbjct: 240 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R+ + S LG+G FG V E P+ TG VAVK L H G +++ E+
Sbjct: 23 RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 189 LGDLVHLNLVKL--IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L L +VK + Y LV E++P G L + L R L S + +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT-- 304
KG+ +L R ++RD NIL++++ + K++DFGLAK P DK + R G
Sbjct: 138 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 193
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + + +SDV+SFGVVL E+ T
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R+ + S LG+G FG V E P+ TG VAVK L H G +++ E+
Sbjct: 11 RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 189 LGDLVHLNLVKL--IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L L +VK + Y LV E++P G L + L R L S + +
Sbjct: 66 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT-- 304
KG+ +L R ++RD NIL++++ + K++DFGLAK P DK + R G
Sbjct: 126 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSP 181
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + + +SDV+SFGVVL E+ T
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 25 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 81 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +PK RP E+V LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 27 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 83 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 141 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 240
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 241 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 72/234 (30%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 129 RNFRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
R FRP L LG+G FG K E TG + +K L + + +L
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFL 55
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------KDGPEG----- 292
A G+A+LH +I+RD + N L+ + N ++DFGLA K PEG
Sbjct: 116 DIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 293 --DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
D+ T V+G + APE + + DV+SFG+VL E++ GR + D +
Sbjct: 173 KPDRKKRYT-VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPD 224
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 136/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G + G +P T VA+KT+N ++ E+L E + + +
Sbjct: 33 LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 146
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 147 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 246
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 247 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 33 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 147 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 246
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 247 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 26 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 82 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 140 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 239
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 240 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 25 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 81 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +P RP E+V LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 20 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 76 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 134 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 233
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 234 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 23 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 79 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAGE 136
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 137 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 236
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 237 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V+KG W +G VK L V T LQ K EV L H+
Sbjct: 20 IGSGSFGTVYKGKW---HGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHV 68
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N++ +GY + Q +V ++ SL +HL + IA A+G+ +LH +
Sbjct: 69 NILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 127
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 314
+ +I+RD K++NI L D K+ DFGLA +H ++ G+ + APE +
Sbjct: 128 S---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 315 --TGHLTSRSDVYSFGVVLLEMLTGR 338
+ + +SDVY+FG+VL E++TG+
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQ 210
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 55 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 168
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 169 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 225
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 226 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 268
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 269 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 29/281 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK L V T LQ K EV L H+N
Sbjct: 16 IGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQ--LQAFKN---EVGVLRKTRHVN 65
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY Q +V ++ SL +HL + IA A+G+ +LH ++
Sbjct: 66 ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K++NI L D K+ DFGLA +H ++ G+ + APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ +SDVY+FG+VL E++TG+ N N + + R +L R P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+L A CL + RPL +++ +++ L
Sbjct: 241 -----------AMKRLMAECLKKKRDERPLFPQILASIELL 270
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 26 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 82 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 140 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 239
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 240 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/286 (27%), Positives = 129/286 (45%), Gaps = 31/286 (10%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G FG V +G ++ AP K + VA+KTL + + E+L+E + +G
Sbjct: 21 EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G +++ EFM G+L++ L + + G A G+ +L
Sbjct: 75 EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 134
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAA 309
AE ++RD NIL++++ K+SDFGL++ E T +G + A
Sbjct: 135 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA 191
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368
PE + TS SD +S+G+V+ E+++ G R N +E + YR
Sbjct: 192 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QDYR 241
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L P QL C +D ARP +VV AL +
Sbjct: 242 LPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R+ + S LG+G FG V E P+ TG VAVK L H G +++ E+
Sbjct: 7 RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 189 LGDLVHLNLVKL--IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L L +VK + Y + LV E++P G L + L R L S + +
Sbjct: 62 LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVSTRVMGTY 305
KG+ +L R ++RD NIL++++ + K++DFGLAK P + D V
Sbjct: 122 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + + +SDV+SFGVVL E+ T
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
+ ++G G FG V+KG ++ + P VA+KTL + + ++L E +G
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G + +++ E+M G+L+ L + + + G A G+ +L
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAA 309
A ++RD NIL++++ K+SDFGL++ D PE T ++ + A
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTA 218
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
PE + TS SDV+SFG+V+ E++T
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMT 245
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 19 LGGGQFGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 69 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 184
Query: 316 GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T G P+ + L+E + YR+ P
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP-- 232
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
EG +K +L C +P RP +E+ +A + +
Sbjct: 233 EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 79/286 (27%), Positives = 129/286 (45%), Gaps = 31/286 (10%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G FG V +G ++ AP K + VA+KTL + + E+L+E + +G
Sbjct: 19 EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G +++ EFM G+L++ L + + G A G+ +L
Sbjct: 73 EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 132
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAA 309
AE ++RD NIL++++ K+SDFGL++ E T +G + A
Sbjct: 133 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA 189
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368
PE + TS SD +S+G+V+ E+++ G R N +E + YR
Sbjct: 190 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QDYR 239
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L P QL C +D ARP +VV AL +
Sbjct: 240 LPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 80/292 (27%), Positives = 134/292 (45%), Gaps = 45/292 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 20 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P S +++A
Sbjct: 76 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N + D+ K+ DFG+ +D E D + +
Sbjct: 134 IADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 363
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 233
Query: 364 RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 234 EQVLRFV---MEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 27 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 76 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 239
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 240 -------NCPEELYQLMRLCWKERPEDRP 261
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 29 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 78 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 135
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 136 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 192
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 241
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 242 -------NCPEELYQLMRLCWKERPEDRP 263
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + + VAVK L +++ E L L H +
Sbjct: 49 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------PLPWSIRMK 240
+V+ G C E L+V+E+M G L F RS PL +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+A A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 163 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M + PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 86.3 bits (212), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGLA+ D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + + VAVK L +++ E L L H +
Sbjct: 26 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------PLPWSIRMK 240
+V+ G C E L+V+E+M G L F RS PL +
Sbjct: 82 IVRFFGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+A A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 140 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M + PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 30 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 79 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 136
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 137 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 193
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 242
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 243 -------NCPEELYQLMRLCWKERPEDRP 264
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + + VAVK L +++ E L L H +
Sbjct: 20 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------PLPWSIRMK 240
+V+ G C E L+V+E+M G L F RS PL +
Sbjct: 76 IVRFFGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+A A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 134 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M + PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 184
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 233
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 234 -------NCPEELYQLMRLCWKERPEDRP 255
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 31 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 79
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 80 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 137
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 138 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 194
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 243
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 244 -------NCPEELYQLMRLCWKERPEDRP 265
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 23 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 71
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 72 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 129
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 130 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 186
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 235
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 236 -------NCPEELYQLMRLCWKERPEDRP 257
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 22 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 71 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 129 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 185
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 234
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 235 -------NCPEELYQLMRLCWKERPEDRP 256
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 27 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 76 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 239
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 240 -------NCPEELYQLMRLCWKERPEDRP 261
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 19 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 69 LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 184
Query: 316 GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T G P+ + L+E + YR+ P
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP-- 232
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
EG +K +L C +P RP +E+ +A + +
Sbjct: 233 EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 85.5 bits (210), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINY 184
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 233
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 234 -------NCPEELYQLMRLCWKERPEDRP 255
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 85.5 bits (210), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 26 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 74
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 75 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 132
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 133 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 189
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 238
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 239 -------NCPEELYQLMRLCWKERPEDRP 260
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 36 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N++ L+G C +D ++ E+ +G+L +L R P L +S +
Sbjct: 94 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 155 GIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 184
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 233
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 234 -------NCPEELYQLMRLCWKERPEDRP 255
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 85.1 bits (209), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 39 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 92
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 93 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 152
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 153 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 210 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 258
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 259 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 66 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 126 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 183 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 231
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 232 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 25 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 81 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E + +
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +PK RP E+V LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 36 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N++ L+G C +D ++ E+ +G+L +L R P L +S +
Sbjct: 94 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 82/270 (30%), Positives = 126/270 (46%), Gaps = 39/270 (14%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G W NG VA+KTL G + +L E + L H
Sbjct: 17 LGNGQFGEVWMGTW---NGNT--------KVAIKTLK-PGTMSPESFLEEAQIMKKLKHD 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LV+L + ++ +V E+M +GSL + L R+L LP + M A A G+A++
Sbjct: 65 KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 121
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
I+RD +++NIL+ K++DFGLA+ + + T + APE
Sbjct: 122 ER---MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEA 177
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372
+ G T +SDV+SFG++L E++T R N R L + R YR+ P
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRMPCP 228
Query: 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
+ + S+ +L HC +DP+ RP
Sbjct: 229 Q-DCPISLH------ELMIHCWKKDPEERP 251
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 29 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 82
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 83 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 142
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 143 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 200 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 248
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 249 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 79/300 (26%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E +K +TVAVK L +E L +++LG+
Sbjct: 47 LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 101
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 236
H+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 102 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 237 -IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
V + APE + T SDV+S+G+ L E+ + S
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 262
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL---AAHCLSRDPKARPLMSEVVEALK 412
P + +FY++I EG + A++ C DP RP ++V+ ++
Sbjct: 263 PYPGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 19 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 69 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAY 184
Query: 316 GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T G P+ + L+E + YR+ P
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP-- 232
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
EG +K +L C +P RP +E+ +A + +
Sbjct: 233 EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 16 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 64
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 65 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 122
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 123 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 179
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 228
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 229 -------NCPEELYQLMRLCWKERPEDRP 250
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 25 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N++ L+G C +D ++ E+ +G+L +L R P L +S +
Sbjct: 83 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 67 MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL + D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 28 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N++ L+G C +D ++ E+ +G+L +L R P L +S +
Sbjct: 86 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 29 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N++ L+G C +D ++ E+ +G+L +L R P L +S +
Sbjct: 87 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAV 168
+KV +R+ K T R +LG G FG V KG WI E + + V +
Sbjct: 3 MKVLARIFKET---------ELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCI 47
Query: 169 KTL-NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF 227
K + + G Q + + +G L H ++V+L+G C +L V +++P GSL +H+
Sbjct: 48 KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVR 106
Query: 228 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
+ L + + + AKG+ +L E +++R+ N+LL + +++DFG+A
Sbjct: 107 QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
P DK + + + A E + G T +SDV+S+GV + E++T
Sbjct: 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
+ ++ R LG+G FG V +G AP G ++VAVK L D L + ++
Sbjct: 9 IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 63 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A+G+ +L E++R I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 122 VQVAEGMGYL--ESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 303 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + T + SD + FGV L EM T
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 79/300 (26%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E +K +TVAVK L +E L +++LG+
Sbjct: 54 LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 236
H+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 237 -IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
V + APE + T SDV+S+G+ L E+ + S
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL---AAHCLSRDPKARPLMSEVVEALK 412
P + +FY++I EG + A++ C DP RP ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 36 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N++ L+G C +D ++ E+ +G+L +L R P L +S +
Sbjct: 94 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 79/300 (26%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E +K +TVAVK L +E L +++LG+
Sbjct: 49 LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 103
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 236
H+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 104 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 237 -IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
V + APE + T SDV+S+G+ L E+ + S
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 264
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL---AAHCLSRDPKARPLMSEVVEALK 412
P + +FY++I EG + A++ C DP RP ++V+ ++
Sbjct: 265 PYPGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
+ ++ R LG+G FG V +G AP G ++VAVK L D L + ++
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A+G+ +L E++R I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 128 VQVAEGMGYL--ESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 303 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + T + SD + FGV L EM T
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 25 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 81 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++R+ N ++ D+ K+ DFG+ +D E D + +
Sbjct: 139 IADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +P RP E+V LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 67 MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 79/300 (26%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E +K +TVAVK L +E L +++LG+
Sbjct: 31 LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 236
H+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 237 -IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
V + APE + T SDV+S+G+ L E+ + S
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 246
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL---AAHCLSRDPKARPLMSEVVEALK 412
P + +FY++I EG + A++ C DP RP ++V+ ++
Sbjct: 247 PYPGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 41/290 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 26 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L+V E M G L+++L RSL P +++A
Sbjct: 82 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ + ++R+ N ++ D+ K+ DFG+ +D E D + +
Sbjct: 140 IADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G T+ SD++SFGVVL E+ + L E L +
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 241
Query: 365 RFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++D G+ ++ L C +P RP E+V LK
Sbjct: 242 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
+ ++ R LG+G FG V +G AP G ++VAVK L D L + ++
Sbjct: 9 IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 63 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A+G+ +L E++R I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 122 VQVAEGMGYL--ESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 303 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + T + SD + FGV L EM T
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 21 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 21/228 (9%)
Query: 111 KVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVK 169
KV +R+ K T R +LG G FG V KG WI E + + V +K
Sbjct: 22 KVLARIFKET---------ELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIK 66
Query: 170 TL-NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
+ + G Q + + +G L H ++V+L+G C +L V +++P GSL +H+ +
Sbjct: 67 VIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ 125
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
L + + + AKG+ +L E +++R+ N+LL + +++DFG+A
Sbjct: 126 HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 182
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
P DK + + + A E + G T +SDV+S+GV + E++T
Sbjct: 183 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
+ ++ R LG+G FG V +G AP G ++VAVK L D L + ++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A+G+ +L E++R I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 118 VQVAEGMGYL--ESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 303 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + T + SD + FGV L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
+ ++ R LG+G FG V +G AP G ++VAVK L D L + ++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A+G+ +L E++R I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 118 VQVAEGMGYL--ESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 303 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + T + SD + FGV L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 119 FTFNDLKLATRNF---------RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
FTF D A R F + E ++G G FG V G ++ G + VA+K
Sbjct: 10 FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIK 63
Query: 170 TLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
TL + +++L+E + +G H N++ L G + +++ E+M GSL+ L +
Sbjct: 64 TLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK 123
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK- 287
+ + G G+ +L ++ ++RD NIL++++ K+SDFG+++
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRV 180
Query: 288 --DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
D PE T ++ + APE + TS SDV+S+G+V+ E+++
Sbjct: 181 LEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 67 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 67 MKKLRHEKLVQLYA-VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 10 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 57
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 58 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 115 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 170
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 171 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 221
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 222 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 251
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 8 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 55
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 56 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 112
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 113 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 168
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 169 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 219
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 220 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 249
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 89 LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N++ L+G C +D ++ E+ +G+L +L R P L +S +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 155 GIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 36 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P L +
Sbjct: 94 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ + E LG G FG V+ ++ VAVKT+ G + +LAE N +
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 231
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 246
L H LVKL + + ++ EFM +GSL + L PLP I + A
Sbjct: 232 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--A 288
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+G+AF+ + R I+RD + +NIL+ A K++DFGLA+ G +
Sbjct: 289 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIK 334
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + G T +SDV+SFG++L+E++T
Sbjct: 335 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 364
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 14/215 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
+ ++ R LG+G FG V +G AP G ++VAVK L D L + ++
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A+G+ +L E++R I+RD N+LL K+ DFGL + P+ D V
Sbjct: 128 VQVAEGMGYL--ESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 184
Query: 303 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + T + SD + FGV L EM T
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 82/276 (29%), Positives = 124/276 (44%), Gaps = 51/276 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 17 LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 65
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 66 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 123
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYGYA 308
R I+R+ + +NIL+ + K++DFGLA+ EG K + +
Sbjct: 124 --RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK--------WT 173
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRF 366
APE + G T +SDV+SFG++L E++T R N E NL R
Sbjct: 174 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERG 222
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR++ P ++ QL C P+ RP
Sbjct: 223 YRMVRPD-------NCPEELYQLMRLCWKERPEDRP 251
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 30 LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 88 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 212 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 260
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 261 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 78/294 (26%), Positives = 121/294 (41%), Gaps = 33/294 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNF 188
N + LG G FG V +E K L VAVK L KE L +E+
Sbjct: 39 NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 189 LGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIR 238
+ L H N+V L+G C L++ E+ G L N L R++ PL
Sbjct: 95 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + A+G+AFL A + I+RD N+LL + AK+ DFGLA+D V
Sbjct: 155 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+S+G++L E+ S+ N P
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYP 256
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ +FY+L+ + + + C + +P RP ++ L+
Sbjct: 257 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 310
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 32 LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 90 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ + H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 67 MKKIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 31/294 (10%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L N + ++G G FG V G ++ P K ++VA+KTL + + ++L
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+++L G + ++V E M GSL++ L + + +
Sbjct: 66 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 126 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + +PE + TS SDV+S+G+VL E+++ RP E + + +
Sbjct: 183 I--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVI 231
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
YRL P + QL C +D RP ++V L L
Sbjct: 232 KAVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 35 LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 93 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 78/294 (26%), Positives = 121/294 (41%), Gaps = 33/294 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNF 188
N + LG G FG V +E K L VAVK L KE L +E+
Sbjct: 47 NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 189 LGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIR 238
+ L H N+V L+G C L++ E+ G L N L R++ PL
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + A+G+AFL A + I+RD N+LL + AK+ DFGLA+D V
Sbjct: 163 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+S+G++L E+ S+ N P
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYP 264
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ +FY+L+ + + + C + +P RP ++ L+
Sbjct: 265 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 318
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 80/269 (29%), Positives = 122/269 (45%), Gaps = 37/269 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G G V+ G+ NG VAVK+L G +LAE N + L H
Sbjct: 21 LGAGQAGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L + + ++ E+M GSL + L S + L + + +A A+G+AF+ E
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
R I+RD + +NIL+ + K++DFGLA+ + + T + APE +
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINY 184
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E++T R N E NL R YR++ P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD 233
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
++ QL C P+ RP
Sbjct: 234 -------NCPEELYQLMRLCWKERPEDRP 255
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ + E LG G FG V+ ++ VAVKT+ G + +LAE N +
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVM 237
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 246
L H LVKL + + ++ EFM +GSL + L PLP I + A
Sbjct: 238 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--A 294
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+G+AF+ + R I+RD + +NIL+ A K++DFGLA+ + + T
Sbjct: 295 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIK 350
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + G T +SDV+SFG++L+E++T
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 14/215 (6%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
+ ++ R LG+G FG V +G AP G ++VAVK L D L + ++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A+G+ +L E++R I+RD N+LL K+ DFGL + P+ D V
Sbjct: 118 VQVAEGMGYL--ESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 174
Query: 303 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + T + SD + FGV L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ + E LG G FG V+ ++ VAVKT+ G + +LAE N +
Sbjct: 16 SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 64
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 246
L H LVKL + + ++ EFM +GSL + L PLP I + A
Sbjct: 65 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--A 121
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+G+AF+ + R I+RD + +NIL+ A K++DFGLA+ + + T
Sbjct: 122 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIK 177
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + G T +SDV+SFG++L+E++T
Sbjct: 178 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 207
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 15/216 (6%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L + E ++G G FG V G ++ G V VA+KTL + + ++L
Sbjct: 39 ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDV------AVAIKTLKVGYTEKQRRDFL 92
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + +G H N+V L G ++V EFM G+L+ L + + +
Sbjct: 93 CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR 152
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 300
G A G+ +L A+ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 153 GIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE + TS SDV+S+G+V+ E+++
Sbjct: 210 I--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 67 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 26 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 76 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 132
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 234
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + +++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +G L + L + L LP + M A
Sbjct: 67 MKKLRHEKLVQLYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G FG V+KG + +G VK + V + Q + EV L H+N
Sbjct: 44 IGSGSFGTVYKG--KWHGDVAVK-----ILKVVDPTPEQFQAFRN---EVAVLRKTRHVN 93
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
++ +GY +D+ +V ++ SL HL + + IA A+G+ +LH
Sbjct: 94 ILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA-- 150
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ +I+RD K++NI L K+ DFGLA + + G+ + APE +
Sbjct: 151 -KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 317 H---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI--- 370
+ +SDVYS+G+VL E++TG E H+ R + ++
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTG----------------ELPYSHINNRDQIIFMVGRG 253
Query: 371 --DPRLEGHFSIKGAQKAAQ-LAAHCLSRDPKARPLMSEVVEALKPL 414
P L + K KA + L A C+ + + RPL +++ +++ L
Sbjct: 254 YASPDLSKLY--KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 22 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 72 LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 128
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 129 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 187
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 230
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 231 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 26 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 76 LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 132
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 234
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 26 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 76 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 132
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 234
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 19 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +G L + L + L LP + M A
Sbjct: 67 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 179
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 229
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 82.4 bits (202), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 127 ATRNFRPESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 180
TR+ PE LG+G FG V+K +E T + A K ++ + +
Sbjct: 29 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S
Sbjct: 80 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ L +LH + +I+RD K NIL D + KL+DFG++ + S
Sbjct: 140 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-- 194
Query: 301 VMGTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEM 334
+GT + APE VM R +DV+S G+ L+EM
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 82.4 bits (202), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 229
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 229
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 229
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 26 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 76 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 133
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 234
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 127 ATRNFRPESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 180
TR+ PE LG+G FG V+K +E T + A K ++ + +
Sbjct: 29 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S
Sbjct: 80 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ L +LH + +I+RD K NIL D + KL+DFG++ + S
Sbjct: 140 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS-- 194
Query: 301 VMGTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEM 334
+GT + APE VM R +DV+S G+ L+EM
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 80/298 (26%), Positives = 120/298 (40%), Gaps = 37/298 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNF 188
N + LG G FG V +E K L VAVK L KE L +E+
Sbjct: 47 NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 189 LGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--- 244
+ L H N+V L+G C L++ E+ G L N L R+S L IA
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 245 ----------AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
A+G+AFL A + I+RD N+LL + AK+ DFGLA+D
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354
V + APE + T +SDV+S+G++L E+ S+ N
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN---------- 265
Query: 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
P + +FY+L+ + + + C + +P RP ++ L+
Sbjct: 266 -PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 80/298 (26%), Positives = 120/298 (40%), Gaps = 37/298 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNF 188
N + LG G FG V +E K L VAVK L KE L +E+
Sbjct: 47 NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 189 LGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--- 244
+ L H N+V L+G C L++ E+ G L N L R+S L IA
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 245 ----------AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
A+G+AFL A + I+RD N+LL + AK+ DFGLA+D
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354
V + APE + T +SDV+S+G++L E+ S+ N
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN---------- 265
Query: 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
P + +FY+L+ + + + C + +P RP ++ L+
Sbjct: 266 -PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 35/287 (12%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G G V G + G V VA+K L + + ++L+E + +G
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL--GAAKGLA 250
H N+++L G ++V E+M GSL+ F R+ ++I + + G G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGY 307
+L + ++RD N+L+D++ K+SDFGL++ D P+ T ++ +
Sbjct: 166 YLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRW 220
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + +S SDV+SFGVV+ E+L N N R + Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
RL P + QL C +D RP S++V L L
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 23 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 73 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 129
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 130 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAY 188
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 231
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 232 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 25 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 74
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 131
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 233
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 22 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 72 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 128
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 129 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAY 187
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 230
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 231 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 23 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 73 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 188
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 231
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 232 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 127
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 229
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 23 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 73 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 188
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 231
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 232 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 26 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 76 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 234
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 228 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 277
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 335
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+R+ N L+ ++ K++DFGL++ GD + APE +
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 436
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 35/297 (11%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G FG V G ++ G + VA+KTL + + ++L+E + +G
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 65
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++ L G + +++ EFM GSL++ L + + + G A G+ +L
Sbjct: 66 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAA 309
A+ ++R NIL++++ K+SDFGL++ + T +G + A
Sbjct: 126 ---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368
PE + TS SDV+S+G+V+ E+++ G R N +E + YR
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------QDYR 232
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL---PN-LKDMA 421
L P + QL C +D RP ++V L + PN LK MA
Sbjct: 233 LPPP-------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMA 282
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 34 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 83
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 84 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 141
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 142 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 199
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 242
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 243 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 35/287 (12%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G G V G + G V VA+K L + + ++L+E + +G
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL--GAAKGLA 250
H N+++L G ++V E+M GSL+ F R+ ++I + + G G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGY 307
+L + ++RD N+L+D++ K+SDFGL++ D P+ T ++ +
Sbjct: 166 YLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRW 220
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + +S SDV+SFGVV+ E+L N N R + Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
RL P + QL C +D RP S++V L L
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 9 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 56
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 57 MKKLRHEKLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 114 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT-ARQGAKFPI 169
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 170 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 220
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 221 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 250
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 74/285 (25%), Positives = 127/285 (44%), Gaps = 31/285 (10%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G FG V G ++ G L VA+KTL + + ++L E + +G
Sbjct: 27 ERVIGAGEFGEVCSGRLKLPGKRE------LPVAIKTLKVGYTEKQRRDFLGEASIMGQF 80
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++ L G + ++V E+M GSL+ L + + + G + G+ +L
Sbjct: 81 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYL 140
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAA 309
++ ++RD NIL++++ K+SDFGL++ D PE T ++ + A
Sbjct: 141 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTA 195
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE + TS SDV+S+G+V+ E+++ RP E + + YRL
Sbjct: 196 PEAIAFRKFTSASDVWSYGIVMWEVVSY-----GERPYWEMT----NQDVIKAVEEGYRL 246
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
P + QL C ++ +RP E+V L L
Sbjct: 247 PSP-------MDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L+G C + ++ EFM G+L ++L + + + L A ++ E
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 127
Query: 257 ERP-VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
E+ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 229
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
+GEG FG VF+ G P +P T VAVK L + ++ E + + +
Sbjct: 55 IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL------------------------ 231
N+VKL+G C L++E+M G L F RS+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNE--FLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 232 -PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
PL + ++ IA A G+A+L +ER ++RD T N L+ + K++DFGL+++
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
D + PE + T+ SDV+++GVVL E+ +
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 78/300 (26%), Positives = 119/300 (39%), Gaps = 51/300 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E +K +TVAVK L +E L +++LG+
Sbjct: 54 LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 236
H+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 237 -IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ + AKG+AFL A + I+RD NILL K+ DFGLA+
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
V + APE + T SDV+S+G+ L E+ + S
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL---AAHCLSRDPKARPLMSEVVEALK 412
P + +FY++I EG + A++ C DP RP ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ + +G+L +L R P + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 127 ATRNFRPESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 180
TR+ PE LG+G FG V+K +E T + A K ++ + +
Sbjct: 29 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S
Sbjct: 80 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ L +LH + +I+RD K NIL D + KL+DFG++
Sbjct: 140 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--XIQRRDX 194
Query: 301 VMGTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEM 334
+GT + APE VM R +DV+S G+ L+EM
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 315
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 316 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 372
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 373 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 428
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 479
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 480 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 509
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 267 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 316
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 374
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+R+ N L+ ++ K++DFGL++ GD + APE +
Sbjct: 375 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 432
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 475
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 476 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 83/289 (28%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 35 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 90
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + L H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 91 DELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 149
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 150 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 207 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 225 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 274
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 275 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 332
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+R+ N L+ ++ K++DFGL++ GD + APE +
Sbjct: 333 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 390
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T S P+ G + + Y L++
Sbjct: 391 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 433
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+K +L C +P RP +E+ +A + +
Sbjct: 434 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 473
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 289
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 290 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 345
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 396
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 397 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 127 ATRNFRPES---LLGE-GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
TR+ PE ++GE G FG V+K +E T + A K ++ + +++
Sbjct: 4 VTRDLNPEDFWEIIGELGDFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDY 54
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 55 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 114
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 300
L +LH + +I+RD K NIL D + KL+DFG++ + +T + R
Sbjct: 115 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTXIQRRDS 168
Query: 301 VMGTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEM 334
+GT + APE VM R +DV+S G+ L+EM
Sbjct: 169 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 207
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 83/289 (28%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 21 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 76
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + L H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 77 DELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 135
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 253 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 289
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 290 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 345
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 396
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 397 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGNMSPEAFLQEAQV 233
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 234 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 290
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGL + + + T
Sbjct: 291 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT-ARQGAKFPI 346
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 347 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 397
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C +DP+ RP
Sbjct: 398 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 427
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 12 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 59
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 60 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 117 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 172
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 173 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 223
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 224 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 253
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 39/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDL-VH 194
LG G FG V +E K L VAVK L KE L +E+ + L H
Sbjct: 54 LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 239
N+V L+G C L++ E+ G L N L R+ P L +S +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ A+G+AFL A + I+RD N+LL + AK+ DFGLA+D V
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
+ APE + T +SDV+S+G++L E+ S+ N P
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPG 271
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ +FY+L+ + + + C + +P RP ++ L+
Sbjct: 272 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 324
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 187
+F +LG+G FG VF +P +G A+K L L+ E +
Sbjct: 29 HFELLKVLGQGSFGKVFLV------RKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L D+ H +VKL Y + + +L L+ +F+ G L L + + ++ +A A
Sbjct: 83 ILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 140
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
GL LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT
Sbjct: 141 LGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVE 195
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y APE V + +D +S+GV++ EMLTG
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ + +G+L +L R P + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 26 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 82 LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 255
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 256 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 296
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 79/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 16 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M +
Sbjct: 64 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI-- 120
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 121 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 176
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 177 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 227
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 228 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 76/281 (27%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VAVK + +G E+ E + L H
Sbjct: 16 LGSGQFGVVKLG----------KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LVK G C ++ +V E++ G L N+L L S +++ +G+AFL
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPEYV 313
I+RD N L+D D K+SDFG+ + D +VS+ +GT ++APE
Sbjct: 125 ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSS--VGTKFPVKWSAPEVF 177
Query: 314 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+S+SDV++FG+++ E+ + + N E L + + R YR P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGHRLYR---PH 228
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L + Q+ C P+ RP +++ +++PL
Sbjct: 229 L-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 289
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 290 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPI 345
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 396
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 397 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 26 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 195 LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 82 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 255
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 256 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 296
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 79/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 16 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M +
Sbjct: 64 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI-- 120
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A G+A++ ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 121 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWT-ARQGAKFPI 176
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + G T +SDV+SFG++L E+ T R N R L + R
Sbjct: 177 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 227
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
YR+ P + + L C ++P+ RP
Sbjct: 228 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 35 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 90
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 91 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQP 149
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 150 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 207 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 37 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 92
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 93 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 151
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 152 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 209 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 268
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 269 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 27 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 82
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 83 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 141
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 142 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 199 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 258
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 259 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 47 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 102
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 103 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 161
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 162 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 219 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 278
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 279 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 264
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 265 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 305
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 75
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQP 134
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 12 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 67
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 68 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 126
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 127 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 184 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 243
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 244 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 35 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVYSEQ 90
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 91 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 149
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 150 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 207 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 21 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 76
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 77 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 135
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 253 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 75
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 134
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 29/288 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LGEG FG V++G + G + VAVKT D +KE +++E + +L H
Sbjct: 31 ILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 84
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++VKLIG IE++ ++ E P G L ++L R L + +L K +A+L
Sbjct: 85 PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 143
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++RD NIL+ + KL DFGL++ + D S + + +PE +
Sbjct: 144 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESIN 199
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
T+ SDV+ F V + E+L S K N + +G + RL P L
Sbjct: 200 FRRFTTASDVWMFAVCMWEIL----SFGKQPFFWLEN-----KDVIGVLEKGDRLPKPDL 250
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL-KDMA 421
L C DP RP +E+V +L + + KD+A
Sbjct: 251 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 291
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 264
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 265 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 305
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 21 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 76
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 77 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 135
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 253 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 38 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 93
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 94 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 152
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 153 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 210 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 269
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 270 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 120 TFNDLKLATR-NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ 177
+ +DLK R N LG G FG V++G + P + L VAVKTL Q
Sbjct: 61 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQ 116
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LP 234
++L E + H N+V+ IG ++ R ++ E M G L++ L R + P P
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQP 175
Query: 235 WSIRM----KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 287
S+ M +A A G +L E I+RD N LL AK+ DFG+A+
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT----------- 336
D M + PE M G TS++D +SFGV+L E+ +
Sbjct: 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292
Query: 337 ----------GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
GR KN P + ++ H E R + +I R+E
Sbjct: 293 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 26 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 82 LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 255
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 256 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 296
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 79.3 bits (194), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 26 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 82 LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 255
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 256 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 296
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 79.3 bits (194), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 29/288 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LGEG FG V++G + G + VAVKT D +KE +++E + +L H
Sbjct: 15 ILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++VKLIG IE++ ++ E P G L ++L R L + +L K +A+L
Sbjct: 69 PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++RD NIL+ + KL DFGL++ + D S + + +PE +
Sbjct: 128 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESIN 183
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
T+ SDV+ F V + E+L S K N + +G + RL P L
Sbjct: 184 FRRFTTASDVWMFAVCMWEIL----SFGKQPFFWLEN-----KDVIGVLEKGDRLPKPDL 234
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL-KDMA 421
L C DP RP +E+V +L + + KD+A
Sbjct: 235 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 275
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 79.3 bits (194), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
L + + +G+G FG V G G VAVK + +D + +LAE
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAE 236
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 243
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 237 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 296
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ + +L ++RD N+L+ D AK+SDFGL K+ ST+ G
Sbjct: 297 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTG 346
Query: 304 T--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + +++SDV+SFG++L E+ +
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 79.3 bits (194), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 29/288 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LGEG FG V++G + G + VAVKT D +KE +++E + +L H
Sbjct: 19 ILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++VKLIG IE++ ++ E P G L ++L R L + +L K +A+L
Sbjct: 73 PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++RD NIL+ + KL DFGL++ + D S + + +PE +
Sbjct: 132 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESIN 187
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
T+ SDV+ F V + E+L S K N + +G + RL P L
Sbjct: 188 FRRFTTASDVWMFAVCMWEIL----SFGKQPFFWLEN-----KDVIGVLEKGDRLPKPDL 238
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL-KDMA 421
L C DP RP +E+V +L + + KD+A
Sbjct: 239 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 72 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 301
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 302 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 342
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 238
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRL 264
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 265 KEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 305
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 79.0 bits (193), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
L + + +G+G FG V G N VAVK + +D + +LAE
Sbjct: 9 LNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKNDATA--QAFLAE 55
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 243
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 56 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 115
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ + +L ++RD N+L+ D AK+SDFGL K E T + ++
Sbjct: 116 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL-- 167
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
+ APE + +++SDV+SFG++L E+
Sbjct: 168 PVKWTAPEALREAAFSTKSDVWSFGILLWEI 198
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 79.0 bits (193), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 86/291 (29%), Positives = 121/291 (41%), Gaps = 38/291 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 37 LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 195 LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL-FRRSLPLPWSIR------------MK 240
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 93 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKE 266
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 267 GTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 305
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 79.0 bits (193), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
L + + +G+G FG V G N VAVK + +D + +LAE
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKNDATA--QAFLAE 64
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 243
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 65 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ + +L ++RD N+L+ D AK+SDFGL K+ ST+ G
Sbjct: 125 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTG 174
Query: 304 T--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + +++SDV+SFG++L E+ +
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 86/292 (29%), Positives = 121/292 (41%), Gaps = 39/292 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 36 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSI-------------RM 239
LN+V L+G C + L+V EF G+L +L +R+ +P+ +
Sbjct: 92 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
+ APE + T +SDV+SFGV+L E+ + S P + + R
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLK 265
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
G R R P + Q C +P RP SE+VE L
Sbjct: 266 EGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 305
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 78.6 bits (192), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 78/307 (25%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNF 188
N + LG G FG V +E K L VAVK L KE L +E+
Sbjct: 32 NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 189 LGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-------------- 233
+ L H N+V L+G C L++ E+ G L N L R++ +
Sbjct: 88 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 234 ------PWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
P +R + + A+G+AFL A + I+RD N+LL + AK+ DFGL
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
A+D V + APE + T +SDV+S+G++L E+ S+ N
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN- 259
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
P + +FY+L+ + + + C + +P RP
Sbjct: 260 ----------PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ 309
Query: 406 EVVEALK 412
++ L+
Sbjct: 310 QICSFLQ 316
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 78.6 bits (192), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
L + + +G+G FG V G G VAVK + +D + +LAE
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAE 49
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 243
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ + +L ++RD N+L+ D AK+SDFGL K+ ST+ G
Sbjct: 110 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTG 159
Query: 304 T--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
+ APE + +++SDV+SFG++L E+
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 78.6 bits (192), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAE 185
++ F+ LG G + V+KG + TG+ VA+K + D +G + E
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIRE 53
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMK 240
++ + +L H N+V+L +++ LV+EFM L+ ++ R++ L ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+GLAF HE +++RD K N+L++ KL DFGLA+ G + +
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR--AFGIPVNTFSS 167
Query: 301 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y AP+ +M S S D++S G +L EM+TG+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 78.6 bits (192), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 87/289 (30%), Positives = 121/289 (41%), Gaps = 36/289 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIRMK----------IA 242
LN+V L+G C + L+V EF G+L +L +R+ +P+ K +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
+ APE + T +SDV+SFGV+L E+ + S P + + R G
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEGT 264
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
R R P + Q C +P RP SE+VE L
Sbjct: 265 RMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 301
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 189
+ E ++G G FG V G ++ G + VA+KTL + +++L+E + +
Sbjct: 16 IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
G H N++ L G + +++ E+M GSL+ L + + + G G+
Sbjct: 70 GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 129
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYG 306
+L ++ ++RD NIL++++ K+SDFG+++ D PE T ++
Sbjct: 130 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIR 184
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + TS SDV+S+G+V+ E+++
Sbjct: 185 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 33/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V+ G V LTVAVKTL D ++ +E+L E + ++ H N
Sbjct: 40 LGGGQYGEVYVG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 89
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + +V E+MP G+L ++L + + + + +A + + +L
Sbjct: 90 LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE-- 147
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++ I+RD N L+ ++ K++DFGL++ GD + APE +
Sbjct: 148 -KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 205
Query: 316 GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
+ +SDV++FGV+L E+ T G + ++L+E + YR+ P
Sbjct: 206 NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLE----------KGYRMEQP-- 253
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
EG K +L C P RP +E +A + +
Sbjct: 254 EG-----CPPKVYELMRACWKWSPADRPSFAETHQAFETM 288
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 87/289 (30%), Positives = 121/289 (41%), Gaps = 36/289 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIRMK----------IA 242
LN+V L+G C + L+V EF G+L +L +R+ +P+ K +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
+ APE + T +SDV+SFGV+L E+ + S P + + R G
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFXRRLKEGT 264
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
R R P + Q C +P RP SE+VE L
Sbjct: 265 RMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 301
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 81/291 (27%), Positives = 120/291 (41%), Gaps = 30/291 (10%)
Query: 114 SRLRKFTFNDLKLATRN-FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
+R ++ + + + T+N FR +LG+GGFG V + G K
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 173 HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSL 231
K+ L +VN V + Y E D LV M G L+ H++
Sbjct: 228 EAMALNEKQILEKVNS-------RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 232 P-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
P + + A GL LH E ++YRD K NILLD + ++SD GLA P
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
EG + RV GT GY APE V T D ++ G +L EM+ G+ + + +
Sbjct: 338 EGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
VE RL+ E +S + + +A L + L +DP R
Sbjct: 395 EEVE-------------RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 189
+ E ++G G FG V G ++ G + VA+KTL + +++L+E + +
Sbjct: 10 IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
G H N++ L G + +++ E+M GSL+ L + + + G G+
Sbjct: 64 GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 123
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYG 306
+L ++ ++RD NIL++++ K+SDFG+++ D PE T ++
Sbjct: 124 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIR 178
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + TS SDV+S+G+V+ E+++
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 81/291 (27%), Positives = 120/291 (41%), Gaps = 30/291 (10%)
Query: 114 SRLRKFTFNDLKLATRN-FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
+R ++ + + + T+N FR +LG+GGFG V + G K
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 173 HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSL 231
K+ L +VN V + Y E D LV M G L+ H++
Sbjct: 228 EAMALNEKQILEKVNS-------RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 232 P-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
P + + A GL LH E ++YRD K NILLD + ++SD GLA P
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
EG + RV GT GY APE V T D ++ G +L EM+ G+ + + +
Sbjct: 338 EGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
VE RL+ E +S + + +A L + L +DP R
Sbjct: 395 EEVE-------------RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 50/297 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 186
NFR E +G G F V++ +G + VA+K + L K + + E+
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDG---------VPVALKKVQIFDLMDAKARADCIKEI 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLPWSIRMKIAL 243
+ L L H N++K IED++ +V E G L H ++ +P K +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
L +H R V++RD K +N+ + A KL D GL + KT + ++G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 198
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y +PE + +SD++S G +L EM P G++
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 240
Query: 364 RRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
Y L P H+S ++ QL C++ DP+ RP ++ V + K
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYVYDVAK 293
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 16 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 70 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 129 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 68 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 86/295 (29%), Positives = 117/295 (39%), Gaps = 44/295 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V IE + K T TVAVK L H+ ++E+ L + H
Sbjct: 37 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 195 LNLVKLIGYCIEDDQRLLVY------------------EFMPRGSLENHLFRRSLPLPWS 236
LN+V L+G C + L+V EF+P L++ L L
Sbjct: 93 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
I + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 153 I--CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
+ APE + T +SDV+SFGV+L E+ + S P + +
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCR 264
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
R G R R P + Q C +P RP SE+VE L
Sbjct: 265 RLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 307
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 13 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 67 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 126 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 69 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 22 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 75
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 76 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 134
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 135 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 192 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 69 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 18 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 71
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 72 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 130
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 131 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 188 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 68 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 69 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 13 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 67 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 126 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 15 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 69 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 89/362 (24%), Positives = 139/362 (38%), Gaps = 57/362 (15%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+KL +F +LG+G FG VF ++ T A+K L D + +
Sbjct: 13 IKLKIEDFELHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDD-- 61
Query: 184 AEVNFLGDLV------HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
E + V H L + + V E++ G L H+ + S
Sbjct: 62 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSR 120
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
A GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD
Sbjct: 121 ATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-- 175
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
+ GT Y APE ++ D +SFGV+L EML G+ +G+
Sbjct: 176 TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-----HGQ-------- 222
Query: 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ-LAAHCLSRDPKAR----------PLMSE 406
E F+ + R++ F + +K A+ L R+P+ R PL E
Sbjct: 223 ---DEEELFHSI---RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 276
Query: 407 V----VEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSI 462
+ +E + P + S + E + P RA S+ +N R+
Sbjct: 277 INWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLXFADRALINSMDQNMFRNFXF 336
Query: 463 PN 464
N
Sbjct: 337 MN 338
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 19 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 73 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 37 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 90
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 91 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 149
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 150 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 207 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG +G V+K +E TG VA+K + + +E + E++ + +
Sbjct: 37 LGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPH 85
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+VK G ++ +V E+ GS+ + + R+ L I KGL +LH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ I+RD K NILL+ + +AKL+DFG+A G D V+GT + APE +
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 317 HLTSRSDVYSFGVVLLEMLTGR 338
+D++S G+ +EM G+
Sbjct: 201 GYNCVADIWSLGITAIEMAEGK 222
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ N T VAVKTL G + +L E N + L H
Sbjct: 21 LGAGQFGEVWMGYYN-NST---------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 69
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 253
LV+L ++ ++ E+M +GSL + L + LP I + A+G+A++
Sbjct: 70 LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 127
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ I+RD + +N+L+ K++DFGLA+ + + T + APE +
Sbjct: 128 R---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAI 183
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
G T +SDV+SFG++L E++T
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVT 206
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 59
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 118
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ N T VAVKTL G + +L E N + L H
Sbjct: 20 LGAGQFGEVWMGYYN-NST---------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 253
LV+L +++ ++ EFM +GSL + L + LP I + A+G+A++
Sbjct: 69 LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 126
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ I+RD + +N+L+ K++DFGLA+ + + T + APE +
Sbjct: 127 R---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAI 182
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
G T +S+V+SFG++L E++T
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVT 205
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 20/228 (8%)
Query: 115 RLRKFTFNDLK---LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
RL F K L +F S LG G G VFK KP +GL +A K +
Sbjct: 51 RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLI 101
Query: 172 NHDGLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
+ + + + + E+ L + +V G D + + E M GSL + + +++
Sbjct: 102 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKA 160
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
+P I K+++ KGL +L E+ + +++RD K SNIL+++ KL DFG++
Sbjct: 161 GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 218
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ ++ +GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 219 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 23/241 (9%)
Query: 105 KLEE-ELKVASRLRKFTFNDLK-----LATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 158
KLEE EL R R F K L +F S LG G G VFK
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSH 54
Query: 159 KPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFM 217
KP +GL +A K ++ + + + + E+ L + +V G D + + E M
Sbjct: 55 KP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
GSL + + +++ +P I K+++ KGL +L E+ + +++RD K SNIL+++
Sbjct: 114 DGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGE 170
Query: 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
KL DFG++ + ++ +GT Y +PE + H + +SD++S G+ L+EM G
Sbjct: 171 IKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 338 R 338
R
Sbjct: 227 R 227
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 182
++L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL + + +++ +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ KGL +L E+ + +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENG--TAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
K + ++F+ LG G FG V NG A + V +K + H
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E L + H ++++ G + Q ++ +++ G L + L R+S P + A
Sbjct: 55 -DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYA 112
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
L +LH + +IYRD K NILLD + + K++DFG AK P+ V+ +
Sbjct: 113 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLC 164
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT Y APE V T D +SFG+++ EML G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 185
F +LG+G FG VF +++ + + + V +K + + ++ L E
Sbjct: 25 QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
VN H +VKL Y + + +L L+ +F+ G L L + + ++ +A
Sbjct: 83 VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y APE V T +D +SFGV++ EMLTG
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 182
++L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL + + +++ +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ KGL +L E+ + +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 185
F +LG+G FG VF +++ + + + V +K + + ++ L E
Sbjct: 26 QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 83
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
VN H +VKL Y + + +L L+ +F+ G L L + + ++ +A
Sbjct: 84 VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 135
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT
Sbjct: 136 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 190
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y APE V T +D +SFGV++ EMLTG
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 182
++L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL + + +++ +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ KGL +L E+ + +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 89/362 (24%), Positives = 139/362 (38%), Gaps = 57/362 (15%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+KL +F +LG+G FG VF ++ T A+K L D + +
Sbjct: 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDD-- 60
Query: 184 AEVNFLGDLV------HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
E + V H L + + V E++ G L H+ + S
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSR 119
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
A GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD
Sbjct: 120 ATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-- 174
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
+ GT Y APE ++ D +SFGV+L EML G+ +G+
Sbjct: 175 TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-----HGQ-------- 221
Query: 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ-LAAHCLSRDPKAR----------PLMSE 406
E F+ + R++ F + +K A+ L R+P+ R PL E
Sbjct: 222 ---DEEELFHSI---RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
Query: 407 V----VEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSI 462
+ +E + P + S + E + P RA S+ +N R+
Sbjct: 276 INWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFXF 335
Query: 463 PN 464
N
Sbjct: 336 MN 337
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 185
F +LG+G FG VF +++ + + + V +K + + ++ L E
Sbjct: 25 QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
VN H +VKL Y + + +L L+ +F+ G L L + + ++ +A
Sbjct: 83 VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y APE V T +D +SFGV++ EMLTG
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
+L +F S LG G G VFK KP +GL +A K ++ + + + +
Sbjct: 5 ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 55
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L + +V G D + + E M GSL + + +++ +P I K+++
Sbjct: 56 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 114
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
KGL +L E+ + +++RD K SNIL+++ KL DFG++ G D+ ++ +G
Sbjct: 115 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFVG 168
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
T Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 75.5 bits (184), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 182
++L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL + + +++ +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ KGL +L E+ + +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 75.5 bits (184), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 182
++L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL + + +++ +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ KGL +L E+ + +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL---NHDGLQGHKE 181
K+ ++ LG GG V ++ E+ +K VA+K + + + K
Sbjct: 7 KIINERYKIVDKLGGGGMSTV---YLAEDTILNIK------VAIKAIFIPPREKEETLKR 57
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
+ EV+ L H N+V +I EDD LV E++ +L ++ PL +
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINF 116
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
G+ H+ +++RD K NIL+D++ K+ DFG+AK E T + V
Sbjct: 117 TNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHV 172
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+GT Y +PE +D+YS G+VL EML G
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 75.1 bits (183), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +L G FG V+KG WI E + VA+K L + +KE L
Sbjct: 19 LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 73 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 68 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFG AK +K + +
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 9 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 62
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 63 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 121
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A+G+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 122 QIAEGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 179 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 68 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFG AK +K + +
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 8 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 56
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 57 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 170
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +L G FG V+KG WI E + VA+K L + +KE L
Sbjct: 12 LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 16 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L++ + MP G L +++ + + +
Sbjct: 70 DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFG AK +K + +
Sbjct: 129 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 185
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +L G FG V+KG WI E + VA+K L + +KE L
Sbjct: 19 LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 73 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 14 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 68 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFG AK +K + +
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG VFKG +N T V VA+K ++ + ++ E+ L
Sbjct: 30 IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 138
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
S++D++S G+ +E+ G + P L+ P P LE
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLE 240
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
G++S + + CL+++P RP E+++
Sbjct: 241 GNYS----KPLKEFVEACLNKEPSFRPTAKELLK 270
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 4 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 20/233 (8%)
Query: 110 LKVASRLRKFTFNDLK---LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
L+ RL F K L +F S LG G G VFK KP +GL +
Sbjct: 3 LQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVM 53
Query: 167 AVKTLNHDGLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
A K ++ + + + + E+ L + +V G D + + E M GSL +
Sbjct: 54 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQ 112
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
+ +++ +P I K+++ KGL +L E+ +++RD K SNIL+++ KL DFG+
Sbjct: 113 VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 170
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ G D ++ +GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 171 S--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 11 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 60 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHE 164
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
+ T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+ L + +KE L
Sbjct: 46 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIMELREATSPKANKEIL 99
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 159 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 69/226 (30%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
LGEG FG V K TA G TVAVK L + ++ L+E N L +
Sbjct: 31 LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLP------------------- 232
H +++KL G C +D LL+ E+ GSL L R+ P
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 233 --LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
L + A ++G+ +L AE +++RD NIL+ K+SDFGL++D
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 19 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 73 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFG AK +K + +
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 69/226 (30%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
LGEG FG V K TA G TVAVK L + ++ L+E N L +
Sbjct: 31 LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLP------------------- 232
H +++KL G C +D LL+ E+ GSL L R+ P
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 233 --LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
L + A ++G+ +L AE +++RD NIL+ K+SDFGL++D
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 4 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI E + VA+K L + +KE L
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + ++ +L+G C+ +L+ + MP G L +++ + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L + R +++RD N+L+ + K++DFG AK +K + +
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 4 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 11 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 60 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG A K + + ++++ E+ L H
Sbjct: 27 LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+VKL+G D + ++ EF P G+++ + L + + L FLH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ +I+RD K N+L+ + + +L+DFG++ + + S +GT + APE VM
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 317 HLTS-----RSDVYSFGVVLLEM 334
+ ++D++S G+ L+EM
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG VFKG +N T V VA+K ++ + ++ E+ L
Sbjct: 15 IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 66 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 123
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
S++D++S G+ +E+ G + P L+ P P LE
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLE 225
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
G++S + + CL+++P RP E+++
Sbjct: 226 GNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 40/291 (13%)
Query: 126 LATRNFRPESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQG 178
L ++ PE L +G+G FG VFKG +N T V VA+K ++ +
Sbjct: 18 LYFQSMDPEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDE 68
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
++ E+ L + K G ++D + ++ E++ GS + L PL +
Sbjct: 69 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQI 126
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
I KGL +LH E + I+RD K +N+LL KL+DFG+A G D
Sbjct: 127 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKR 181
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
+GT + APE + S++D++S G+ +E+ G + P L+ P
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP 241
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
P LEG++S + + CL+++P RP E+++
Sbjct: 242 -------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 275
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 183
L R +LG G FG V+KG WI P + VA+K L + + +KE L
Sbjct: 14 LKETELRKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 67
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + +L+G C+ +L V + MP G L +H+ L + +
Sbjct: 68 DEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCM 126
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 301
AKG+++L + +++RD N+L+ + + K++DFGLA+ D E + +V
Sbjct: 127 QIAKGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ T +SDV+S+GV + E++T
Sbjct: 184 --PIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L++ + +L +P +
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSY 108
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ K ++L E L H
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
I+RD N L+ K+SDFG++++ +G + APE +
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 316 GHLTSRSDVYSFGVVLLEMLT 336
G +S SDV+SFG++L E +
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG VFKG +N T V VA+K ++ + ++ E+ L
Sbjct: 15 IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 66 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 123
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
S++D++S G+ +E+ G + P L+ P P LE
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLE 225
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
G++S + + CL+++P RP E+++
Sbjct: 226 GNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG A K + + ++++ E+ L H
Sbjct: 19 LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+VKL+G D + ++ EF P G+++ + L + + L FLH
Sbjct: 70 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 126
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ +I+RD K N+L+ + + +L+DFG++ + + S +GT + APE VM
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 184
Query: 317 HLTS-----RSDVYSFGVVLLEM 334
+ ++D++S G+ L+EM
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEM 207
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 69/226 (30%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
LGEG FG V K TA G TVAVK L + ++ L+E N L +
Sbjct: 31 LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLP------------------- 232
H +++KL G C +D LL+ E+ GSL L R+ P
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 233 --LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
L + A ++G+ +L AE +++RD NIL+ K+SDFGL++D
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L++ + +L +P +
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L++ + +L +P +
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 110
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ K ++L E L H
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
I+RD N L+ K+SDFG++++ +G + APE +
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 316 GHLTSRSDVYSFGVVLLEMLT 336
G +S SDV+SFG++L E +
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 53
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 54 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 112
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 113 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 4 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GL+F H V++RD K N+L++ + KL+DFGLA+ G T + T
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 166
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 5 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 244
++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 54 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V T
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 167
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + ++ D++S G + EM+T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 31/247 (12%)
Query: 109 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
E+ + ++ ++ ++ L+ F E LGE FG V+KG + G AP + VA+
Sbjct: 8 EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAI 61
Query: 169 KTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
KTL D +G +E+ E L H N+V L+G +D +++ + G L L
Sbjct: 62 KTLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
Query: 227 FRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
RS L P + + + A G+ +L + V+++D T N
Sbjct: 121 VMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRN 175
Query: 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 329
+L+ N K+SD GL ++ D + + + APE +M G + SD++S+GV
Sbjct: 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235
Query: 330 VLLEMLT 336
VL E+ +
Sbjct: 236 VLWEVFS 242
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 72/283 (25%), Positives = 116/283 (40%), Gaps = 35/283 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLA-EV 186
+F+ +LLG+G F V++ TGL VA+K ++ + G + + EV
Sbjct: 12 DFKVGNLLGKGSFAGVYRAE---------SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H ++++L Y + + LV E G + +L R P +
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+ +LH +++RD SN+LL + N K++DFGLA + H + + GT
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPN 177
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
Y +PE SDV+S G + +L GR D + N V A
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA---------- 227
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
D + SI+ QL L R+P R +S V++
Sbjct: 228 ----DYEMPSFLSIEAKDLIHQL----LRRNPADRLSLSSVLD 262
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 204 CIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262
C + + RL V E++ G L H+ +R LP + + L +LHE R +IY
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHE---RGIIY 176
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 321
RD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFS 233
Query: 322 SDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 379
D ++ GV++ EM+ GR D + N + N ++ + E++ R+ S
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRIPRSLS 286
Query: 380 IKGAQKAAQLAAHCLSRDPKAR 401
+ KAA + L++DPK R
Sbjct: 287 V----KAASVLKSFLNKDPKER 304
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+EF+ L+ + +L +P +
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY 109
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 204 CIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262
C + + RL V E++ G L H+ +R LP + + L +LHE R +IY
Sbjct: 74 CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHE---RGIIY 129
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 321
RD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 130 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGEDYGFS 186
Query: 322 SDVYSFGVVLLEMLTGRRSMDK--NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 379
D ++ GV++ EM+ GR D + N + N ++ + E++ R+ S
Sbjct: 187 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRIPRSLS 239
Query: 380 IKGAQKAAQLAAHCLSRDPKAR 401
+ KAA + L++DPK R
Sbjct: 240 V----KAASVLKSFLNKDPKER 257
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 204 CIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262
C + + RL V E++ G L H+ +R LP + + L +LHE R +IY
Sbjct: 78 CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHE---RGIIY 133
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 321
RD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGEDYGFS 190
Query: 322 SDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 379
D ++ GV++ EM+ GR D + N + N ++ + E++ R+ S
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRIPRSLS 243
Query: 380 IKGAQKAAQLAAHCLSRDPKAR 401
+ KAA + L++DPK R
Sbjct: 244 V----KAASVLKSFLNKDPKER 261
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 204 CIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262
C + + RL V E++ G L H+ +R LP + + L +LHE R +IY
Sbjct: 89 CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHE---RGIIY 144
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 321
RD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 145 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGEDYGFS 201
Query: 322 SDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 379
D ++ GV++ EM+ GR D + N + N ++ + E++ R+ S
Sbjct: 202 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRIPRSMS 254
Query: 380 IKGAQKAAQLAAHCLSRDPKAR 401
+ KAA + L++DPK R
Sbjct: 255 V----KAASVLKSFLNKDPKER 272
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 10/204 (4%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG GGFG VF ++ G K + G K+ LA+V H
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+ + Y E L LV M G + H++ P + A+ ++ L
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+R +IYRD K N+LLD D N ++SD GLA + G + GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGR 338
D ++ GV L EM+ R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 10/204 (4%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG GGFG VF ++ G K + G K+ LA+V H
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+ + Y E L LV M G + H++ P + A+ ++ L
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+R +IYRD K N+LLD D N ++SD GLA + G + GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGR 338
D ++ GV L EM+ R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 10/204 (4%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG GGFG VF ++ G K + G K+ LA+V H
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+ + Y E L LV M G + H++ P + A+ ++ L
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+R +IYRD K N+LLD D N ++SD GLA + G + GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGR 338
D ++ GV L EM+ R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 10/204 (4%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG GGFG VF ++ G K + G K+ LA+V H
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+ + Y E L LV M G + H++ P + A+ ++ L
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+R +IYRD K N+LLD D N ++SD GLA + G + GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGR 338
D ++ GV L EM+ R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 86/282 (30%), Positives = 115/282 (40%), Gaps = 40/282 (14%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + E T G A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 52 TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH R V+YRD K N++LD D + K++DFGL K+G T +
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-- 164
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 359
GT Y APE + D + GVV+ EM+ GR N +H L E
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L E RF R + P +A L A L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
++ L +F ++G GGFG V+ K TG A+K L+ ++ +
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ-- 230
Query: 183 LAEVNFLGDLVHLNLVK--------LIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPL 233
E L + + L+LV + Y +L + + M G L HL + +
Sbjct: 231 -GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 289
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+R A GL +H R V+YRD K +NILLD + ++SD GLA D +
Sbjct: 290 EADMRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-K 344
Query: 294 KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
K H S +GT+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 345 KPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
NF+ +GEG +G V+K + G L + + ++ E++ L
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 56
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKG 248
+L H N+VKL+ +++ LV+EF+ L+ + +L +P + +G
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
LAF H V++RD K N+L++ + KL+DFGLA+ G T + T Y
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYR 170
Query: 309 APEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ + ++ D++S G + EM+T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
++ L +F ++G GGFG V+ K TG A+K L+ ++ +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ-- 231
Query: 183 LAEVNFLGDLVHLNLVK--------LIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPL 233
E L + + L+LV + Y +L + + M G L HL + +
Sbjct: 232 -GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+R A GL +H R V+YRD K +NILLD + ++SD GLA D +
Sbjct: 291 EADMRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-K 345
Query: 294 KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
K H S +GT+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 346 KPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
NF+ +GEG +G V+K + G L + + ++ E++ L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 55
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKG 248
+L H N+VKL+ +++ LV+EF+ L+ + +L +P + +G
Sbjct: 56 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
LAF H V++RD K N+L++ + KL+DFGLA+ G T + T Y
Sbjct: 115 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYR 169
Query: 309 APEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ + ++ D++S G + EM+T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 73/301 (24%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 3 MESKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVL 46
Query: 172 NHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
L+ + EV L H N+++L GY + + L+ E+ PRG + L +
Sbjct: 47 FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S I A L++ H + VI+RD K N+LL + K++DFG +
Sbjct: 107 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P + T + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 163 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + R+E F + A L + L +P RP++ EV+
Sbjct: 219 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 409 E 409
E
Sbjct: 261 E 261
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
++ L +F ++G GGFG V+ K TG A+K L+ ++ +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ-- 231
Query: 183 LAEVNFLGDLVHLNLVK--------LIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPL 233
E L + + L+LV + Y +L + + M G L HL + +
Sbjct: 232 -GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+R A GL +H R V+YRD K +NILLD + ++SD GLA D +
Sbjct: 291 EADMRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-K 345
Query: 294 KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
K H S +GT+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 346 KPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
++ L +F ++G GGFG V+ K TG A+K L+ ++ +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ-- 231
Query: 183 LAEVNFLGDLVHLNLVK--------LIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPL 233
E L + + L+LV + Y +L + + M G L HL + +
Sbjct: 232 -GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
+R A GL +H R V+YRD K +NILLD + ++SD GLA D +
Sbjct: 291 EADMRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-K 345
Query: 294 KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
K H S +GT+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 346 KPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 68/233 (29%), Positives = 111/233 (47%), Gaps = 37/233 (15%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGH 179
+ND+K + ++GEG FG V K I+ K G + A+K + + H
Sbjct: 24 WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 69
Query: 180 KEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
+++ E+ L L H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 70 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPA 128
Query: 239 MKIALGAAKGLA---FLHEEA----------ERPVIYRDFKTSNILLDADYNAKLSDFGL 285
IA A L+ LH A ++ I+RD NIL+ +Y AK++DFGL
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 286 AKDGPEGDKTHVSTRVMGT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
++ G + +V + MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 189 SR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 86/282 (30%), Positives = 115/282 (40%), Gaps = 40/282 (14%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + E T G A+K L + + E
Sbjct: 4 KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 54
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 55 TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 113
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH R V+YRD K N++LD D + K++DFGL K+G T +
Sbjct: 114 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-- 167
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 359
GT Y APE + D + GVV+ EM+ GR N +H L E
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 220
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L E RF R + P +A L A L +DPK R
Sbjct: 221 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 250
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 72.4 bits (176), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 84/283 (29%), Positives = 112/283 (39%), Gaps = 38/283 (13%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
D K+ +F LLG+G FG V + E T G A+K L + + E
Sbjct: 4 DPKVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEV 54
Query: 183 ---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR 238
+ E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 55 AHTVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 113
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
A L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 114 FYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 167
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
GT Y APE + D + GVV+ EM+ GR L+
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----- 222
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L E RF R + P +A L A L +DPK R
Sbjct: 223 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 252
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 72.4 bits (176), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 68/233 (29%), Positives = 111/233 (47%), Gaps = 37/233 (15%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGH 179
+ND+K + ++GEG FG V K I+ K G + A+K + + H
Sbjct: 14 WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 59
Query: 180 KEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
+++ E+ L L H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 60 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPA 118
Query: 239 MKIALGAAKGLA---FLHEEA----------ERPVIYRDFKTSNILLDADYNAKLSDFGL 285
IA A L+ LH A ++ I+RD NIL+ +Y AK++DFGL
Sbjct: 119 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 178
Query: 286 AKDGPEGDKTHVSTRVMGT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
++ G + +V + MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 179 SR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 86/282 (30%), Positives = 115/282 (40%), Gaps = 40/282 (14%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + E T G A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 52 TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH R V+YRD K N++LD D + K++DFGL K+G T +
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-- 164
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 359
GT Y APE + D + GVV+ EM+ GR N +H L E
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L E RF R + P +A L A L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 184
N++ LGEG FG V + TG VA+K +N L QG E
Sbjct: 14 NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 62
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+++L L H +++KL D+ ++V E+ + + R + + R +
Sbjct: 63 EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 122
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+A H+ +++RD K N+LLD N K++DFGL+ +G+ S G+
Sbjct: 123 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 174
Query: 305 YGYAAPEYVMTGHLTS--RSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 354
YAAPE V++G L + DV+S GV+L ML R D KN NG + L +
Sbjct: 175 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 233
Query: 355 WARP 358
+ P
Sbjct: 234 FLSP 237
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 184
N++ LGEG FG V + TG VA+K +N L QG E
Sbjct: 15 NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 63
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+++L L H +++KL D+ ++V E+ + + R + + R +
Sbjct: 64 EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 123
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+A H+ +++RD K N+LLD N K++DFGL+ +G+ S G+
Sbjct: 124 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 175
Query: 305 YGYAAPEYVMTGHLTS--RSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 354
YAAPE V++G L + DV+S GV+L ML R D KN NG + L +
Sbjct: 176 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 234
Query: 355 WARP 358
+ P
Sbjct: 235 FLSP 238
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 39/224 (17%)
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNL 197
G FGCV+K + + VAVK LQ + W +E + H NL
Sbjct: 26 GRFGCVWKAQLMND-----------FVAVKIFP---LQDKQSWQSEREIFSTPGMKHENL 71
Query: 198 VKLI-----GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
++ I G +E + L+ F +GSL ++L + + W+ +A ++GL++L
Sbjct: 72 LQFIAAEKRGSNLEV-ELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYL 128
Query: 253 HE-------EAERPVI-YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
HE E +P I +RDFK+ N+LL +D A L+DFGLA G + +GT
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGT 188
Query: 305 YGYAAPEYVMTGHLT------SRSDVYSFGVVLLEMLTGRRSMD 342
Y APE V+ G + R D+Y+ G+VL E+++ ++ D
Sbjct: 189 RRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 39/280 (13%)
Query: 131 FRPES-----LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
RPE +LG+GG+G VF+ + + A + V K + + AE
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
N L ++ H +V LI Y + +L L+ E++ G L L R + + + +A
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-E 129
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVSTRVMG 303
+ L LH++ +IYRD K NI+L+ + KL+DFGL K+ +G TH G
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCG 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y APE +M D +S G ++ +MLTG A P GE
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG------------------APPFTGEN 225
Query: 364 RRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKAR 401
R+ + ID L+ ++ Q+A L L R+ +R
Sbjct: 226 RK--KTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 184
N++ LGEG FG V + TG VA+K +N L QG E
Sbjct: 5 NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+++L L H +++KL D+ ++V E+ + + R + + R +
Sbjct: 54 EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 113
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+A H+ +++RD K N+LLD N K++DFGL+ +G+ S G+
Sbjct: 114 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 165
Query: 305 YGYAAPEYVMTGHLTS--RSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 354
YAAPE V++G L + DV+S GV+L ML R D KN NG + L +
Sbjct: 166 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 224
Query: 355 WARP 358
+ P
Sbjct: 225 FLSP 228
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 86/282 (30%), Positives = 114/282 (40%), Gaps = 40/282 (14%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + E T G A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 52 TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKX 164
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 359
GT Y APE + D + GVV+ EM+ GR N +H L E
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L E RF R + P +A L A L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 184
N++ LGEG FG V + TG VA+K +N L QG E
Sbjct: 9 NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 57
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+++L L H +++KL D+ ++V E+ + + R + + R +
Sbjct: 58 EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 117
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+A H+ +++RD K N+LLD N K++DFGL+ +G+ S G+
Sbjct: 118 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 169
Query: 305 YGYAAPEYVMTGHLTS--RSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 354
YAAPE V++G L + DV+S GV+L ML R D KN NG + L +
Sbjct: 170 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 228
Query: 355 WARP 358
+ P
Sbjct: 229 FLSP 232
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 72.0 bits (175), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 83/283 (29%), Positives = 115/283 (40%), Gaps = 37/283 (13%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
D ++ F LLG+G FG V ++E T G A+K L + + E
Sbjct: 4 DPRVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEV 54
Query: 183 ---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR 238
L E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 55 AHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 113
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
A L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T
Sbjct: 114 FYGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 168
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
GT Y APE + D + GVV+ EM+ GR L+
Sbjct: 169 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----- 223
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L E RF R + P +A L + L +DPK R
Sbjct: 224 -LMEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 253
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 72.0 bits (175), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 86/282 (30%), Positives = 114/282 (40%), Gaps = 40/282 (14%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + E T G A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 52 TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKX 164
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 359
GT Y APE + D + GVV+ EM+ GR N +H L E
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L E RF R + P +A L A L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
K + D KL T + LG G FG V KG+ + V + + N L+
Sbjct: 362 KEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK 415
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
E LAE N + L + +V++IG C E + +LV E G L +L + +I
Sbjct: 416 --DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+++ + G+ +L E ++RD N+LL + AK+SDFGL+K D+ +
Sbjct: 473 -IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYY 527
Query: 298 STRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ G + + APE + +S+SDV+SFGV++ E +
Sbjct: 528 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V + +G VAVK ++ Q + EV + D H N
Sbjct: 159 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALS 261
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 262 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPY 312
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + D++S G++++EM+ G P ++ R +L R +
Sbjct: 313 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKN 369
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P L+G L RDP R +E+++
Sbjct: 370 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 400
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 377 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 431
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 432 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 489
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 490 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 545
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFS 567
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 74/293 (25%), Positives = 114/293 (38%), Gaps = 50/293 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTA--PVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDL 192
+LG G FG V N TA K G + VAVK L +E L +E+ + L
Sbjct: 52 VLGSGAFGKVM------NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 193 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------------------- 232
H N+V L+G C L++E+ G L N+L +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 233 ---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289
L + + A AKG+ FL + ++RD N+L+ K+ DFGLA+D
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 349
V + APE + G T +SDV+S+G++L E+ S+ N
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF----SLGVN----- 273
Query: 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
P + FY+LI + ++ + C + D + RP
Sbjct: 274 ------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHL 195
LG G FG V +G + VA+K L + +E + E + L +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V+LIG C + + +LV E G L L + +P S ++ + G+ +L E
Sbjct: 71 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE- 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYV 313
+ ++RD N+LL + AK+SDFGL+K D ++ + R G + + APE +
Sbjct: 129 --KNFVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
+SRSDV+S+GV + E L+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 41/285 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGDL 192
+GEG +G V+K K G VA+K + D G+ + E++ L +L
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAF 251
H N+V LI + LV+EFM + L+ L L S ++KI L +G+A
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-QIKIYLYQLLRGVAH 134
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H+ +++RD K N+L+++D KL+DFGLA+ G T + T Y AP+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLWYRAPD 189
Query: 312 YVMTGHLTSRS-DVYSFGVVLLEMLTGR-----RSMDKNRPN-----GEHNLVEWARPHL 360
+M S S D++S G + EM+TG+ + D P G N EW P +
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW--PQV 247
Query: 361 GE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
E ++R +++ + + Q+ L ++ L DP R
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 82/281 (29%), Positives = 115/281 (40%), Gaps = 37/281 (13%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--- 181
++ F LLG+G FG V ++E T G A+K L + + E
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 197
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 198 TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 256
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T +
Sbjct: 257 GA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 311
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT Y APE + D + GVV+ EM+ GR L+ L
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 365
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
E RF R + P +A L + L +DPK R
Sbjct: 366 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 394
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 82/281 (29%), Positives = 115/281 (40%), Gaps = 37/281 (13%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--- 181
++ F LLG+G FG V ++E T G A+K L + + E
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 194
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 195 TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T +
Sbjct: 254 GA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 308
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT Y APE + D + GVV+ EM+ GR L+ L
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 362
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
E RF R + P +A L + L +DPK R
Sbjct: 363 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 391
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 41/285 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGDL 192
+GEG +G V+K K G VA+K + D G+ + E++ L +L
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAF 251
H N+V LI + LV+EFM + L+ L L S ++KI L +G+A
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-QIKIYLYQLLRGVAH 134
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H+ +++RD K N+L+++D KL+DFGLA+ G T + T Y AP+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLWYRAPD 189
Query: 312 YVMTGHLTSRS-DVYSFGVVLLEMLTGR-----RSMDKNRPN-----GEHNLVEWARPHL 360
+M S S D++S G + EM+TG+ + D P G N EW P +
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW--PQV 247
Query: 361 GE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
E ++R +++ + + Q+ L ++ L DP R
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 39/280 (13%)
Query: 131 FRPES-----LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
RPE +LG+GG+G VF+ + + A + V K + + AE
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
N L ++ H +V LI Y + +L L+ E++ G L L R + + + +A
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-E 129
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVSTRVMG 303
+ L LH++ +IYRD K NI+L+ + KL+DFGL K+ +G TH G
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH---XFCG 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y APE +M D +S G ++ +MLTG A P GE
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG------------------APPFTGEN 225
Query: 364 RRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKAR 401
R+ + ID L+ ++ Q+A L L R+ +R
Sbjct: 226 RK--KTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 83/281 (29%), Positives = 111/281 (39%), Gaps = 38/281 (13%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + E T G A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 52 TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKX 164
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT Y APE + D + GVV+ EM+ GR L+ L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------L 218
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
E RF R + P +A L A L +DPK R
Sbjct: 219 MEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 40/306 (13%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEEL AS+ + + A +F LG+G FG V+ ++ + +
Sbjct: 14 EEEL--ASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFIL 62
Query: 167 AVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223
A+K L L+ + EV L H N+++L GY + + L+ E+ P G++
Sbjct: 63 ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY 122
Query: 224 NHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283
L + S I A L++ H + VI+RD K N+LL + K++DF
Sbjct: 123 RELQKLSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADF 178
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343
G + P + T + GT Y PE + + D++S GV+ E L G+ +
Sbjct: 179 GWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234
Query: 344 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 403
N + Y+ I R+E F + A L + L +P RP+
Sbjct: 235 N-----------------TYQETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPM 276
Query: 404 MSEVVE 409
+ EV+E
Sbjct: 277 LREVLE 282
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 59/294 (20%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGDL 192
+ ++G+G FG V+ G + ++ A+K+L+ +Q + +L E + L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQ------CAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 193 VHLNLVKLIGYCIEDD---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAK 247
H N++ LIG + + LL Y M G L F RS +++ I+ G A+
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQ--FIRSPQRNPTVKDLISFGLQVAR 135
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD----KTHVSTRVMG 303
G+ +L AE+ ++RD N +LD + K++DFGLA+D + + + H R+
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL-- 190
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
+ A E + T T++SDV+SFGV+L E+LT + P
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT------RGAPP---------------- 228
Query: 364 RRFYRLIDPRLEGHFSIKGAQ---------KAAQLAAHCLSRDPKARPLMSEVV 408
YR IDP HF +G + Q+ C DP RP +V
Sbjct: 229 ---YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 31/235 (13%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-- 178
++ L+ F E LGE FG V+KG + G AP + VA+KTL D +G
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAIKTLK-DKAEGPL 55
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------- 230
+E+ E L H N+V L+G +D +++ + G L L RS
Sbjct: 56 REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 231 ---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
L P + + + A G+ +L + V+++D T N+L+ N K+S
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRNVLVYDKLNVKIS 170
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
D GL ++ D + + + APE +M G + SD++S+GVVL E+ +
Sbjct: 171 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 184
+L +F S LG G G V K +G + L + N + +
Sbjct: 12 ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN--------QIIR 63
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+ L + +V G D + + E M GSL + + + + +P I K+++
Sbjct: 64 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIA 122
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GLA+L E+ + +++RD K SNIL+++ KL DFG++ + ++ +GT
Sbjct: 123 VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGT 176
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE + H + +SD++S G+ L+E+ GR
Sbjct: 177 RSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 37/222 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K N TG VA+K + D G+ + E
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYE--------FMPRGSLENHLFRRSLPLPWSI 237
++ L +L H N+VKL+ +++ LV+E FM +L +PLP +
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG------IPLP--L 103
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+GLAF H V++RD K N+L++ + KL+DFGLA+ G
Sbjct: 104 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRT 158
Query: 298 STRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T + T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ N VA+K +++ G Q +++W + EV FL L
Sbjct: 62 IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G + + LV E+ GS + L PL + GA +GLA+LH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+I+RD K NILL KL DFG A + +GT + APE +
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVI 222
Query: 314 MT---GHLTSRSDVYSFGVVLLEM 334
+ G + DV+S G+ +E+
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIEL 246
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 82/281 (29%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--- 181
++ F LLG+G FG V ++E T G A+K L + + E
Sbjct: 4 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 54
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 55 TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 113
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T
Sbjct: 114 GA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 168
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT Y APE + D + GVV+ EM+ GR L+ L
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 222
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
E RF R + P +A L + L +DPK R
Sbjct: 223 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 251
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 82/281 (29%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
++ F LLG+G FG V ++E T G A+K L + + E
Sbjct: 5 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 55
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L E L + H L L Y + RL V E+ G L HL R + R
Sbjct: 56 TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 114
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T
Sbjct: 115 GA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 169
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT Y APE + D + GVV+ EM+ GR L+ L
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 223
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
E RF R + P +A L + L +DPK R
Sbjct: 224 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 252
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
+L NF +LG+G FG V ++E TG AVK L D + +
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVEC 69
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ E L + + + C + RL V EF+ G L H+ ++S +
Sbjct: 70 TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARF 128
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
A L FLH++ +IYRD K N+LLD + + KL+DFG+ K+G T +
Sbjct: 129 YAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TAT 183
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT Y APE + D ++ GV+L EML G
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V + +G VAVK ++ Q + EV + D H N
Sbjct: 82 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 184
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 185 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPY 235
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + D++S G++++EM+ G P ++ R +L R +
Sbjct: 236 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKN 292
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P L+G L RDP R +E+++
Sbjct: 293 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 323
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHL 195
LG G FG V +G + VA+K L + +E + E + L +
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V+LIG C + + +LV E G L L + +P S ++ + G+ +L E
Sbjct: 397 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE- 454
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYV 313
+ ++R+ N+LL + AK+SDFGL+K D ++ + R G + + APE +
Sbjct: 455 --KNFVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
+SRSDV+S+GV + E L+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
LG GGFG V + WI ++ TG VA+K + ++E W E+ + L H
Sbjct: 23 LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 196 NLVKL------IGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAK 247
N+V + +D LL E+ G L +L F L + +
Sbjct: 74 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
L +LHE +I+RD K NI+L K+ D G AK E D+ + T +GT
Sbjct: 134 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGT 187
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339
Y APE + T D +SFG + E +TG R
Sbjct: 188 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 67/233 (28%), Positives = 111/233 (47%), Gaps = 37/233 (15%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGH 179
+ND+K + ++GEG FG V K I+ K G + A+K + + H
Sbjct: 21 WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 66
Query: 180 KEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
+++ E+ L L H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 67 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPA 125
Query: 239 MKIALGAAKGLA---FLHEEA----------ERPVIYRDFKTSNILLDADYNAKLSDFGL 285
IA A L+ LH A ++ I+R+ NIL+ +Y AK++DFGL
Sbjct: 126 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGL 185
Query: 286 AKDGPEGDKTHVSTRVMGT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
++ G + +V + MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 186 SR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 3 MESKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVL 46
Query: 172 NHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
L+ + EV L H N+++L GY + + L+ E+ PRG + L +
Sbjct: 47 FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S I A L++ H + VI+RD K N+LL + K++DFG +
Sbjct: 107 LSKFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P + + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 163 APSSRR----XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + R+E F + A L + L +P RP++ EV+
Sbjct: 219 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 409 E 409
E
Sbjct: 261 E 261
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ N VA+K +++ G Q +++W + EV FL L
Sbjct: 23 IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G + + LV E+ GS + L PL + GA +GLA+LH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+I+RD K NILL KL DFG A + +GT + APE +
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVI 183
Query: 314 MT---GHLTSRSDVYSFGVVLLEM 334
+ G + DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
LG GGFG V + WI ++ TG VA+K + ++E W E+ + L H
Sbjct: 22 LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 196 NLVKL------IGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAK 247
N+V + +D LL E+ G L +L F L + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
L +LHE +I+RD K NI+L K+ D G AK E D+ + T +GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGT 186
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339
Y APE + T D +SFG + E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 182
+ NF+ +GEG +G V+K N TG VA+K + D G+
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 241
+ E++ L +L H N+VKL+ +++ LV+E + + L+ + +L +P +
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 74/299 (24%), Positives = 124/299 (41%), Gaps = 45/299 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 17 SKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFK 60
Query: 174 DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
L+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 61 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 120
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 121 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 176
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+ T + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 177 SSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------ 226
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ Y+ I R+E F + A L + L +P RP++ EV+E
Sbjct: 227 -----------TYQETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG VFKG +N T V VA+K ++ + ++ E+ L
Sbjct: 31 IGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ K G ++ + ++ E++ GS + L R+ P + KGL +LH E
Sbjct: 82 YVTKYYGSYLKGSKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 194
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
S++D++S G+ +E+ G P L+ P P L
Sbjct: 195 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLV 241
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
G F+ + + CL++DP RP E+++
Sbjct: 242 GDFT----KSFKEFIDACLNKDPSFRPTAKELLK 271
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 33 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 87
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 88 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 145
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 146 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 201
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFS 223
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + +L H
Sbjct: 32 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + ++ E+M G L N+L +++ + + +L
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ ++RD N L++ K+SDFGL++ + ++T S ++ PE +M
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMYS 196
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
+S+SD+++FGV++ E+ + + + N E H+ + R YR P L
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL-- 245
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEAL 411
++K + C RP L+S +++ +
Sbjct: 246 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V + +G VAVK ++ Q + EV + D H N
Sbjct: 39 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 90 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 141
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 142 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPY 192
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + D++S G++++EM+ G P ++ R +L R +
Sbjct: 193 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKN 249
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P L+G L RDP R +E+++
Sbjct: 250 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 280
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 4 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 47
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 48 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 107
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 108 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR 163
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T +S GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 164 RTTLS----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 220 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 34/274 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V+KG +N T V VA+K ++ + ++ E+ L
Sbjct: 27 IGKGSFGEVYKGI--DNHTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ + G ++ + ++ E++ GS + L + PL + I KGL +LH E
Sbjct: 78 YITRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 135
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
++D++S G+ +E+ G P L+ P P LE
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 237
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
G S + + CL++DP+ RP E+++
Sbjct: 238 GQHS----KPFKEFVEACLNKDPRFRPTAKELLK 267
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 35 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 90 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 147
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 35 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 90 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 147
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V + +G VAVK ++ Q + EV + D H N
Sbjct: 37 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 88 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 139
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 140 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPY 190
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + D++S G++++EM+ G P ++ R +L R +
Sbjct: 191 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKN 247
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P L+G L RDP R +E+++
Sbjct: 248 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 278
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 1 MESKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVL 44
Query: 172 NHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
L+ + EV L H N+++L GY + + L+ E+ P G++ L +
Sbjct: 45 FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S I A L++ H + VI+RD K N+LL + K++DFG +
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P + T + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 161 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + R+E F + A L + L +P RP++ EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 409 E 409
E
Sbjct: 259 E 259
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 45/299 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 1 SKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFK 44
Query: 174 DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
L+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 45 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 105 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+T + GT Y PE + + D++S GV+ E L G+ + N +
Sbjct: 161 SSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+E F + A L + L +P RP++ EV+E
Sbjct: 217 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 3 MESKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVL 46
Query: 172 NHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
L+ + EV L H N+++L GY + + L+ E+ P G++ L +
Sbjct: 47 FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 106
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S I A L++ H + VI+RD K N+LL + K++DFG +
Sbjct: 107 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P + T + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 163 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + R+E F + A L + L +P RP++ EV+
Sbjct: 219 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 409 E 409
E
Sbjct: 261 E 261
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 25 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 79
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 137
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 19 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 74 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 131
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 187
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 13 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 67
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 68 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 125
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 126 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 181
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V + TG VAVK ++ Q + EV + D H N
Sbjct: 53 IGEGSTGIV---------CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V + + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIATVCLSVLRALS 155
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
+LH + VI+RD K+ +ILL +D KLSDFG ++K+ P+ ++GT
Sbjct: 156 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKXLVGTPY 206
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE + + D++S G++++EM+ G
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 45/299 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 5 SKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFK 48
Query: 174 DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
L+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 49 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 109 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+T + GT Y PE + + D++S GV+ E L G+ + N +
Sbjct: 165 SSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 220
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+E F + A L + L +P RP++ EV+E
Sbjct: 221 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 69.7 bits (169), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 15 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 69
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 127
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + + G + + APE +
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V + +G VAVK ++ Q + EV + D H N
Sbjct: 32 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 83 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 134
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 135 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPY 185
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + D++S G++++EM+ G P ++ R +L R +
Sbjct: 186 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKN 242
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P L+G L RDP R +E+++
Sbjct: 243 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 273
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 1 MESKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVL 44
Query: 172 NHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
L+ + EV L H N+++L GY + + L+ E+ P G++ L +
Sbjct: 45 FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S I A L++ H + VI+RD K N+LL + K++DFG +
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P +T + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 161 APSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + R+E F + A L + L +P RP++ EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 409 E 409
E
Sbjct: 259 E 259
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V + +G VAVK ++ Q + EV + D H N
Sbjct: 28 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 130
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPY 181
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + D++S G++++EM+ G P ++ R +L R +
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKN 238
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P L+G L RDP R +E+++
Sbjct: 239 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 269
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 38/232 (16%)
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLGDLVHLNL 197
G FGCV+K + VAVK +Q + W E V L + H N+
Sbjct: 35 GRFGCVWKAQLLNE-----------YVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENI 80
Query: 198 VKLIGY----CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
++ IG D L+ F +GSL + F ++ + W+ IA A+GLA+LH
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSD--FLKANVVSWNELCHIAETMARGLAYLH 138
Query: 254 EE------AERPVI-YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
E+ +P I +RD K+ N+LL + A ++DFGLA G + +GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 307 YAAPEYVMTGHLT------SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
Y APE V+ G + R D+Y+ G+VL E+ + R + P E+ L
Sbjct: 199 YMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEYML 247
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 RTELC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 64/279 (22%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + +L H
Sbjct: 32 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + ++ E+M G L N+L +++ + + +L
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ ++RD N L++ K+SDFGL++ + + T S ++ PE +M
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 196
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
+S+SD+++FGV++ E+ + + + N E H+ + R YR P L
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL-- 245
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEAL 411
++K + C RP L+S +++ +
Sbjct: 246 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 69.3 bits (168), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/306 (24%), Positives = 126/306 (41%), Gaps = 40/306 (13%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEEL AS+ + + A +F LG+G FG V+ ++ + +
Sbjct: 14 EEEL--ASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFIL 62
Query: 167 AVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223
A+K L L+ + EV L H N+++L GY + + L+ E+ P G++
Sbjct: 63 ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY 122
Query: 224 NHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283
L + S I A L++ H + VI+RD K N+LL + K++DF
Sbjct: 123 RELQKLSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADF 178
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343
G + P + + GT Y PE + + D++S GV+ E L G+ +
Sbjct: 179 GWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234
Query: 344 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 403
N + Y+ I R+E F + A L + L +P RP+
Sbjct: 235 N-----------------TYQETYKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPM 276
Query: 404 MSEVVE 409
+ EV+E
Sbjct: 277 LREVLE 282
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
+G VAVK ++ Q + EV + D H N+V++ + ++ ++ EF+ G+
Sbjct: 69 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
L + + L + + LA+LH + VI+RD K+ +ILL D KLS
Sbjct: 129 LTD--IVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLS 183
Query: 282 DFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
DFG ++KD P+ ++GT + APE + + D++S G++++EM+ G
Sbjct: 184 DFGFCAQISKDVPK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 64/279 (22%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + +L H
Sbjct: 16 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 64
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + ++ E+M G L N+L +++ + + +L
Sbjct: 65 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 121
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ ++RD N L++ K+SDFGL++ + + T S ++ PE +M
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 180
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
+S+SD+++FGV++ E+ + + + N E H+ + R YR P L
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL-- 229
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEAL 411
++K + C RP L+S +++ +
Sbjct: 230 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 263
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ ++ + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+ T + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 R----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 45/299 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 5 SKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFK 48
Query: 174 DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
L+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 49 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 109 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+ T + GT Y PE + + D++S GV+ E L G+ + N +
Sbjct: 165 SSRR----TTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 220
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+E F + A L + L +P RP + EV+E
Sbjct: 221 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 64/279 (22%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + +L H
Sbjct: 23 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 71
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + ++ E+M G L N+L +++ + + +L
Sbjct: 72 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ ++RD N L++ K+SDFGL++ + + T S ++ PE +M
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 187
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
+S+SD+++FGV++ E+ + + + N E H+ + R YR P L
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL-- 236
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEAL 411
++K + C RP L+S +++ +
Sbjct: 237 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 270
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 RTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 41/282 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + +L H
Sbjct: 17 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + ++ E+M G L N+L +++ + + +L
Sbjct: 66 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPEYV 313
+ ++RD N L++ K+SDFGL++ D + S+R G+ ++ PE +
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSR--GSKFPVRWSPPEVL 178
Query: 314 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
M +S+SD+++FGV++ E+ + + + N E H+ + R YR P
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PH 229
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEAL 411
L ++K + C RP L+S +++ +
Sbjct: 230 L-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 264
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 64/279 (22%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + +L H
Sbjct: 17 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + ++ E+M G L N+L +++ + + +L
Sbjct: 66 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ ++RD N L++ K+SDFGL++ + + T S ++ PE +M
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 181
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
+S+SD+++FGV++ E+ + + + N E H+ + R YR P L
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL-- 230
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEAL 411
++K + C RP L+S +++ +
Sbjct: 231 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 264
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 RTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 RTXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V KG+ + V + + N L+ E LAE N + L +
Sbjct: 19 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V++IG C E + +LV E G L +L + +I +++ + G+ +L E
Sbjct: 74 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 131
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYVM 314
++RD N+LL + AK+SDFGL+K D+ + G + + APE +
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYAPECIN 187
Query: 315 TGHLTSRSDVYSFGVVLLEMLT 336
+S+SDV+SFGV++ E +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 64/279 (22%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + +L H
Sbjct: 12 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + ++ E+M G L N+L +++ + + +L
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+ ++RD N L++ K+SDFGL++ + + T S ++ PE +M
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 176
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
+S+SD+++FGV++ E+ + + + N E H+ + R YR P L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL-- 225
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEAL 411
++K + C RP L+S +++ +
Sbjct: 226 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 259
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 11/214 (5%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
D+K + + LGEG F V+K + T + + + ++ DG+ ++
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGI--NRTA 59
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L E+ L +L H N++ L+ LV++FM LE + SL L S
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
L +GL +LH+ +++RD K +N+LLD + KL+DFGLAK ++ + V
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV- 174
Query: 303 GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEML 335
T Y APE + + D+++ G +L E+L
Sbjct: 175 -TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 2 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 45
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 46 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 105
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 106 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 161
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 162 RTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 217
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 218 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 68.6 bits (166), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 73/309 (23%), Positives = 131/309 (42%), Gaps = 41/309 (13%)
Query: 108 EELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 167
+ L ++ L++ D+ + + F +LG+G FG V + +++ + G+ + VA
Sbjct: 3 DSLGISDELKE-KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ------EDGSFVKVA 55
Query: 168 VKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPR 219
VK L D + +E+L E + + H ++ KL+G + + +++ FM
Sbjct: 56 VKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH 115
Query: 220 GSLENHLFRRSL-----PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
G L L + LP ++ + A G+ +L + R I+RD N +L
Sbjct: 116 GDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAE 172
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
D ++DFGL++ GD + A E + T SDV++FGV + E+
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
Query: 335 LTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 393
+T ++ N E +N + +G RL P + ++ L C
Sbjct: 233 MTRGQTPYAGIENAEIYNYL------IGGN----RLKQPP-------ECMEEVYDLMYQC 275
Query: 394 LSRDPKARP 402
S DPK RP
Sbjct: 276 WSADPKQRP 284
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 82/297 (27%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 162 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VAVK ++ L ++ EV + L H N+VKL + LV E+
Sbjct: 38 TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLD 273
G + ++L RMK AK + + H+ + +++RD K N+LLD
Sbjct: 98 GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLL 332
AD N K++DFG + + G+K G+ YAAPE DV+S GV+L
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR--FYRLID-PRLEGHFSIKGAQKAAQL 389
+++G + P NL E L + R FY D L F I K L
Sbjct: 205 TLVSG------SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 390 AAHCLSRDPKARPLMSEVVEALKPLPNLKD------MASSSYYFQTMQAERIGSSPN 440
R E+ ++PLP+ KD M S Y + +Q +G N
Sbjct: 259 EQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMGYTREEIQDSLVGQRYN 315
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ E+N + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLA-REKN--------SKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+ + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 RAALC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P + VA+KT + +E +L E + H
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL--E 508
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ A KL DFGL++ E + +++ + APE +
Sbjct: 509 SKR-FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 316 GHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586
Score = 28.9 bits (63), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 12/48 (25%), Positives = 25/48 (52%)
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265
P + F+ +L W I +++A+G +G+++L ++ P DF
Sbjct: 219 PVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGANPTHLADF 266
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 7 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 50
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 51 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 110
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 111 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 166
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 167 RTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 222
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 223 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P L VA+KT + +E +L E + H
Sbjct: 21 IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 75 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL--E 131
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 132 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRL 374
TS SDV+ FGV + E+L M +P G N R GER P L
Sbjct: 190 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 244
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L C + DP RP +E+ L +
Sbjct: 245 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 272
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P L VA+KT + +E +L E + H
Sbjct: 46 IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 100 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL--E 156
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 157 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 214
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRL 374
TS SDV+ FGV + E+L M +P G N R GER P L
Sbjct: 215 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 269
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L C + DP RP +E+ L +
Sbjct: 270 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 297
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P L VA+KT + +E +L E + H
Sbjct: 20 IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 74 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL--E 130
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 131 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 188
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRL 374
TS SDV+ FGV + E+L M +P G N R GER P L
Sbjct: 189 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 243
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L C + DP RP +E+ L +
Sbjct: 244 YS------------LMTKCWAYDPSRRPRFTELKAQLSTI 271
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 45/299 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 2 SKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFK 45
Query: 174 DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
L+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 46 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I A L++ H + VI+RD K N+LL + K+++FG + P
Sbjct: 106 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP 161
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+ T + GT Y PE + + D++S GV+ E L G+ + N +
Sbjct: 162 SSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 217
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+E F + A L + L +P RP++ EV+E
Sbjct: 218 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 45/299 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 2 SKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFK 45
Query: 174 DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
L+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 46 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 106 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 161
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+ + GT Y PE + + D++S GV+ E L G+ + N +
Sbjct: 162 SSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 217
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+E F + A L + L +P RP++ EV+E
Sbjct: 218 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 33/229 (14%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW- 182
+KL NF +LG+G FG V + GT A+K L D + +
Sbjct: 16 VKLTDFNFL--MVLGKGSFGKVMLA---------DRKGTEELYAIKILKKDVVIQDDDVE 64
Query: 183 --LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLP 234
+ E L L + + C + RL V E++ G L H+ F+ +
Sbjct: 65 CTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 124
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
++ + I GL FLH+ R +IYRD K N++LD++ + K++DFG+ K E
Sbjct: 125 YAAEISI------GLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMM 172
Query: 295 THVSTR-VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342
V+TR GT Y APE + D +++GV+L EML G+ D
Sbjct: 173 DGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 1 MESKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVL 44
Query: 172 NHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
L+ + EV L H N+++L GY + + L+ E+ P G++ L +
Sbjct: 45 FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S I A L++ H + VI+RD K N+LL + K+++FG +
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVH 160
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P +T + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 161 APSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + R+E F + A L + L +P RP++ EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 409 E 409
E
Sbjct: 259 E 259
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P + VA+KT + +E +L E + H
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL--E 508
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 509 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 316 GHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586
Score = 28.9 bits (63), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 12/48 (25%), Positives = 25/48 (52%)
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265
P + F+ +L W I +++A+G +G+++L ++ P DF
Sbjct: 219 PVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGANPTHLADF 266
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P L VA+KT + +E +L E + H
Sbjct: 15 IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 69 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL--E 125
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 126 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 316 GHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P L VA+KT + +E +L E + H
Sbjct: 23 IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 77 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL--E 133
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 134 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRL 374
TS SDV+ FGV + E+L M +P G N R GER P L
Sbjct: 192 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 246
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L C + DP RP +E+ L +
Sbjct: 247 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 274
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P + VA+KT + +E +L E + H
Sbjct: 18 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 72 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL--E 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ A KL DFGL++ E + +++ + APE +
Sbjct: 129 SKR-FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 186
Query: 316 GHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P + VA+KT + +E +L E + H
Sbjct: 18 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 72 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL--E 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ + S + + APE +
Sbjct: 129 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI-KWMAPESINF 186
Query: 316 GHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 1 MESKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVL 44
Query: 172 NHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
L+ + EV L H N+++L GY + + L+ E+ P G++ L +
Sbjct: 45 FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
S I A L++ H + VI+RD K N+LL + K++DFG +
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P + + GT Y PE + + D++S GV+ E L G+ + N
Sbjct: 161 APSSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + R+E F + A L + L +P RP++ EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 409 E 409
E
Sbjct: 259 E 259
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 77/299 (25%), Positives = 123/299 (41%), Gaps = 58/299 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F+ L+G GGFG VFK +G T +K + ++ + +E V L
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIKRVKYNNEKAERE----VKAL 58
Query: 190 GDLVHLNLVKLIG------YCIEDDQR----------LLVYEFMPRGSLENHL-FRRSLP 232
L H+N+V G Y E + + EF +G+LE + RR
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
L + +++ KG+ ++H + +I RD K SNI L K+ DFGL
Sbjct: 119 LDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
K R GT Y +PE + + D+Y+ G++L E+L ++
Sbjct: 176 GK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---------------HV 217
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ A E +F+ D R +G S +K L LS+ P+ RP SE++ L
Sbjct: 218 CDTA----FETSKFF--TDLR-DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P L VA+KT + +E +L E + H
Sbjct: 18 IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 72 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL--E 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 129 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 186
Query: 316 GHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 37/297 (12%)
Query: 162 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VAVK ++ L ++ EV + L H N+VKL + LV E+
Sbjct: 38 TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLD 273
G + ++L RMK AK + + H+ + +++RD K N+LLD
Sbjct: 98 GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLL 332
AD N K++DFG + + G+K G YAAPE DV+S GV+L
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR--FYRLID-PRLEGHFSIKGAQKAAQL 389
+++G + P NL E L + R FY D L F I K L
Sbjct: 205 TLVSG------SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 390 AAHCLSRDPKARPLMSEVVEALKPLPNLKD------MASSSYYFQTMQAERIGSSPN 440
R E+ ++PLP+ KD M S Y + +Q +G N
Sbjct: 259 EQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMGYTREEIQDSLVGQRYN 315
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 37/297 (12%)
Query: 162 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VAVK ++ L ++ EV + L H N+VKL + LV E+
Sbjct: 38 TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLD 273
G + ++L RMK AK + + H+ + +++RD K N+LLD
Sbjct: 98 GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLL 332
AD N K++DFG + + G+K G+ YAAPE DV+S GV+L
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR--FYRLID-PRLEGHFSIKGAQKAAQL 389
+++G + P NL E L + R FY D L F I K L
Sbjct: 205 TLVSG------SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 390 AAHCLSRDPKARPLMSEVVEALKPLPNLKD------MASSSYYFQTMQAERIGSSPN 440
R E+ + PLP+ KD M S Y + +Q +G N
Sbjct: 259 EQIMKDRWMNVGHEDDELKPYVAPLPDYKDPRRTELMVSMGYTREEIQDSLVGQRYN 315
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 87/327 (26%), Positives = 129/327 (39%), Gaps = 42/327 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPG----TGLTVAVKTLNHDGLQGH--KEWL 183
N+R +G+G F A VK TG VAVK ++ L ++
Sbjct: 8 NYRLLKTIGKGNF-------------AKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF 54
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
EV + L H N+VKL + LV E+ G + ++L R K
Sbjct: 55 REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR- 113
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ + H+ + +++RD K N+LLDAD N K++DFG + + G+K G
Sbjct: 114 QIVSAVQYCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCG 167
Query: 304 TYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
+ YAAPE DV+S GV+L +++G + P NL E L
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKELRERVLRG 221
Query: 363 RRR--FYRLID-PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 419
+ R FY D L F I K L R E+ ++PLP+ KD
Sbjct: 222 KYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKD 281
Query: 420 ------MASSSYYFQTMQAERIGSSPN 440
M S Y + +Q +G N
Sbjct: 282 PRRTELMVSMGYTREEIQDSLVGQRYN 308
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 297
+++ A + L F H+ +I+RD K +NIL+ A K+ DFG+A+ G+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+ V+GT Y +PE + +RSDVYS G VL E+LTG + P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 45/299 (15%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
S+ R++ D ++ RP LG+G FG V+ + + +A+K L
Sbjct: 1 SKKRQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFK 44
Query: 174 DGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
L+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 45 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 105 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+ + GT Y PE + + D++S GV+ E L G+ + N +
Sbjct: 161 SSRR----DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+E F + A L + L +P RP++ EV+E
Sbjct: 217 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 76/290 (26%), Positives = 120/290 (41%), Gaps = 33/290 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLV 193
L+GEG +G V K ++ TG VA+K + D K + E+ L L
Sbjct: 32 LVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H NLV L+ C + + LV+EF+ L++ LF L + + K G+ F
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLD--YQVVQKYLFQIINGIGFC 140
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H +I+RD K NIL+ KL DFG A+ V + T Y APE
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPEL 195
Query: 313 VMTGHLTSRS-DVYSFGVVLLEMLTGRRSM--DKNRPNGEH------NLVEWARPHLGER 363
++ ++ DV++ G ++ EM G D + H NL+ + +
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 364 RRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVV 408
F + P ++ + K ++ LA CL DP RP +E++
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 220
TG VA+K ++ + L + E+ L +L H ++ +L ++ +V E+ P G
Sbjct: 34 TGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGG 93
Query: 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
L +++ + R+ + +A++H + +RD K N+L D + KL
Sbjct: 94 ELFDYIISQDRLSEEETRV-VFRQIVSAVAYVHSQG---YAHRDLKPENLLFDEYHKLKL 149
Query: 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRR 339
DFGL P+G+K + G+ YAAPE + +L S +DV+S G++L ++ G
Sbjct: 150 IDFGLCA-KPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFL 208
Query: 340 SMD--------KNRPNGEHNLVEWARP 358
D K G++++ +W P
Sbjct: 209 PFDDDNVMALYKKIMRGKYDVPKWLSP 235
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 81/297 (27%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 162 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VAV+ ++ L ++ EV + L H N+VKL + LV E+
Sbjct: 38 TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLD 273
G + ++L RMK AK + + H+ + +++RD K N+LLD
Sbjct: 98 GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLL 332
AD N K++DFG + + G+K G+ YAAPE DV+S GV+L
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR--FYRLID-PRLEGHFSIKGAQKAAQL 389
+++G + P NL E L + R FY D L F I K L
Sbjct: 205 TLVSG------SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 390 AAHCLSRDPKARPLMSEVVEALKPLPNLKD------MASSSYYFQTMQAERIGSSPN 440
R E+ ++PLP+ KD M S Y + +Q +G N
Sbjct: 259 EQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMGYTREEIQDSLVGQRYN 315
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 46/281 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+GGF F+ I + T V G + K+L Q K + E++ L H
Sbjct: 46 FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 99
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 251
++V G+ ++D +V E R SL E H R++L P + +R +I LG +
Sbjct: 100 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 154
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAP 310
LH VI+RD K N+ L+ D K+ DFGLA K +G++ V + GT Y AP
Sbjct: 155 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAP 208
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL- 369
E + + DV+S G ++ +L G +P E + ++ +L ++ Y +
Sbjct: 209 EVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKET--YLRIKKNEYSIP 259
Query: 370 --IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
I+P AA L L DP ARP ++E++
Sbjct: 260 KHINP------------VAASLIQKMLQTDPTARPTINELL 288
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 46/281 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+GGF F+ I + T V G + K+L Q K + E++ L H
Sbjct: 48 FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 101
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 251
++V G+ ++D +V E R SL E H R++L P + +R +I LG +
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 156
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAP 310
LH VI+RD K N+ L+ D K+ DFGLA K +G++ V + GT Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAP 210
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL- 369
E + + DV+S G ++ +L G +P E + ++ +L ++ Y +
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKET--YLRIKKNEYSIP 261
Query: 370 --IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
I+P AA L L DP ARP ++E++
Sbjct: 262 KHINP------------VAASLIQKMLQTDPTARPTINELL 290
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 81/297 (27%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 162 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VAV+ ++ L ++ EV + L H N+VKL + LV E+
Sbjct: 38 TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLD 273
G + ++L RMK AK + + H+ + +++RD K N+LLD
Sbjct: 98 GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLL 332
AD N K++DFG + + G+K G+ YAAPE DV+S GV+L
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR--FYRLID-PRLEGHFSIKGAQKAAQL 389
+++G + P NL E L + R FY D L F I K L
Sbjct: 205 TLVSG------SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 390 AAHCLSRDPKARPLMSEVVEALKPLPNLKD------MASSSYYFQTMQAERIGSSPN 440
R E+ ++PLP+ KD M S Y + +Q +G N
Sbjct: 259 EQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMGYTREEIQDSLVGQRYN 315
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 38/286 (13%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 183
A +F LG+G FG V+ ++ +A+K L L+ +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRK---------FILALKVLFKAQLEKAGVEHQLR 53
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
EV L H N+++L GY + + L+ E+ P G++ L + S I
Sbjct: 54 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 112
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A L++ H + VI+RD K N+LL + K++DFG + P +T + G
Sbjct: 113 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----G 165
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 166 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 216
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 217 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 4/110 (3%)
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 297
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347
+ V+GT Y +PE + +RSDVYS G VL E+LTG + P+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPD 225
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 37/260 (14%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-----LVKLIGYCIEDDQRLLVYEF 216
TG +AVK + G+KE + D+V + +V+ G I + + E
Sbjct: 49 TGHVIAVKQMRR---SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 217 MPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275
M G+ L +R P+P I K+ + K L +L E+ VI+RD K SNILLD
Sbjct: 106 M--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDER 161
Query: 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVV 330
KL DFG++ G D R G Y APE + T R+DV+S G+
Sbjct: 162 GQIKLCDFGIS--GRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 331 LLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 389
L+E+ TG+ + + E V P P L GH G ++
Sbjct: 219 LVELATGQFPYKNCKTDFEVLTKVLQEEP-------------PLLPGHMGFSGDFQS--F 263
Query: 390 AAHCLSRDPKARPLMSEVVE 409
CL++D + RP ++++E
Sbjct: 264 VKDCLTKDHRKRPKYNKLLE 283
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
+GEG FG V +G +P P + VA+KT + +E +L E + H
Sbjct: 18 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++VKLIG I ++ ++ E G L + L R L + + A + LA+L E
Sbjct: 72 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL--E 128
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
++R ++RD N+L+ ++ KL DFGL++ E + +++ + APE +
Sbjct: 129 SKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 186
Query: 316 GHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 46/281 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+GGF F+ I + T V G + K+L Q K + E++ L H
Sbjct: 22 FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 75
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 251
++V G+ ++D +V E R SL E H R++L P + +R +I LG +
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 130
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAP 310
LH VI+RD K N+ L+ D K+ DFGLA K +G++ V + GT Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAP 184
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL- 369
E + + DV+S G ++ +L G +P E + ++ +L ++ Y +
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKET--YLRIKKNEYSIP 235
Query: 370 --IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
I+P AA L L DP ARP ++E++
Sbjct: 236 KHINP------------VAASLIQKMLQTDPTARPTINELL 264
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 89/347 (25%), Positives = 144/347 (41%), Gaps = 58/347 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F+ E + G+G FG V G + TG++VA+K + D ++E L + L
Sbjct: 25 FQVERMAGQGTFGTVQLGK---------EKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLA 74
Query: 191 DLVHLNLVKLIGYCI---EDDQRLL----VYEFMPRG---SLENHLFRRSLPLPWSIRMK 240
L H N+V+L Y E D+R + V E++P N+ R+ P P I++
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV- 133
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFGLAK--DGPEGDKTHV 297
+ + LH + V +RD K N+L+ +AD KL DFG AK E + ++
Sbjct: 134 FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 298 STRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
+R Y APE + H T+ D++S G + EM+ G + G+ L E
Sbjct: 193 CSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIV 245
Query: 357 RPHLGERRRFYRLIDP----------------RLEGHFSIKGAQKAAQLAAHCLSRDPKA 400
R R R ++P + S+K A++A L + L P+
Sbjct: 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305
Query: 401 R---------PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSS 438
R P E+ + LPN KD+ + F + E + +
Sbjct: 306 RMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEA 352
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTR 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTGR 338
+ D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ ++ + +A+K L L
Sbjct: 6 RQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFKAQL 49
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 110 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+ + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 166 RAALC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 222 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 119/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+ + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 RXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 297
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+ V+GT Y +PE + +RSDVYS G VL E+LTG + P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 297
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+ V+GT Y +PE + +RSDVYS G VL E+LTG + P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 119/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ + + +A+K L L
Sbjct: 3 RQWALEDFEIG----RP---LGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 46
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 107 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+ + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 163 RAALC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 219 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTR 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTGR 338
+ D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 297
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+ V+GT Y +PE + +RSDVYS G VL E+LTG + P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTGR 338
+ D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 29 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 80 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 137
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 138 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTR 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGR 338
+ D++S G++ +EM+ G
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGE 214
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D ++ RP LG+G FG V+ ++ + +A+K L L
Sbjct: 6 RQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFKAQL 49
Query: 177 QG---HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 110 EQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+ + GT Y PE + + D++S GV+ E L G+ + N + +
Sbjct: 166 RDDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+E F + A L + L +P RP++ EV+E
Sbjct: 222 S------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLV 193
LG G FG V G E TG VAVK LN ++ + E+ L
Sbjct: 24 LGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H +++KL +V E++ G L +++ + L ++ G+ + H
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH 133
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
V++RD K N+LLDA NAK++DFGL+ +G+ S G+ YAAPE V
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPE-V 186
Query: 314 MTGHLTS--RSDVYSFGVVLLEMLTGRRSMDKN 344
++G L + D++S GV+L +L G D +
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 188
++ + ++G G V + AP K VA+K +N + Q E L E+
Sbjct: 16 DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLF----RRSLPLPWSIRMKI 241
+ H N+V + D+ LV + + GS+ + H+ +S L S I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVS 298
+GL +LH+ + I+RD K NILL D + +++DFG++ G + + V
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 299 TRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
+GT + APE + + G+ ++D++SFG+ +E+ TG K P L
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKA-----AQLAAHCLSRDPKARPLMSEVV 408
P P LE K K ++ + CL +DP+ RP +E++
Sbjct: 243 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 52/284 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+GGF F+ I + T V G + K+L Q K + E++ L H
Sbjct: 28 FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 81
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 251
++V G+ ++D +V E R SL E H R++L P + +R +I LG +
Sbjct: 82 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 136
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVMGTYGY 307
LH VI+RD K N+ L+ D K+ DFGLA DG E KT + GT Y
Sbjct: 137 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKT-----LCGTPNY 187
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + + DV+S G ++ +L G +P E + ++ +L ++ Y
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKET--YLRIKKNEY 238
Query: 368 RL---IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ I+P AA L L DP ARP ++E++
Sbjct: 239 SIPKHINP------------VAASLIQKMLQTDPTARPTINELL 270
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPG----TGLTVAVKTLNHDGLQ--GHKEWL 183
N+R + +G+G F A VK TG VAVK ++ L ++
Sbjct: 16 NYRLQKTIGKGNF-------------AKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
EV + L H N+VKL + LV E+ G + ++L RMK
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-------RMKEKE 115
Query: 244 GAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
AK + + H+ + +++RD K N+LLD D N K++DFG + + G+K
Sbjct: 116 ARAKFRQIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT 172
Query: 298 STRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMD 342
G+ YAAPE DV+S GV+L +++G D
Sbjct: 173 ---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 188
++ + ++G G V + AP K VA+K +N + Q E L E+
Sbjct: 11 DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLF----RRSLPLPWSIRMKI 241
+ H N+V + D+ LV + + GS+ + H+ +S L S I
Sbjct: 62 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVS 298
+GL +LH+ + I+RD K NILL D + +++DFG++ G + + V
Sbjct: 122 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 178
Query: 299 TRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
+GT + APE + + G+ ++D++SFG+ +E+ TG K P L
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 237
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAA-----QLAAHCLSRDPKARPLMSEVV 408
P P LE K K ++ + CL +DP+ RP +E++
Sbjct: 238 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 297
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+ V+GT Y +PE + +RSDVYS G VL E+LTG + P
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 65.9 bits (159), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 52/284 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+GGF F+ I + T V G + K+L Q K + E++ L H
Sbjct: 24 FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 251
++V G+ ++D +V E R SL E H R++L P + +R +I LG +
Sbjct: 78 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVMGTYGY 307
LH VI+RD K N+ L+ D K+ DFGLA DG E KT + GT Y
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKT-----LCGTPNY 183
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + + DV+S G ++ +L G +P E + ++ +L ++ Y
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKET--YLRIKKNEY 234
Query: 368 RL---IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ I+P AA L L DP ARP ++E++
Sbjct: 235 SIPKHINP------------VAASLIQKMLQTDPTARPTINELL 266
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 65.9 bits (159), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 78/313 (24%), Positives = 126/313 (40%), Gaps = 73/313 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F+ L+G GGFG VFK +G T ++ + ++ + +E V L
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIRRVKYNNEKAERE----VKAL 59
Query: 190 GDLVHLNLVKLIGYCIE---------DDQR---------------------LLVYEFMPR 219
L H+N+V G C + DD + EF +
Sbjct: 60 AKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 220 GSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
G+LE + RR L + +++ KG+ ++H + +I+RD K SNI L
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQV 175
Query: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
K+ DFGL K TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 176 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL--- 229
Query: 339 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 398
++ + A E +F+ D R +G S +K L LS+ P
Sbjct: 230 ------------HVCDTA----FETSKFF--TDLR-DGIISDIFDKKEKTLLQKLLSKKP 270
Query: 399 KARPLMSEVVEAL 411
+ RP SE++ L
Sbjct: 271 EDRPNTSEILRTL 283
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 52/284 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+GGF F+ I + T V G + K+L Q K + E++ L H
Sbjct: 24 FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 251
++V G+ ++D +V E R SL E H R++L P + +R +I LG +
Sbjct: 78 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVMGTYGY 307
LH VI+RD K N+ L+ D K+ DFGLA DG E KT + GT Y
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKT-----LCGTPNY 183
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + + DV+S G ++ +L G +P E + ++ +L ++ Y
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKET--YLRIKKNEY 234
Query: 368 RL---IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ I+P AA L L DP ARP ++E++
Sbjct: 235 SIPKHINP------------VAASLIQKMLQTDPTARPTINELL 266
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 71/250 (28%), Positives = 110/250 (44%), Gaps = 49/250 (19%)
Query: 109 ELKVASRLRKFTFND----LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
E K A+ + KF N +KL NF +LG+G FG V + GT
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVM---------LSERKGTDE 367
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG---------YCIEDDQRL-LVY 214
AVK L D + + + + +V ++ L G C + RL V
Sbjct: 368 LYAVKILKKDVV------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421
Query: 215 EFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
E++ G L H+ F+ + ++ + I GL FL + +IYRD K N
Sbjct: 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI------GLFFLQSKG---IIYRDLKLDN 472
Query: 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-VMGTYGYAAPEYVMTGHLTSRSDVYSFG 328
++LD++ + K++DFG+ K E V+T+ GT Y APE + D ++FG
Sbjct: 473 VMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529
Query: 329 VVLLEMLTGR 338
V+L EML G+
Sbjct: 530 VLLYEMLAGQ 539
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 65.1 bits (157), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 78/291 (26%), Positives = 114/291 (39%), Gaps = 25/291 (8%)
Query: 162 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VAVK ++ L ++ EV L H N+VKL + LV E+
Sbjct: 38 TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279
G + ++L R K + + H+ + +++RD K N+LLDAD N K
Sbjct: 98 GEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQ---KFIVHRDLKAENLLLDADXNIK 153
Query: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGR 338
++DFG + + G+K G YAAPE DV+S GV+L +++G
Sbjct: 154 IADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210
Query: 339 RSMDKNRPNGEHNLVEWARPHLGERRR--FYRLID-PRLEGHFSIKGAQKAAQLAAHCLS 395
D NL E L + R FY D L F I K L
Sbjct: 211 LPFDG------QNLKELRERVLRGKYRIPFYXSTDCENLLKKFLILNPSKRGTLEQIXKD 264
Query: 396 RDPKARPLMSEVVEALKPLPNLKD------MASSSYYFQTMQAERIGSSPN 440
R E+ ++PLP+ KD S Y + +Q +G N
Sbjct: 265 RWXNVGHEDDELKPYVEPLPDYKDPRRTELXVSXGYTREEIQDSLVGQRYN 315
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT-LNHDG 175
RKFT +D + RP LG+G FG V+ ++N K L V K+ L +G
Sbjct: 9 RKFTIDDFDIV----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 56
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
++ + E+ L H N++++ Y + + L+ EF PRG L L +
Sbjct: 57 VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG----- 109
Query: 236 SIRMKIALGAAKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ F+ E A ER VI+RD K N+L+ K++DFG +
Sbjct: 110 ------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163
Query: 289 GPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342
P + R M GT Y PE + + D++ GV+ E L G D
Sbjct: 164 APS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT-LNHDG 175
RKFT +D + RP LG+G FG V+ ++N K L V K+ L +G
Sbjct: 10 RKFTIDDFDIG----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 57
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
++ + E+ L H N++++ Y + + L+ EF PRG L L +
Sbjct: 58 VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG----- 110
Query: 236 SIRMKIALGAAKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ F+ E A ER VI+RD K N+L+ K++DFG +
Sbjct: 111 ------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 164
Query: 289 GPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342
P + R M GT Y PE + + D++ GV+ E L G D
Sbjct: 165 APS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT-LNHDG 175
RKFT +D + RP LG+G FG V+ ++N K L V K+ L +G
Sbjct: 9 RKFTIDDFDIG----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 56
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
++ + E+ L H N++++ Y + + L+ EF PRG L L +
Sbjct: 57 VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG----- 109
Query: 236 SIRMKIALGAAKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ F+ E A ER VI+RD K N+L+ K++DFG +
Sbjct: 110 ------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163
Query: 289 GPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342
P + R M GT Y PE + + D++ GV+ E L G D
Sbjct: 164 APS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 48/145 (33%), Positives = 68/145 (46%), Gaps = 20/145 (13%)
Query: 203 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 256
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 197
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 315
RD K N+LLD + KL+DFG E H T V GT Y +PE + +
Sbjct: 198 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQ 250
Query: 316 ---GHLTSRSDVYSFGVVLLEMLTG 337
G+ D +S GV L EML G
Sbjct: 251 GGDGYYGRECDWWSVGVFLFEMLVG 275
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 29 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 80 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 137
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+R+ K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 138 ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 191
Query: 316 GHLTSRSDVYSFGVVLLEMLTGR 338
+ D++S G++ +EM+ G
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGE 214
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 13 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 121
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG G FG V K EE T GL +A K + G++ +E E++ + L H
Sbjct: 96 ILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
NL++L + +LV E++ G L + + S L + +G+ +H
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-- 204
Query: 256 AERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
+ +++ D K NIL DA K+ DFGLA+ +K V+ GT + APE
Sbjct: 205 -QMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEV 259
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
V ++ +D++S GV+ +L+G
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG 284
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 66/233 (28%), Positives = 107/233 (45%), Gaps = 44/233 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF- 188
N + L+G G +G V+KG ++E +P VAVK + Q ++ E N
Sbjct: 14 NLKLLELIGRGRYGAVYKGSLDE------RP-----VAVKVFSFANRQN---FINEKNIY 59
Query: 189 -LGDLVHLNLVKLI--GYCIEDDQR---LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ + H N+ + I + D R LLV E+ P GSL +L + W ++A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD--WVSSCRLA 117
Query: 243 LGAAKGLAFLHEEAER-----PVI-YRDFKTSNILLDADYNAKLSDFGLA------KDGP 290
+GLA+LH E R P I +RD + N+L+ D +SDFGL+ +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS--------DVYSFGVVLLEML 335
G++ + + +GT Y APE V+ G + R D+Y+ G++ E+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT-LNHDG 175
R++T D + RP LG+G FG V+ ++ K L V KT L G
Sbjct: 7 RQWTLEDFDIG----RP---LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAG 54
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
++ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 55 VE--HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
I A L++ H + VI+RD K N+LL ++ K++DFG + P +
Sbjct: 113 RTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR- 167
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
T + GT Y PE + + D++S GV+ E L G
Sbjct: 168 ---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E T VA+K L+ D L E+ L +L H
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V+L D + LV+EF + L+ + + L I KGL F H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
R V++RD K N+L++ + KL+DFGLA+ G + + T Y P+ +
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSM 341
L S S D++S G + E+ R +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPL 202
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 10/184 (5%)
Query: 162 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VA+K ++ L ++ EV + L H N+VKL + L+ E+
Sbjct: 36 TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 95
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279
G + ++L R K + + H+ + +++RD K N+LLDAD N K
Sbjct: 96 GEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIK 151
Query: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGR 338
++DFG + + G K G+ YAAPE DV+S GV+L +++G
Sbjct: 152 IADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 208
Query: 339 RSMD 342
D
Sbjct: 209 LPFD 212
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/175 (33%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 167 AVKTLNHDGLQGHKE---WLAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 222
AVK L + KE ++E N L ++ H LV L D+ V +++ G L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282
HL R L R A A L +LH ++YRD K NILLD+ + L+D
Sbjct: 127 FYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTD 182
Query: 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
FGL K+ E + T ++ GT Y APE + D + G VL EML G
Sbjct: 183 FGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 22/241 (9%)
Query: 107 EEELKVASRLR--KFTFNDLKLATRNFRPESLLGEGGFGCVF---KGWIEENGTA-PVKP 160
E+ L V LR T + K+ NF +LG G +G VF K + G +K
Sbjct: 30 EQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 89
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPR 219
T+ K + + ++ L + LV L+ Y + + +L L+ +++
Sbjct: 90 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH------YAFQTETKLHLILDYING 143
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279
G L HL +R +++ + L LH+ +IYRD K NILLD++ +
Sbjct: 144 GELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVV 199
Query: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLT 336
L+DFGL+K+ D+T + GT Y AP+ V +GH D +S GV++ E+LT
Sbjct: 200 LTDFGLSKEFV-ADETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLT 257
Query: 337 G 337
G
Sbjct: 258 G 258
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 14 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 65 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG +G V V T VAVK ++ + + E+ L H
Sbjct: 15 LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VK G+ E + + L E+ G L + + +P P + R L A G+ +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +RD K N+LLD N K+SDFGLA ++ + ++ GT Y APE +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 315 TGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
+ DV+S G+VL ML G D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 37/231 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+F P LG GGFG VF+ + + A+K + + +E + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPNRELAREKVMREVKA 56
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL--ENHLFRRSLPLPW----------- 235
L L H +V+ +E + + P+ L + L R+ W
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 236 -SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL--AKDGPEG 292
S+ + I L A+ + FLH + +++RD K SNI D K+ DFGL A D E
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 293 DKTHVS--------TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
++T ++ T +GT Y +PE + + + D++S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 62.8 bits (151), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 10/184 (5%)
Query: 162 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219
TG VA+K ++ L ++ EV + L H N+VKL + L+ E+
Sbjct: 39 TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279
G + ++L R K + + H+ + +++RD K N+LLDAD N K
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIK 154
Query: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGR 338
++DFG + + G K G YAAPE DV+S GV+L +++G
Sbjct: 155 IADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 339 RSMD 342
D
Sbjct: 212 LPFD 215
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 62.8 bits (151), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 162 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218
TG VAVK LN ++ + E+ L H +++KL +V E++
Sbjct: 35 TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
G L +++ + R ++ + + H V++RD K N+LLDA NA
Sbjct: 95 GGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA 150
Query: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS--RSDVYSFGVVLLEMLT 336
K++DFGL+ +G+ S G+ YAAPE V++G L + D++S GV+L +L
Sbjct: 151 KIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLC 206
Query: 337 GRRSMD 342
G D
Sbjct: 207 GTLPFD 212
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 18/183 (9%)
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
P+ + + A+G+ FL + R I+RD NILL + K+ DFGLA+D +
Sbjct: 195 PITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
+ APE + +++SDV+S+GV+L E+ + S P + +
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGS---PYPGVQMD 308
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+R G R R P + Q+ C RDPK RP +E+VE L
Sbjct: 309 EDFCSRLREGMRMRAPEYSTPEI------------YQIMLDCWHRDPKERPRFAELVEKL 356
Query: 412 KPL 414
L
Sbjct: 357 GDL 359
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL-VH 194
LG G FG V ++ + K T TVAVK L +K + E+ L + H
Sbjct: 35 LGRGAFGKV----VQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHH 90
Query: 195 LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL 226
LN+V L+G C + L+V E+ G+L N+L
Sbjct: 91 LNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYL 123
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 45/110 (40%), Positives = 55/110 (50%), Gaps = 9/110 (8%)
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+P I KI L K L L E + +I+RD K SNILLD N KL DFG++ G
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLV 177
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGR 338
D TR G Y APE + RSDV+S G+ L E+ TGR
Sbjct: 178 DSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 54/304 (17%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 193
+G+G +G V++G W G +VAVK + + + W E ++
Sbjct: 16 VGKGRYGEVWRGLW------------HGESVAVKIFSS---RDEQSWFRETEIYNTVLLR 60
Query: 194 HLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
H N++ I + Q L+ + GSL + L R++L ++R+ A+ AA GL
Sbjct: 61 HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRL--AVSAACGL 118
Query: 250 AFLHEEA----ERPVI-YRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTR-VM 302
A LH E +P I +RDFK+ N+L+ ++ ++D GLA +G D + +
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178
Query: 303 GTYGYAAPEY----VMTGHLTSR--SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
GT Y APE + T S +D+++FG+VL E+ RR++ NG +VE
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI----VNG---IVEDY 229
Query: 357 RPHLGERRRFYRLI--DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
RP FY ++ DP E + + + L+ DP L + E P
Sbjct: 230 RP------PFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPN 283
Query: 415 PNLK 418
P+ +
Sbjct: 284 PSAR 287
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 62.4 bits (150), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 52/285 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+GEG FG E+G V +K +N + +E EV L ++ H
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYV---------IKEINISRMSSKEREESRREVAVLANMKH 82
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 247
N+V+ E+ +V ++ G L + LF+ L W +++ +AL
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL---- 138
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
+H+ R +++RD K+ NI L D +L DFG+A+ ++ +GT Y
Sbjct: 139 --KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELARACIGTPYY 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
+PE ++SD+++ G VL E+ T + + + NLV
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLV-------------L 235
Query: 368 RLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++I P + H+S +QL R+P+ RP ++ ++E
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQL----FKRNPRDRPSVNSILE 276
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 49 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALGAA 246
H N++ I D R E M L HL ++ L
Sbjct: 100 HENIIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 196
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 315
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 197 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 250
Query: 316 --GHLTSRSDVYSFGVVLLEMLTG 337
G+ D +S GV L EML G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + + W E
Sbjct: 4 RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 49
Query: 189 LGDLV--HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
++ H N++ I +D+ Q LV ++ GSL ++L R ++ + I K+A
Sbjct: 50 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 107
Query: 243 LGAAKGLAFLHEEAE----RPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTH 296
L A GLA LH E +P I +RD K+ NIL+ + ++D GLA + D
Sbjct: 108 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 167
Query: 297 VS-TRVMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEM 334
++ +GT Y APE + H S R+D+Y+ G+V E+
Sbjct: 168 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + + W E
Sbjct: 3 RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 48
Query: 189 LGDLV--HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
++ H N++ I +D+ Q LV ++ GSL ++L R ++ + I K+A
Sbjct: 49 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 106
Query: 243 LGAAKGLAFLHEEAE----RPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTH 296
L A GLA LH E +P I +RD K+ NIL+ + ++D GLA + D
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166
Query: 297 VS-TRVMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEM 334
++ +GT Y APE + H S R+D+Y+ G+V E+
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F L+G G +G V+KG VK TG A+K ++ G + +E E+N L
Sbjct: 26 FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 75
Query: 191 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 133
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL+ LH+ VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 134 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRT-VGRR 186
Query: 301 --VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 337
+GT + APE + +SD++S G+ +EM G
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 191
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 315
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 192 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 316 --GHLTSRSDVYSFGVVLLEMLTG 337
G+ D +S GV L EML G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVG 269
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLA 250
L H N+VK G+ E + + L E+ G L + + +P P + R L A G+
Sbjct: 61 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT Y AP
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 311 EYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDK 343
E + + DV+S G+VL ML G D+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+L++ + K+ DFGLA+ PE D T T + T
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 196
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 315
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 197 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 250
Query: 316 --GHLTSRSDVYSFGVVLLEMLTG 337
G+ D +S GV L EML G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + + W E
Sbjct: 6 RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 51
Query: 189 LGDLV--HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
++ H N++ I +D+ Q LV ++ GSL ++L R ++ + I K+A
Sbjct: 52 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 109
Query: 243 LGAAKGLAFLHEEAE----RPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTH 296
L A GLA LH E +P I +RD K+ NIL+ + ++D GLA + D
Sbjct: 110 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 169
Query: 297 VS-TRVMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEM 334
++ +GT Y APE + H S R+D+Y+ G+V E+
Sbjct: 170 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 62.0 bits (149), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+LG+G FG V K T AVK +N + L EV L L
Sbjct: 29 MLGKGSFGEVLKCK---------DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N++KL + +V E G L + + +R +I G+ ++H
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH 138
Query: 254 EEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+ +++RD K NILL++ D + K+ DFGL+ + T + R+ GT Y AP
Sbjct: 139 K---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAP 192
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTG 337
E V+ G + DV+S GV+L +L+G
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG 218
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + + W E
Sbjct: 9 RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 54
Query: 189 LGDLV--HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
++ H N++ I +D+ Q LV ++ GSL ++L R ++ + I K+A
Sbjct: 55 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 112
Query: 243 LGAAKGLAFLHEEAE----RPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTH 296
L A GLA LH E +P I +RD K+ NIL+ + ++D GLA + D
Sbjct: 113 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 172
Query: 297 VS-TRVMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEM 334
++ +GT Y APE + H S R+D+Y+ G+V E+
Sbjct: 173 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 29 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 80 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 29 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 80 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 31 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 82 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 132
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 133 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 45/231 (19%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+KL NF +LG+G FG V + GT AVK L D + +
Sbjct: 17 MKLTDFNFL--MVLGKGSFGKV---------MLSERKGTDELYAVKILKKDVV------I 59
Query: 184 AEVNFLGDLVHLNLVKLIG---------YCIEDDQRL-LVYEFMPRGSLENHL-----FR 228
+ + +V ++ L G C + RL V E++ G L H+ F+
Sbjct: 60 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 119
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ ++ + I GL FL + +IYRD K N++LD++ + K++DFG+ K
Sbjct: 120 EPHAVFYAAEIAI------GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK- 169
Query: 289 GPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
E V+T+ GT Y APE + D ++FGV+L EML G+
Sbjct: 170 --ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + + W E
Sbjct: 42 RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 87
Query: 189 LGDLV--HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
++ H N++ I +D+ Q LV ++ GSL ++L R ++ + I K+A
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 145
Query: 243 LGAAKGLAFLHEEAE----RPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTH 296
L A GLA LH E +P I +RD K+ NIL+ + ++D GLA + D
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 297 VS-TRVMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEM 334
++ +GT Y APE + H S R+D+Y+ G+V E+
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 29 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 80 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 33 SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + + W E
Sbjct: 29 RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 74
Query: 189 LGDLV--HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
++ H N++ I +D+ Q LV ++ GSL ++L R ++ + I K+A
Sbjct: 75 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 132
Query: 243 LGAAKGLAFLHEEAE----RPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTH 296
L A GLA LH E +P I +RD K+ NIL+ + ++D GLA + D
Sbjct: 133 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 192
Query: 297 VS-TRVMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEM 334
++ +GT Y APE + H S R+D+Y+ G+V E+
Sbjct: 193 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 31 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 81
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 82 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 132
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 133 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDL 192
+LG+G FG V K T AVK +N + L EV L L
Sbjct: 28 CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++KL + +V E G L + + +R +I G+ ++
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM 137
Query: 253 HEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
H+ +++RD K NILL++ D + K+ DFGL+ + T + R+ GT Y A
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIA 191
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE V+ G + DV+S GV+L +L+G
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 49 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 150
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 151 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 33 SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 130 NFRPESLLGEGGFGCVFKG---------WIEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 177
+F ++LG+G FG V K I++ K T L+ + + +LNH ++
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+ WL NF VK + + + E+ G+L + + +L
Sbjct: 67 YYAAWLERRNF---------VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------DGPE 291
++ + L+++H + +I+RD K NI +D N K+ DFGLAK D +
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 292 GDKTHVS------TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 335
D ++ T +GT Y A E + TGH + D+YS G++ EM+
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 29 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 80 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDL 192
+LG+G FG V K T AVK +N + L EV L L
Sbjct: 28 CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++KL + +V E G L + + +R +I G+ ++
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM 137
Query: 253 HEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
H+ +++RD K NILL++ D + K+ DFGL+ + T + R+ GT Y A
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIA 191
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE V+ G + DV+S GV+L +L+G
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 162 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218
TG VAVK LN ++ + E+ L H +++KL +V E++
Sbjct: 35 TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
G L +++ + R ++ + + H V++RD K N+LLDA NA
Sbjct: 95 GGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA 150
Query: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS--RSDVYSFGVVLLEMLT 336
K++DFGL+ +G+ S G+ YAAPE V++G L + D++S GV+L +L
Sbjct: 151 KIADFGLSNMMSDGEFLRDSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLC 206
Query: 337 GRRSMD 342
G D
Sbjct: 207 GTLPFD 212
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 31 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 82 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 132
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 133 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 34 SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 85 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 135
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 136 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 35 SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 85
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 86 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 136
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 137 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 26 SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 76
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 77 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 127
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 128 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 33 SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA- 184
+AT + P + +G G +G V+K P +G VA+K++ G L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPI 56
Query: 185 ----EVNFLGDLV---HLNLVKLIGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP 232
EV L L H N+V+L+ C D+ + LV+E + + L +L + P
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP 115
Query: 233 -LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
LP + +GL FLH +++RD K NIL+ + KL+DFGLA+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI--- 169
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
T V+ T Y APE ++ + D++S G + EM
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ +F+ +SLLGEG +G V +A KP TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM------- 239
L H N++ + QR +E + L + L S +M
Sbjct: 61 KILKHFKHENIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHV 297
+ + LH VI+RD K SN+L++++ + K+ DFGLA+ D D +
Sbjct: 116 YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 298 S------TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T + T Y APE ++T SR+ DV+S G +L E+ R
Sbjct: 173 TGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 133 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 130 NFRPESLLGEGGFG----CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
N+ P+ +LG G C+ K +E + G + + + + + + L E
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 186 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
V+ L + H N+++L + LV++ M +G L ++L + + L KI
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRA 132
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ + LH+ +++RD K NILLD D N KL+DFG + G+K V GT
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGT 186
Query: 305 YGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTG 337
Y APE + D++S GV++ +L G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 133 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 37 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 88 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 138
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 139 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 193
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLV 193
S +GEG +G V + N + VA+K ++ Q + + L E+ L
Sbjct: 29 SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 194 HLNLVKLIG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
H N++ + Y ++D +Y+ + L N L
Sbjct: 80 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVST 299
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 300 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++S D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ +F+ +SLLGEG +G V +A KP TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM------- 239
L H N++ + QR +E + L + L S +M
Sbjct: 61 KILKHFKHENIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHV 297
+ + LH VI+RD K SN+L++++ + K+ DFGLA+ D D +
Sbjct: 116 YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 298 S------TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T + T Y APE ++T SR+ DV+S G +L E+ R
Sbjct: 173 TGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 52/293 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQG E+ + L H
Sbjct: 27 VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 196 NLVKLIGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + +D+ L LV +++P + H R LP I +K+ +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE + LG
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VLGT 241
Query: 363 RRR---------FYRLIDPRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R + P+++ H F + +A L + L P AR
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 130 NFRPESLLGEGGFG----CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
N+ P+ +LG G C+ K +E + G + + + + + + L E
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 186 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
V+ L + H N+++L + LV++ M +G L ++L + + L KI
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRA 132
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ + LH+ +++RD K NILLD D N KL+DFG + G+K V GT
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGT 186
Query: 305 YGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTG 337
Y APE + D++S GV++ +L G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 23/222 (10%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT-LNHDG 175
R++T D + RP LG+G FG V+ ++ K L V KT L G
Sbjct: 7 RQWTLEDFDIG----RP---LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAG 54
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
++ + EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 55 VE--HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
I A L++ H + VI+RD K N+LL ++ K++DFG + P +
Sbjct: 113 RTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD 168
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT Y PE + + D++S GV+ E L G
Sbjct: 169 TLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
F + + + ++ + +LG+G FG V TG AVK ++ ++
Sbjct: 22 FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 72
Query: 179 HKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
+ L EV L L H N++KL + + LV E G L + + R
Sbjct: 73 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSE 131
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEG 292
+I G+ ++H+ +++RD K N+LL++ D N ++ DFGL+
Sbjct: 132 VDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 188
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
K +GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 189 KKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 78/296 (26%), Positives = 120/296 (40%), Gaps = 44/296 (14%)
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
T +DL + R LG G FG V +EE + GL +KT+N D Q
Sbjct: 19 TIDDLFIFKRK------LGSGAFGDV--HLVEERSS-------GLERVIKTINKDRSQVP 63
Query: 180 KEWL-AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPW 235
E + AE+ L L H N++K+ + +V E G L + R L
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDGPEG 292
++ LA+ H + V+++D K NIL D ++ K+ DFGLA+
Sbjct: 124 GYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ ST GT Y APE V +T + D++S GVV+ +LTG
Sbjct: 181 EH---STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ P+ R + P +A L L++DP+ RP ++V+
Sbjct: 237 ATYKEPNYAVE---CRPLTP------------QAVDLLKQMLTKDPERRPSAAQVL 277
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 130 NFRPESLLGEGGFG----CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
N+ P+ +LG G C+ K +E + G + + + + + + L E
Sbjct: 5 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 60
Query: 186 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
V+ L + H N+++L + LV++ M +G L ++L + + L KI
Sbjct: 61 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRA 119
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ + LH+ +++RD K NILLD D N KL+DFG + G+K V GT
Sbjct: 120 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGT 173
Query: 305 YGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTG 337
Y APE + D++S GV++ +L G
Sbjct: 174 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 49/237 (20%)
Query: 130 NFRPESLLGEGGFGCVFKG---------WIEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 177
+F ++LG+G FG V K I++ K T L+ + + +LNH ++
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRRSL 231
+ WL NF+ + + + +E + +Y+ + +L LFR+ L
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---- 287
+ L+++H + +I+RD K NI +D N K+ DFGLAK
Sbjct: 127 ---------------EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 288 --DGPEGDKTHVS------TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 335
D + D ++ T +GT Y A E + TGH + D+YS G++ EM+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQG E+ + L H
Sbjct: 27 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 196 NLVKLIGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + +D+ L LV +++P + H R LP I +K+ +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 183
+AT + P + +G G +G V+K P +G VA+K++ +G +G +
Sbjct: 1 MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 184 AEVNFLGDLV---HLNLVKLIGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP-LP 234
EV L L H N+V+L+ C D+ + LV+E + + L +L + P LP
Sbjct: 52 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ +GL FLH +++RD K NIL+ + KL+DFGLA+
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSY 164
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
V+ T Y APE ++ + D++S G + EM
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E T VA+K L+ D L E+ L +L H
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V+L D + LV+EF + L+ + + L I KGL F H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
R V++RD K N+L++ + KL++FGLA+ G + + T Y P+ +
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTGRRSM 341
L S S D++S G + E+ R +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LG+GGF ++ I + T V G + ++ H KE ++ E+ L +
Sbjct: 49 FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 250
++V G+ +DD +V E R SL E H R+++ P + +R I +G+
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVMGTYG 306
+LH VI+RD K N+ L+ D + K+ DFGLA DG E KT + GT
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG-ERKKT-----LCGTPN 207
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE + + D++S G +L +L G+
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 181
A + + + +GEG +G VFK +NG G VA+K + G +G
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPW 235
+A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
T V+ T Y APE ++ + D++S G + EM
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 42/228 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLV 193
LG+G +G V+K + TG VAVK + D Q + E+ L +L
Sbjct: 17 LGKGAYGIVWKS---------IDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 194 -HLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H N+V L+ D+ R LV+++M + H R+ L + + K +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-----------------DGPEG- 292
+LH +++RD K SNILL+A+ + K++DFGL++ + E
Sbjct: 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 293 -DKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
D + T + T Y APE ++ + T D++S G +L E+L G+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 63 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 109
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLF 168
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 223
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 224 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 278
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 279 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 330
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV 193
LGEG FG V T VA+K ++ L+ H E+++L L
Sbjct: 17 LGEGSFGKV---------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H +++KL ++V E+ G L +++ + R + + + H
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH 125
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+++RD K N+LLD + N K++DFGL+ +G+ S G+ YAAPE V
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-V 178
Query: 314 MTGHLTS--RSDVYSFGVVLLEMLTGRRSMD 342
+ G L + DV+S G+VL ML GR D
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVF--KGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
F + + + ++ + +LG+G FG V K I TG AVK ++ +
Sbjct: 39 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-----------TGQECAVKVISKRQV 87
Query: 177 QGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + L EV L L H N++KL + + LV E G L + + R
Sbjct: 88 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RF 146
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGP 290
+I G+ ++H+ +++RD K N+LL++ D N ++ DFGL+
Sbjct: 147 SEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 203
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
K +GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 204 ASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 65 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 111
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLF 170
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 226 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 280
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 281 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 332
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 183
+AT + P + +G G +G V+K P +G VA+K++ +G +G +
Sbjct: 1 MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 184 AEVNFLGDLV---HLNLVKLIGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP-LP 234
EV L L H N+V+L+ C D+ + LV+E + + L +L + P LP
Sbjct: 52 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ +GL FLH +++RD K NIL+ + KL+DFGLA+
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSY 164
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
V+ T Y APE ++ + D++S G + EM
Sbjct: 165 QMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 48/291 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQG E+ + L H
Sbjct: 27 VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 196 NLVKLIGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + +D+ L LV +++P + H R LP I +K+ +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + LG
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VLGTPT 243
Query: 365 R---------FYRLIDPRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R + P+++ H F + +A L + L P AR
Sbjct: 244 REQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVF--KGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
F + + + ++ + +LG+G FG V K I TG AVK ++ +
Sbjct: 40 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-----------TGQECAVKVISKRQV 88
Query: 177 QGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + L EV L L H N++KL + + LV E G L + + R
Sbjct: 89 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RF 147
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGP 290
+I G+ ++H+ +++RD K N+LL++ D N ++ DFGL+
Sbjct: 148 SEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 204
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
K +GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 205 ASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 61 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLF 166
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 276
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 106 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 152
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLF 211
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 266
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 267 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 321
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 322 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 373
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 181
A + + + +GEG +G VFK +NG G VA+K + G +G
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPW 235
+A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
T V+ T Y APE ++ + D++S G + EM
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LG+GGF ++ I + T V G + ++ H KE ++ E+ L +
Sbjct: 49 FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 250
++V G+ +DD +V E R SL E H R+++ P + +R I +G+
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAA 309
+LH VI+RD K N+ L+ D + K+ DFGLA K +G++ + GT Y A
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIA 210
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
PE + + D++S G +L +L G+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVN 187
++ + +LG+G FG V TG AVK ++ ++ + L EV
Sbjct: 28 YKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L L H N++KL + + LV E G L + + R +I
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLS 137
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
G+ ++H+ +++RD K N+LL++ D N ++ DFGL+ K +GT
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 191
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y APE V+ G + DV+S GV+L +L+G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 55 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 101
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 160
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 215
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 216 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 270
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 271 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 322
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 181
A + + + +GEG +G VFK +NG G VA+K + G +G
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPW 235
+A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
T V+ T Y APE ++ + D++S G + EM
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LG+GGF ++ I + T V G + ++ H KE ++ E+ L +
Sbjct: 49 FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 250
++V G+ +DD +V E R SL E H R+++ P + +R I +G+
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAA 309
+LH VI+RD K N+ L+ D + K+ DFGLA K +G++ + GT Y A
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIA 210
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
PE + + D++S G +L +L G+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HDGLQ-GHK 180
+AT + P + +G G +G V+K P +G VA+K++ +GL
Sbjct: 1 MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP-LP 234
+A + L H N+V+L+ C D+ + LV+E + + L +L + P LP
Sbjct: 52 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ +GL FLH +++RD K NIL+ + KL+DFGLA+
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSY 164
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
V+ T Y APE ++ + D++S G + EM
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 61 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLF 166
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 220
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 278
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 30 QNLSP---IGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 78 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 135
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 136 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 192 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 32 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 78
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 79 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 137
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 193 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 247
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 248 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 40 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 86
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 87 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 145
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 200
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 201 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 255
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 256 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 307
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 59.7 bits (143), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 32 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 138 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ +F+ +SLLGEG +G V +A KP TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM------- 239
L H N++ + QR +E + L + L S +M
Sbjct: 61 KILKHFKHENIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHV 297
+ + LH VI+RD K SN+L++++ + K+ DFGLA+ D D +
Sbjct: 116 YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 298 S------TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ + T Y APE ++T SR+ DV+S G +L E+ R
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 39 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 86 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 144
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 198
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 256
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 257 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 159 KPGTGLTVAVKTLNHDGL-QGHKEWL-AEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VY 214
+ G + K L++ + + K+ L +EVN L +L H N+V+ I+ L V
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 215 EFMPRGSLENHLF-----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
E+ G L + + R+ L + +R+ L A + V++RD K +N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 329
+ LD N KL DFGLA+ T + +GT Y +PE + +SD++S G
Sbjct: 147 VFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204
Query: 330 VLLEM 334
+L E+
Sbjct: 205 LLYEL 209
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 36 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 84 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 141
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 142 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 197
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 198 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 32 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 138 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 35 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 81
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 82 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 140
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 194
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 252
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 253 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 302
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LG+GGF ++ I + T V G + ++ H KE ++ E+ L +
Sbjct: 33 FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 85
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 250
++V G+ +DD +V E R SL E H R+++ P + +R I +G+
Sbjct: 86 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 140
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAA 309
+LH VI+RD K N+ L+ D + K+ DFGLA K +G++ + GT Y A
Sbjct: 141 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIA 194
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
PE + + D++S G +L +L G+
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 223
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 30 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 78 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 135
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 136 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 192 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 32 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 138 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 193
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 27 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 75 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 132
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 133 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 189 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T + T
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 32 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 138 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T + T
Sbjct: 140 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ ++S D++S G +L EML+ R
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 31 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 79 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 136
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 137 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 193 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 27 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 75 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 132
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 133 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 189 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 30 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 78 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 135
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 136 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 191
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 192 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 24 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 71
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 72 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 129
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 130 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 185
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 186 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 44 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 92 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 149
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 150 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 205
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 206 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 36 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 84 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 141
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 142 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 197
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 198 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 27 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 196 NLVKLIGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + +D+ L LV +++P + H R LP I +K+ +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK--THVSTRVMG 303
+ LA++H + +RD K N+LLD D KL DFG AK G+ +++ +R
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Y APE + TS DV+S G VL E+L G+ + +G LVE +
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 363 RRRFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R R ++ P+++ H F + +A L + L P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 159 KPGTGLTVAVKTLNHDGL-QGHKEWL-AEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VY 214
+ G + K L++ + + K+ L +EVN L +L H N+V+ I+ L V
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 215 EFMPRGSLENHLF-----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
E+ G L + + R+ L + +R+ L A + V++RD K +N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 329
+ LD N KL DFGLA+ T + +GT Y +PE + +SD++S G
Sbjct: 147 VFLDGKQNVKLGDFGLAR--ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204
Query: 330 VLLEM 334
+L E+
Sbjct: 205 LLYEL 209
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 37 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 85 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 142
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 143 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 199 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 46 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 92
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 93 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 151
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 205
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 263
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 264 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 313
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 45 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 93 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 150
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 151 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 207 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 27 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 75 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 132
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 133 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 189 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 37 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 85 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 142
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 143 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 199 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 39 VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 86 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 144
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 198
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 256
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 257 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 59.3 bits (142), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 31 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 79 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 136
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 137 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 193 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 27 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 74 NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 244
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 48 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 96 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 153
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 154 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 209
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 210 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 31 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 79 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 136
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 137 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 192
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 193 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDL 192
+GEG +G V+K + G T A+K + +G+ + E++ L +L
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H+ R V++RD K N+L++ + K++DFGLA+ G T + T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDV 171
Query: 313 VM-TGHLTSRSDVYSFGVVLLEMLTG 337
+M + ++ D++S G + EM+ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 37 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL 84
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 85 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 142
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 143 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 199 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 27 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 196 NLVKLIGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + +D+ L LV +++P + H R LP I +K+ +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 244
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 27 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 75 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 132
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 133 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 188
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 189 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 27 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 196 NLVKLIGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + +D+ L LV +++P + H R LP I +K+ +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 186
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 244
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDL 192
+GEG +G V+K + G T A+K + +G+ + E++ L +L
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H+ R V++RD K N+L++ + K++DFGLA+ G T + T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDV 171
Query: 313 VM-TGHLTSRSDVYSFGVVLLEMLTG 337
+M + ++ D++S G + EM+ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 30 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 78 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 135
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 136 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 191
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 192 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 48 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 96 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 153
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 154 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR 209
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 210 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 28 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 74
Query: 196 NLVKLIGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + +D+ L LV +++P + H R LP I +K+ +
Sbjct: 75 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 133
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 187
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 245
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 246 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 295
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 22 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 70 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 127
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 128 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 183
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 184 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 21 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 126
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 127 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 23 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 70
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 71 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 128
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 129 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 184
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 185 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDL 192
+GEG +G V+K + G T A+K + +G+ + E++ L +L
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H+ R V++RD K N+L++ + K++DFGLA+ G T + T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDV 171
Query: 313 VM-TGHLTSRSDVYSFGVVLLEMLTG 337
+M + ++ D++S G + EM+ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG V++ + ++G VA+K + LQ + E+ + L H
Sbjct: 31 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 77
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 246
N+V+L + ++ LV +++P + H R LP I +K+ +
Sbjct: 78 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 136
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ LA++H + +RD K N+LLD D KL DFG AK G+ + + +
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSR 190
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
Y APE + TS DV+S G VL E+L G+ + +G LVE + R
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 248
Query: 365 RFYRLID--------PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKAR 401
R ++ P+++ H F + +A L + L P AR
Sbjct: 249 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 58.9 bits (141), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 22 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 70 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 127
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 128 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 183
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 184 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + V+KG T VA+K + + +G + EV+ L DL H
Sbjct: 10 LGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V L + LV+E++ + L+ +L + +GLA+ H +
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 314
V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 120 K---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLG 174
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGR 338
+ +++ D++ G + EM TGR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 38 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 88
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL +C +DD++L + G L ++ R+ +
Sbjct: 89 DVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 146
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 147 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R FT +D ++ RP LG+G FG V+ + + VA+K L +
Sbjct: 18 RHFTIDDFEIG----RP---LGKGKFGNVYLAR---------EKKSHFIVALKVLFKSQI 61
Query: 177 QGH---KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ + E+ L H N+++L Y + + L+ E+ PRG L L ++S
Sbjct: 62 EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL-QKSCTF 120
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
I A L + H + VI+RD K N+LL K++DFG + P
Sbjct: 121 DEQRTATIMEELADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR 177
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ + GT Y PE + + D++ GV+ E+L G
Sbjct: 178 RKTMC----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 131 FRPESLLGEGGFGCVF--KGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 185
++ + +LG+G FG V K I TG AVK ++ ++ + L E
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKI-----------TGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
V L L H N+ KL + + LV E G L + + R +I
Sbjct: 77 VQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQV 135
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
G+ + H+ +++RD K N+LL++ D N ++ DFGL+ K +
Sbjct: 136 LSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---I 189
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGL + + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 23/212 (10%)
Query: 137 LGEGGFG----CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
LG G +G C K E +K N + + H+E E++ L L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++KL + LV EF G L + R I G+ +L
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL 162
Query: 253 HEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGL----AKDGPEGDKTHVSTRVMGTY 305
H + +++RD K NILL+ N K+ DFGL +KD D+ +GT
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR-------LGTA 212
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y APE V+ + DV+S GV++ +L G
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ D+GLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 159 KPGTGLTVAVKTLNHDGL-QGHKEWL-AEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VY 214
+ G + K L++ + + K+ L +EVN L +L H N+V+ I+ L V
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 215 EFMPRGSLENHLF-----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
E+ G L + + R+ L + +R+ L A + V++RD K +N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 329
+ LD N KL DFGLA+ + + +GT Y +PE + +SD++S G
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204
Query: 330 VLLEM 334
+L E+
Sbjct: 205 LLYEL 209
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV-- 186
+ + P+ ++G G V + V TG AVK + + E L EV
Sbjct: 94 QKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 187 ------NFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ L + H +++ LI LV++ M +G L ++L + + L
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETR 203
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
I + ++FLH +++RD K NILLD + +LSDFG + G+K
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR--- 257
Query: 300 RVMGTYGYAAPEYVMTGHLTS------RSDVYSFGVVLLEMLTG 337
+ GT GY APE + + D+++ GV+L +L G
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 188
++ S +G G +G V + VK +GL +AVK L+ + K E+
Sbjct: 53 YQTLSPVGSGAYGSVCSSY-------DVK--SGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 189 LGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L + H N++ L+ E + LV M G+ N++ + ++ I
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI- 160
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 161 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-- 215
Query: 303 GTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 216 ---WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 42/239 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 187
N+ + L+G G +G V+ + T VA+K +N + L K L E+
Sbjct: 27 NYIIKHLIGRGSYGYVYLAY---------DKNTEKNVAIKKVNRMFEDLIDCKRILREIT 77
Query: 188 FLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L L +++L I DD L + + L+ LF+ + L I
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTPIFLTEEHIKTILY 136
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--------------- 288
G F+HE +I+RD K +N LL+ D + K+ DFGLA+
Sbjct: 137 NLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 289 ----GPEGD--KTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRS 340
GP K +++ V+ T Y APE ++ ++S D++S G + E+L +S
Sbjct: 194 NEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 21/228 (9%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
R +F N + N+ + LG+G F V + V TGL A K +N
Sbjct: 15 RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTK 65
Query: 175 GLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
L ++ E L H N+V+L E+ LV++ + G L + R
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDG 289
I + +A+ H +++R+ K N+LL + KL+DFGLA +
Sbjct: 126 SEADASHCIQ-QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ + H GT GY +PE + + D+++ GV+L +L G
Sbjct: 182 NDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 26/182 (14%)
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+P I KIA+ K L LH + VI+RD K SN+L++A K+ DFG++ G
Sbjct: 150 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS--GYLV 205
Query: 293 DKTHVSTRVMGTYGYAAPEYV-----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347
D T G Y APE + G+ + +SD++S G+ ++E+ R D
Sbjct: 206 DSV-AKTIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD----- 258
Query: 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
W P + ++ P+L K + + + CL ++ K RP E+
Sbjct: 259 ------SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPEL 308
Query: 408 VE 409
++
Sbjct: 309 MQ 310
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 31 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 79 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 136
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 137 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 193 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 21 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + + ++
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFL 126
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 127 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 44 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 92 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 149
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 150 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 205
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 206 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK + TG VA+K + D K L E+ L L H
Sbjct: 11 IGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
NLV L+ + LV+E+ L + L R +P + I + + F H+
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVL-HELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEY 312
I+RD K NIL+ KL DFG A+ GP + + T Y +PE
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDDEVATRWYRSPEL 173
Query: 313 VM-TGHLTSRSDVYSFGVVLLEMLTG 337
++ DV++ G V E+L+G
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSG 199
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 45 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 93 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 150
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 151 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 207 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 33/76 (43%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 321
+RD K NIL+ AD A L DFG+A + T + V GT Y APE H T R
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 322 SDVYSFGVVLLEMLTG 337
+D+Y+ VL E LTG
Sbjct: 216 ADIYALTCVLYECLTG 231
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 146 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 197
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 21 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 126
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 127 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 32/185 (17%)
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL------- 285
+P I KIA+ K L LH ++ VI+RD K SN+L++A K+ DFG+
Sbjct: 106 IPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163
Query: 286 -AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
AKD G K +++ + PE G+ + +SD++S G+ ++E+ R D
Sbjct: 164 VAKDIDAGCKPYMAPERIN------PELNQKGY-SVKSDIWSLGITMIELAILRFPYD-- 214
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404
W P + ++ P+L K + + + CL ++ K RP
Sbjct: 215 ---------SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTY 261
Query: 405 SEVVE 409
E+++
Sbjct: 262 PELMQ 266
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
KGL ++H V++RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 206
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE +++ H D++S G ++ EMLTG+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ FGLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
KGL ++H V++RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 188
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE +++ H D++S G ++ EMLTG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ D GLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 45/249 (18%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 187
N+ + L+G G +G V+ + ++N VA+K +N + L K L E+
Sbjct: 29 NYEIKHLIGRGSYGYVYLAY-DKNANK--------NVAIKKVNRMFEDLIDCKRILREIT 79
Query: 188 FLGDLVHLNLVKLIGYCI-ED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L +++L I ED D+ +V E S LF+ + L I
Sbjct: 80 ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEQHVKTIL 137
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS---- 298
G F+HE +I+RD K +N LL+ D + K+ DFGLA+ H+
Sbjct: 138 YNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 299 -------------------TRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
T + T Y APE ++ + T+ D++S G + E+L
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMM 254
Query: 339 RSMDKNRPN 347
+S N N
Sbjct: 255 KSHINNPTN 263
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 18/181 (9%)
Query: 166 VAVKTLNH--DGLQGHKEWLAEVNFLGDLVHLNLVKLI-----GYCIEDDQRLLVYEFMP 218
VAVK L+ L + E+ L L H N++ L+ IED + + +
Sbjct: 56 VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
L N +S L + +GL ++H +I+RD K SN+ ++ D
Sbjct: 116 GADLNN--IVKSQALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSEL 170
Query: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 337
++ DFGLA+ E +V+TR Y APE ++ H D++S G ++ E+L G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 338 R 338
+
Sbjct: 226 K 226
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 55.8 bits (133), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ E +V+TR
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----W 185
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+L G+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ D GLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 55.5 bits (132), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ E +V+TR
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----W 193
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+L G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+ AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+ APE + T +SDV+SFGV+L E+ + S P + + R G
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEG 317
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
R R P + Q C +P RP SE+VE L
Sbjct: 318 TRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 355
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+ AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+ APE + T +SDV+SFGV+L E+ + S P + + R G
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEG 310
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
R R P + Q C +P RP SE+VE L
Sbjct: 311 TRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 348
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 45 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 93 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 150
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + V+TR
Sbjct: 151 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR 206
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 207 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+ AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+ APE + T +SDV+SFGV+L E+ + S P + + R G
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEG 319
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
R R P + Q C +P RP SE+VE L
Sbjct: 320 TRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 357
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+ AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+ APE + T +SDV+SFGV+L E+ + S P + + R G
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEG 312
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
R R P + Q C +P RP SE+VE L
Sbjct: 313 TRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHL 350
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 33 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 84 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTAEI 141
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + + SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TGL VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ D GLA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + V+TR
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----W 183
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 10 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 60
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 61 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 118
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 119 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAE 185
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 4 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 54
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H N+V+L E+ LV++ + G L + R I
Sbjct: 55 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVM 302
+ +A+ H +++R+ K N+LL + KL+DFGLA + + + H
Sbjct: 114 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 167
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT GY +PE + + D+++ GV+L +L G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVH 194
+G G +G V ++ + TG VA+K + + D + K L E+ L H
Sbjct: 63 IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 113
Query: 195 LNLVKL-------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
N++ + + Y E +V + M S + + S PL +
Sbjct: 114 DNIIAIKDILRPTVPYG-EFKSVYVVLDLM--ESDLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTY 305
GL ++H VI+RD K SN+L++ + K+ DFG+A+ + + T + T
Sbjct: 171 GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 306 GYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRR 339
Y APE +++ H T D++S G + EML R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAE 185
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H N+V+L E+ LV++ + G L + R I
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVM 302
+ +A+ H +++R+ K N+LL + KL+DFGLA + + + H
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT GY +PE + + D+++ GV+L +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAE 185
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H N+V+L E+ LV++ + G L + R I
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVM 302
+ +A+ H +++R+ K N+LL + KL+DFGLA + + + H
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT GY +PE + + D+++ GV+L +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 9 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 60 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 117
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 11 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 61
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 62 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 119
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 120 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 8 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 59 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 117 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVH 194
+G G +G V ++ + TG VA+K + + D + K L E+ L H
Sbjct: 62 IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 112
Query: 195 LNLVKL-------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
N++ + + Y E +V + M S + + S PL +
Sbjct: 113 DNIIAIKDILRPTVPYG-EFKSVYVVLDLM--ESDLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTY 305
GL ++H VI+RD K SN+L++ + K+ DFG+A+ + + T + T
Sbjct: 170 GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 306 GYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRR 339
Y APE +++ H T D++S G + EML R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 34 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 85 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 142
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 34/285 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G F +FKG E G T V +K L+ + + + + L H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV G C+ D+ +LV EF+ GSL+ +L + + ++++A A + FL E
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVM 314
+I+ + NILL + + K + K G V + + + PE +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 315 T-GHLTSRSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
+L +D +SFG L E+ +G ++D R + E R ++L
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----------KLQFYEDR--HQL 237
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
P+ A + A L +C+ +P RP ++ L L
Sbjct: 238 PAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 189
F + LG G F V EE T G AVK + L+G + + E+ L
Sbjct: 24 FEFKETLGTGAFSEVVLA--EEKAT-------GKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAK 247
+ H N+V L + LV + + G L + + + S ++ L A
Sbjct: 75 RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA-- 132
Query: 248 GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ +LH +++RD K N+L D + +SDFGL+K +GD V + GT
Sbjct: 133 -VYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGT 185
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GY APE + + D +S GV+ +L G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 34 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 85 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 142
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 33 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 84 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 85/317 (26%), Positives = 128/317 (40%), Gaps = 73/317 (23%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+ R+ +G+G +G V++G W EN VAVK + + K W
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 184 AEVNFLGDLVHLNLVKLIGYCIED-------DQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
E L + V L ++G+ D Q L+ + GSL ++L +L
Sbjct: 49 RETE-LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC 107
Query: 237 IRMKIALGAAKGLAFLHEEA----ERPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGP 290
+R I L A GLA LH E +P I +RD K+ NIL+ + ++D GLA
Sbjct: 108 LR--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 291 EGDKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEMLTGRRSMDK 343
++ V +GT Y APE + S R D+++FG+VL E+ RR +
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV-- 221
Query: 344 NRPNGEHNLVEWARPHLGERRRFYRLI--DPRLEGH-----------------FSIKGAQ 384
NG +VE +P FY ++ DP E FS
Sbjct: 222 --SNG---IVEDYKPP------FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLT 270
Query: 385 KAAQLAAHCLSRDPKAR 401
A+L C ++P AR
Sbjct: 271 SLAKLMKECWYQNPSAR 287
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 31 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 82 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 139
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 33 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 84 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 28/223 (12%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--- 179
+++ R+ +P +G G +G V + V TG VA+K L + Q
Sbjct: 22 EVRAVYRDLQP---VGSGAYGAV---------CSAVDGRTGAKVAIKKL-YRPFQSELFA 68
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIED---DQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
K E+ L + H N++ L+ D D Y MP + + L
Sbjct: 69 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
+ KGL ++H +I+RD K N+ ++ D K+ DFGLA+
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGX 185
Query: 297 VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
V TR Y APE ++ T D++S G ++ EM+TG+
Sbjct: 186 VVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 15 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 65
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 66 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 124 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 31 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 82 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 139
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 33 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 84 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 33 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 84 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 36 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 86
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 87 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 144
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 145 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 31 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 82 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 139
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
++ AT R LG G FG V + +E+ T G AVK + + +
Sbjct: 90 EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 134
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
E+ L +V L G E + E + GSL L + LP +
Sbjct: 135 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY 190
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG----LAKDGPEGDKTH 296
A +GL +LH R +++ D K N+LL +D +A L DFG L DG G
Sbjct: 191 LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKSLL 246
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT + APE V+ ++ DV+S ++L ML G
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 85/317 (26%), Positives = 127/317 (40%), Gaps = 73/317 (23%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+ R +G+G +G V++G W EN VAVK + + K W
Sbjct: 33 RTVARQITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 77
Query: 184 AEVNFLGDLVHLNLVKLIGYCIED-------DQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
E L + V L ++G+ D Q L+ + GSL ++L +L
Sbjct: 78 RETE-LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC 136
Query: 237 IRMKIALGAAKGLAFLHEEA----ERPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGP 290
+R I L A GLA LH E +P I +RD K+ NIL+ + ++D GLA
Sbjct: 137 LR--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 194
Query: 291 EGDKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEMLTGRRSMDK 343
++ V +GT Y APE + S R D+++FG+VL E+ RR +
Sbjct: 195 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV-- 250
Query: 344 NRPNGEHNLVEWARPHLGERRRFYRLI--DPRLEGH-----------------FSIKGAQ 384
NG +VE +P FY ++ DP E FS
Sbjct: 251 --SNG---IVEDYKPP------FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLT 299
Query: 385 KAAQLAAHCLSRDPKAR 401
A+L C ++P AR
Sbjct: 300 SLAKLMKECWYQNPSAR 316
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 33 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 84 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 30 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 81 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 138
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGT 304
L +LH + +I+RD K NILL+ D + +++DFG AK PE + ++ V GT
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GT 194
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMK 240
L EV L L H N++KL + + LV E G L + + R + ++ MK
Sbjct: 69 LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHV 297
L G +LH+ +++RD K N+LL++ D K+ DFGL+ G K
Sbjct: 129 QVLS---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK- 181
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+GT Y APE V+ + DV+S GV+L +L G
Sbjct: 182 --ERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 186
+F+ +LGEG F V + T A+K L H + ++ E
Sbjct: 30 DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 81 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 138
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y +PE + SD+++ G ++ +++ G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMK 240
L EV L L H N++KL + + LV E G L + + R + ++ MK
Sbjct: 52 LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHV 297
L G +LH+ +++RD K N+LL++ D K+ DFGL+ G K
Sbjct: 112 QVLS---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK- 164
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+GT Y APE V+ + DV+S GV+L +L G
Sbjct: 165 --ERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 6/154 (3%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + L H VKL + +DD++L + G L ++ R+ +
Sbjct: 80 ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA 137
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
L +LH + +I+RD K NILL+ D + +++DFG AK K + +G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
T Y +PE + SD+++ G ++ +++ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 84/305 (27%), Positives = 125/305 (40%), Gaps = 73/305 (23%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G+G +G V++G W EN VAVK + + K W E L + V L
Sbjct: 16 VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETE-LYNTVML 59
Query: 196 NLVKLIGYCIED-------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
++G+ D Q L+ + GSL ++L +L +R I L A G
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASG 117
Query: 249 LAFLHEEA----ERPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTR-V 301
LA LH E +P I +RD K+ NIL+ + ++D GLA ++ V
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 302 MGTYGYAAPEY----VMTGHLTS--RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
+GT Y APE + S R D+++FG+VL E+ RR + NG +VE
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVS----NG---IVED 228
Query: 356 ARPHLGERRRFYRLI--DPRLEGH-----------------FSIKGAQKAAQLAAHCLSR 396
+P FY ++ DP E FS A+L C +
Sbjct: 229 YKPP------FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282
Query: 397 DPKAR 401
+P AR
Sbjct: 283 NPSAR 287
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
++ AT R LG G FG V + +E+ T G AVK + + +
Sbjct: 71 EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 115
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
E+ L +V L G E + E + GSL L + LP +
Sbjct: 116 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY 171
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG----LAKDGPEGDKTH 296
A +GL +LH R +++ D K N+LL +D +A L DFG L DG G
Sbjct: 172 LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKDLL 227
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT + APE V+ ++ DV+S ++L ML G
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL Y +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL Y +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL Y +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 186
+N P +G G +G V A TG VAVK L+ + K E+
Sbjct: 25 QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
L + H N++ L+ E + LV M G+ N++ + ++
Sbjct: 73 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL ++H +I+RD K SN+ ++ D K+ DF LA+ + +V+TR
Sbjct: 131 I-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR 186
Query: 301 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E+MP G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D K++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 32/185 (17%)
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL------- 285
+P I KIA+ K L LH ++ VI+RD K SN+L++A K DFG+
Sbjct: 133 IPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190
Query: 286 -AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
AKD G K + + + PE G+ + +SD++S G+ +E+ R D
Sbjct: 191 VAKDIDAGCKPYXAPERIN------PELNQKGY-SVKSDIWSLGITXIELAILRFPYDS- 242
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404
W P + ++ P+L K + + + CL ++ K RP
Sbjct: 243 ----------WGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTY 288
Query: 405 SEVVE 409
E+ +
Sbjct: 289 PELXQ 293
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E+MP G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D K++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G +G V+ G N + +A+K + + + E+ L H
Sbjct: 29 VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GLAFL 252
N+V+ +G E+ + E +P GSL L + PL + I + GL +L
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYL 138
Query: 253 HEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
H+ +++RD K N+L++ Y+ K+SDFG +K + GT Y AP
Sbjct: 139 HDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 192
Query: 311 EYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
E + G +D++S G ++EM TG+
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 53.1 bits (126), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 17/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V + + TG A K + + E+ + L H
Sbjct: 59 LGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV L +D++ +++YEFM G L + + ++ KGL +HE
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 257 ERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++ D K NI+ + KL DFGL V+T GT +AAPE
Sbjct: 170 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 223
Query: 315 TGHLTSRSDVYSFGVVLLEMLTG 337
+ +D++S GV+ +L+G
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL--AKDGPEGDK 294
+ + I + A+ + FLH + +++RD K SNI D K+ DFGL A D E ++
Sbjct: 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 295 THVSTR--------VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
T ++ +GT Y +PE + + + + D++S G++L E+L
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 49/237 (20%)
Query: 130 NFRPESLLGEGGFGCVFKG---------WIEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 177
+F ++LG+G FG V K I++ K T L+ + +LNH ++
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRRSL 231
+ WL NF+ + + E + +Y+ + +L LFR+ L
Sbjct: 67 YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---- 287
+ L+++H + +I+R+ K NI +D N K+ DFGLAK
Sbjct: 127 ---------------EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHR 168
Query: 288 --DGPEGDKTHVS------TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 335
D + D ++ T +GT Y A E + TGH + D YS G++ E +
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
+FR +LG G F V E+ T + VA+K + + L+G + + E+
Sbjct: 21 DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L + H N+V L L+ + + G L + + + ++
Sbjct: 70 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 249 LAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +LH+ +++RD K N+L LD D +SDFGL+K D V + GT
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTP 182
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GY APE + + D +S GV+ +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
+FR +LG G F V E+ T + VA+K + L+G + + E+
Sbjct: 21 DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKKALEGKEGSMENEIAV 69
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L + H N+V L L+ + + G L + + + ++
Sbjct: 70 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 249 LAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +LH+ +++RD K N+L LD D +SDFGL+K D V + GT
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTP 182
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GY APE + + D +S GV+ +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
+FR +LG G F V E+ T + VA+K + + L+G + + E+
Sbjct: 21 DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L + H N+V L L+ + + G L + + + ++
Sbjct: 70 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 249 LAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +LH+ +++RD K N+L LD D +SDFGL+K D V + GT
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTP 182
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GY APE + + D +S GV+ +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 67/285 (23%), Positives = 115/285 (40%), Gaps = 34/285 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G F +FKG E G T V +K L+ + + + + L H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV G C D+ +LV EF+ GSL+ +L + + ++++A A + FL E
Sbjct: 74 LVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENT 133
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVM 314
+I+ + NILL + + K + K G V + + + PE +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 315 T-GHLTSRSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
+L +D +SFG L E+ +G ++D R + E R ++L
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----------KLQFYEDR--HQL 237
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
P+ A + A L +C+ +P RP ++ L L
Sbjct: 238 PAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V + V+ TG K +N E++ + L H
Sbjct: 59 LGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
L+ L + + +L+ EF+ G L + + + + + A +GL +HE +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 257 ERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+++ D K NI+ + + K+ DFGLA + V+T T +AAPE V
Sbjct: 170 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVD 223
Query: 315 TGHLTSRSDVYSFGVVLLEMLTG 337
+ +D+++ GV+ +L+G
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSG 246
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
+FR +LG G F V E+ T + VA+K + + L+G + + E+
Sbjct: 21 DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L + H N+V L L+ + + G L + + + ++
Sbjct: 70 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 249 LAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +LH+ +++RD K N+L LD D +SDFGL+K D V + GT
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTP 182
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GY APE + + D +S GV+ +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 62/276 (22%), Positives = 120/276 (43%), Gaps = 29/276 (10%)
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMK 240
L EV L L H N++KL + + LV E G L + + R + ++ +K
Sbjct: 84 LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHV 297
L G+ +LH+ +++RD K N+LL++ D K+ DFGL+ ++ +
Sbjct: 144 QVLS---GVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKM 195
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG--------RRSMDKNRPNGE 349
R +GT Y APE V+ + DV+S GV+L +L G + + + G+
Sbjct: 196 KER-LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253
Query: 350 HNLV--EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR-PLMSE 406
+ EW G + +++ + S + A + + C ++ P ++
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313
Query: 407 VVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 442
+E ++ N + +A ++ + A ++ S T+
Sbjct: 314 AIENMRKFQNSQKLAQAALLY---MASKLTSQEETK 346
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 52.8 bits (125), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 65/302 (21%), Positives = 121/302 (40%), Gaps = 44/302 (14%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 180
F + + R + +G GG VF+ E+ +K V ++ ++ L ++
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 181 EWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSI 237
+A +N L H + +++L Y I D +Y M G+++ N ++ + PW
Sbjct: 75 NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
R + + +H+ +++ D K +N L+ D KL DFG+A + V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 184
Query: 298 STRVMGTYGYAAPEYV-----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+GT Y PE + ++ +SDV+S G +L M G+ +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--- 241
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+ + + + +IDP E F + + CL RDPK R + E
Sbjct: 242 ------------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 407 VV 408
++
Sbjct: 290 LL 291
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 17/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V + + TG A K + + E+ + L H
Sbjct: 165 LGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV L +D++ +++YEFM G L + + ++ KGL +HE
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 257 ERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++ D K NI+ + KL DFGL V+T GT +AAPE
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329
Query: 315 TGHLTSRSDVYSFGVVLLEMLTG 337
+ +D++S GV+ +L+G
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G +G V+ G N + +A+K + + + E+ L H
Sbjct: 15 VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GLAFL 252
N+V+ +G E+ + E +P GSL L + PL + I + GL +L
Sbjct: 66 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYL 124
Query: 253 HEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
H+ +++RD K N+L++ Y+ K+SDFG +K + GT Y AP
Sbjct: 125 HDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 178
Query: 311 EYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
E + G +D++S G ++EM TG+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 57/186 (30%), Positives = 85/186 (45%), Gaps = 26/186 (13%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN---LVKLIGYCIEDDQRL-LVYEFM 217
TG A+K L+ + KE +N L +N LVKL + +D+ L +V E+
Sbjct: 65 TGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL-EFSFKDNSNLYMVMEYA 123
Query: 218 PRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
P G + +HL R S P +I L +LH +IYRD K N+++D
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQ 176
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 331
K++DFGLAK V R + GT Y APE +++ D ++ GV++
Sbjct: 177 QGYIKVTDFGLAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 332 LEMLTG 337
EM G
Sbjct: 229 YEMAAG 234
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 70 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 123
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 178
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 227
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 86/211 (40%), Gaps = 29/211 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G F V+KG ++ T V + + L Q KE E L L H N
Sbjct: 34 IGRGSFKTVYKG-LDTETTVEV---AWCELQDRKLTKSERQRFKE---EAEXLKGLQHPN 86
Query: 197 LVKLIGY---------CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+V+ CI +LV E G+L+ +L R + +R K
Sbjct: 87 IVRFYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLR-SWCRQILK 140
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
GL FLH P+I+RD K NI + + K+ D GLA + + V+GT
Sbjct: 141 GLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPE 195
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE + S DVY+FG LE T
Sbjct: 196 FXAPEXYEEKYDES-VDVYAFGXCXLEXATS 225
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 52.0 bits (123), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 42 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 95
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 96 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 150
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 199
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 65/302 (21%), Positives = 120/302 (39%), Gaps = 44/302 (14%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 180
F + + R + +G GG VF+ E+ +K V ++ ++ L ++
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 181 EWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSI 237
+A +N L H + +++L Y I D +Y M G+++ N ++ + PW
Sbjct: 75 NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
R + + +H+ +++ D K +N L+ D KL DFG+A V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVV 184
Query: 298 STRVMGTYGYAAPEYV-----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+GT Y PE + ++ +SDV+S G +L M G+ +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--- 241
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+ + + + +IDP E F + + CL RDPK R + E
Sbjct: 242 ------------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 407 VV 408
++
Sbjct: 290 LL 291
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E+ P G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+++D K++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 137 LGEGGFG--CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGD 191
+G+G FG C+ +++N T + A+K +N E E+ +
Sbjct: 23 IGKGSFGKVCI----VQKNDTKKM-------YAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L H LV L Y +D++ + +V + + G L HL + ++++ I L
Sbjct: 72 LEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALD 129
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+L + +I+RD K NILLD + ++DF +A P +T ++T + GT Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPYMAP 183
Query: 311 EYVMTGHLTSRS---DVYSFGVVLLEMLTGRR 339
E + S D +S GV E+L GRR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 38/240 (15%)
Query: 194 HLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 246
H N+++L+ YC+ + + L+ F RG+L N + R + L + + LG
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP---EGDKTHVSTRVMG 303
+GL +H + +RD K +NILL + L D G EG + ++ +
Sbjct: 145 RGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 304 ----TYGYAAPE-YVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
T Y APE + + H + R+DV+S G VL M+ G D G+ +
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-- 259
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEALKP 413
+ +L S + + QL ++ DP R PL+ +EAL+P
Sbjct: 260 -------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D K++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 186
+R + LGEG +G V+K + T TVA+K + +G+ G + EV
Sbjct: 36 YRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTA--IREV 84
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA--- 242
+ L +L H N+++L I + RL L++E+ EN L + P + M++
Sbjct: 85 SLLKELQHRNIIEL-KSVIHHNHRLHLIFEYA-----ENDLKKYMDKNP-DVSMRVIKSF 137
Query: 243 -LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTH 296
G+ F H R ++RD K N+LL + K+ DFGLA+ G
Sbjct: 138 LYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIR 192
Query: 297 VSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 335
T + T Y PE ++ + H ++ D++S + EML
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/285 (21%), Positives = 114/285 (40%), Gaps = 42/285 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G GG VF+ E+ +K V ++ ++ L ++ +A +N L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQHSD-K 117
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
+++L Y I D +Y M G+++ N ++ + PW R + + +H+
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV- 313
+++ D K +N L+ D KL DFG+A + V +GT Y PE +
Sbjct: 174 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 314 ----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
++ +SDV+S G +L M G+ + + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 274
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + +IDP E F + + CL RDPK R + E++
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G GG VF+ E+ +K V ++ ++ L ++ +A +N L H +
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 197 -LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 253
+++L Y I D +Y M G+++ N ++ + PW R + + +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ +++ D K +N L+ D KL DFG+A + V +GT Y PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 314 -----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
++ +SDV+S G +L M G+ + + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQ 273
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + +IDP E F + + CL RDPK R + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ F +LG G F VF + TG A+K + E+
Sbjct: 9 KTFIFMEVLGSGAFSEVF---------LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP--WSIRMKIALGAA 246
L + H N+V L LV + + G L + + R + S+ ++ L A
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 247 KGLAFLHEEAERPVIYRDFKTSNIL-LDADYNAKL--SDFGLAKDGPEGDKTHVSTRVMG 303
K +LHE +++RD K N+L L + N+K+ +DFGL+K G + + G
Sbjct: 120 K---YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACG 169
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
T GY APE + + D +S GV+ +L G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 85/205 (41%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H +IYRD K N+L+D +++DFG AK T + GT Y APE
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEI 210
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 87/214 (40%), Gaps = 23/214 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E G VK + K L VNF
Sbjct: 42 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 95
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++P G + +HL R R A +LH
Sbjct: 96 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 152
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 153 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 202
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+++ D ++ GV++ EM G ++P
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G GG VF+ E+ +K V ++ ++ L ++ +A +N L H +
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 69
Query: 197 -LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 253
+++L Y I D +Y M G+++ N ++ + PW R + + +H
Sbjct: 70 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 125
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ +++ D K +N L+ D KL DFG+A + V +GT Y PE +
Sbjct: 126 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 314 -----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
++ +SDV+S G +L M G+ + + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 226
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + +IDP E F + + CL RDPK R + E++
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G GG VF+ E+ +K V ++ ++ L ++ +A +N L H +
Sbjct: 20 IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 72
Query: 197 -LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 253
+++L Y I D +Y M G+++ N ++ + PW R + + +H
Sbjct: 73 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 128
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ +++ D K +N L+ D KL DFG+A + V +GT Y PE +
Sbjct: 129 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 314 -----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
++ +SDV+S G +L M G+ + + +
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQ 229
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + +IDP E F + + CL RDPK R + E++
Sbjct: 230 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 29/217 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
PE +++ D ++ GV++ EM G ++P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 15/181 (8%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TG AVK + + + + E+ L +V L G E + E + GS
Sbjct: 82 TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKL 280
L L ++ LP + A +GL +LH R +++ D K N+LL +D A L
Sbjct: 137 L-GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 192
Query: 281 SDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
DFG L DG G + GT + APE VM ++ D++S ++L ML
Sbjct: 193 CDFGHALCLQPDGL-GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251
Query: 337 G 337
G
Sbjct: 252 G 252
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 15/181 (8%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TG AVK + + + + E+ L +V L G E + E + GS
Sbjct: 96 TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 150
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKL 280
L L ++ LP + A +GL +LH R +++ D K N+LL +D A L
Sbjct: 151 L-GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 206
Query: 281 SDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
DFG L DG G + GT + APE VM ++ D++S ++L ML
Sbjct: 207 CDFGHALCLQPDGL-GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 265
Query: 337 G 337
G
Sbjct: 266 G 266
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 15/181 (8%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TG AVK + + + + E+ L +V L G E + E + GS
Sbjct: 98 TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 152
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKL 280
L L ++ LP + A +GL +LH R +++ D K N+LL +D A L
Sbjct: 153 L-GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 208
Query: 281 SDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
DFG L DG G + GT + APE VM ++ D++S ++L ML
Sbjct: 209 CDFGHALCLQPDGL-GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 267
Query: 337 G 337
G
Sbjct: 268 G 268
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E+ P G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D K++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E+ P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+++D +++DFGLAK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 15/137 (10%)
Query: 208 DQRLLVYEFMPRGSL---ENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 260
D+ ++YE+M S+ + + F + +P + I +++H E + +
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNI 173
Query: 261 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHL 318
+RD K SNIL+D + KLSDFG ++ DK +R GTY + PE+ + +
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGSR--GTYEFMPPEFFSNESSYN 229
Query: 319 TSRSDVYSFGVVLLEML 335
++ D++S G+ L M
Sbjct: 230 GAKVDIWSLGICLYVMF 246
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G G FG VF+ + E+ VA+K + LQ + E+ + + H
Sbjct: 47 VIGNGSFGVVFQAKLVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHP 92
Query: 196 NLVKLIGYCIEDDQRL------LVYEFMP----RGSLENHLFRRSLPLPWSIRMKIAL-G 244
N+V L + + + LV E++P R S ++++P+ + +K+ +
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM---LLIKLYMYQ 149
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMG 303
+ LA++H + +RD K N+LLD KL DFG AK G+ + +
Sbjct: 150 LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXIC 203
Query: 304 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
+ Y APE + + T+ D++S G V+ E++ G+
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 28/181 (15%)
Query: 198 VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 250
+ + Y +DD L LV ++ G L L + LP + M IA+ + L
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
++H RD K NIL+D + + +L+DFG E D T S+ +GT Y +P
Sbjct: 196 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISP 245
Query: 311 EYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
E + G D +S GV + EML G P +LVE + + R
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHKER 299
Query: 366 F 366
F
Sbjct: 300 F 300
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G GG VF+ E+ +K V ++ ++ L ++ +A +N L H +
Sbjct: 16 IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 68
Query: 197 -LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 253
+++L Y I D +Y M G+++ N ++ + PW R + + +H
Sbjct: 69 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 124
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+ +++ D K +N L+ D KL DFG+A + V +GT Y PE +
Sbjct: 125 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 314 -----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
++ +SDV+S G +L M G+ + + +
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQ 225
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + +IDP E F + + CL RDPK R + E++
Sbjct: 226 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E+ P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+++D K++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 35 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 88
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++P G + +HL R S P +I L +L
Sbjct: 89 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 143
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H +IYRD K N+L+D +++DFG AK T + GT Y APE
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEI 195
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+++ D ++ GV++ EM G ++P
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 192
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 23/214 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++P G + +HL R R A +LH
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 209
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+++ D ++ GV++ EM G ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F ES LG G V++ ++ GT KP L V KT++ ++ E+ L
Sbjct: 55 FEVESELGRGATSIVYR--CKQKGTQ--KP-YALKVLKKTVDKKIVR------TEIGVLL 103
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 247
L H N++KL + LV E + G L + + + +S R A A K
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERD--AADAVKQIL 158
Query: 248 -GLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+A+LHE +++RD K N+L D K++DFGL+K + + V G
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCG 212
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
T GY APE + D++S G++ +L G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 23/214 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++P G + +HL R R A +LH
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 160
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 210
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+++ D ++ GV++ EM G ++P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 23/214 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 70 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 123
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 178
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H +IYRD K N+L+D +++DFG AK T + GT Y APE
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAPEI 230
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+++ D ++ GV++ EM G ++P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 23/214 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++P G + +HL R R A +LH
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 209
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+++ D ++ GV++ EM G ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 82/205 (40%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E+ P G + +HL R R A +LH
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+++D K++DFG AK V R + GT Y APE
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 209
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 66/263 (25%), Positives = 108/263 (41%), Gaps = 40/263 (15%)
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMP 218
G + V V + + +++ E L H N++ ++G C L+ +MP
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 219 RGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD-FKTSNILLDADY 276
GSL N L + + S +K AL A+G+AFLH P+I R + ++++D D
Sbjct: 93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDM 150
Query: 277 NAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSR--SDVYSFGVVL 331
A++S D + P M + APE + T+R +D++SF V+L
Sbjct: 151 TARISMADVKFSFQSPGR---------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 332 LEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 389
E++T N G +E RP I P + H S +L
Sbjct: 202 WELVTREVPFADLSNMEIGMKVALEGLRP----------TIPPGISPHVS--------KL 243
Query: 390 AAHCLSRDPKARPLMSEVVEALK 412
C++ DP RP +V L+
Sbjct: 244 MKICMNEDPAKRPKFDMIVPILE 266
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G + V+ Y Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVVTRY-Y 193
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ EM+ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 83/208 (39%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-------P 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
+ + + +D+ L +V E+ P G + +HL R S P +I L +L
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+++D K++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 29/234 (12%)
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA----ERPVI-YR 263
Q L+ ++ GSL ++L +S L +K+A + GL LH E +P I +R
Sbjct: 109 QLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 264 DFKTSNILLDADYNAKLSDFGLA----KDGPEGDKTHVSTRVMGTYGYAAPEY----VMT 315
D K+ NIL+ + ++D GLA D E D +TRV GT Y PE +
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD-IPPNTRV-GTKRYMPPEVLDESLNR 224
Query: 316 GHLTS--RSDVYSFGVVLLEMLTGRRSMD----KNRPNGEHNLVEWARPHLGERRRFYRL 369
H S +D+YSFG++L E+ RR + + H+LV + P + R +
Sbjct: 225 NHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVP-SDPSYEDMREIVCI 281
Query: 370 --IDPRLEGHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 420
+ P +S + ++ +L C + +P +R V + L + +D+
Sbjct: 282 KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 83/208 (39%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-------P 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
+ + + +D+ L +V E+ P G + +HL R S P +I L +L
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+++D K++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E+ P G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+++D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 42/285 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G GG VF+ E+ +K V ++ ++ L ++ +A +N L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQHSD-K 117
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
+++L Y I D +Y M G+++ N ++ + PW R + + +H+
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV- 313
+++ D K +N L+ D KL DFG+A + V +G Y PE +
Sbjct: 174 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 314 ----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
++ +SDV+S G +L M G+ + + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 274
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
+ + +IDP E F + + CL RDPK R + E++
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 103
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLXGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 71/296 (23%), Positives = 110/296 (37%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 15 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 196 N--------LVKLIGYCIEDDQRLLVYEFM-----------PRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E M RG+L+ L R W
Sbjct: 66 KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF---WQ 122
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 123 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 168
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 169 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 218
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 219 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLAGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 80/205 (39%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-------P 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ + + +D+ L +V E+ P G + +HL R R A +LH
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 160
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+++D K++DFG AK V R + GT Y APE
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 210
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 238
E+ L L H ++K+ + + + +V E M G L N + + + +
Sbjct: 70 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
M +A+ +LHE +I+RD K N+LL + D K++DFG +K E T
Sbjct: 129 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 176
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ + GT Y APE ++ T D +S GV+L L+G
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 221
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSI------KGAQKAAQLAAHCLSRDPKAR 401
P E R L D G ++ + ++KA L L DPKAR
Sbjct: 222 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 272
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 48.9 bits (115), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 48/296 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 26 IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 192 LVHLNLVKLIGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV++F G L N L + +L S +
Sbjct: 74 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHV 297
+ GL ++H +++RD K +N+L+ D KL+DFGLA+
Sbjct: 130 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 298 STRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 355
RV+ T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 356 ---ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
P + Y L + +LE +KG ++ + RDP A L+ +++
Sbjct: 246 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL 297
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 49/242 (20%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 238
E+ L L H ++K+ + + + +V E M G L N + + + +
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
M +A+ +LHE +I+RD K N+LL + D K++DFG +K E T
Sbjct: 248 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 295
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ + GT Y APE ++ T D +S GV+L L+G
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 340
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSI------KGAQKAAQLAAHCLSRDPKARPLMSE 406
P E R L D G ++ + ++KA L L DPKAR E
Sbjct: 341 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 407 VV 408
+
Sbjct: 397 AL 398
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 36 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 89
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 90 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 144
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 193
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 88/217 (40%), Gaps = 29/217 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
LLGEG + V V G AVK + EV L +
Sbjct: 20 LLGEGAYAKV---------QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+++LI + EDD R LV+E + GS+ H+ ++ ++ A L FLH
Sbjct: 71 KNILELIEF-FEDDTRFYLVFEKLQGGSILAHI-QKQKHFNEREASRVVRDVAAALDFLH 128
Query: 254 EEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAK-----DGPEGDKTHVSTRVMGTY 305
+ + +RD K NIL ++ K+ DF L + T T G+
Sbjct: 129 TKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 306 GYAAPEY--VMTGHLT---SRSDVYSFGVVLLEMLTG 337
Y APE V T T R D++S GVVL ML+G
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 238
E+ L L H ++K+ + + + +V E M G L N + + + +
Sbjct: 64 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
M +A+ +LHE +I+RD K N+LL + D K++DFG +K E T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 170
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ + GT Y APE ++ T D +S GV+L L+G
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSI------KGAQKAAQLAAHCLSRDPKAR 401
P E R L D G ++ + ++KA L L DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 238
E+ L L H ++K+ + + + +V E M G L N + + + +
Sbjct: 64 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
M +A+ +LHE +I+RD K N+LL + D K++DFG +K E T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 170
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ + GT Y APE ++ T D +S GV+L L+G
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSI------KGAQKAAQLAAHCLSRDPKAR 401
P E R L D G ++ + ++KA L L DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 238
E+ L L H ++K+ + + + +V E M G L N + + + +
Sbjct: 63 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 121
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
M +A+ +LHE +I+RD K N+LL + D K++DFG +K E T
Sbjct: 122 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 169
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ + GT Y APE ++ T D +S GV+L L+G
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 214
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSI------KGAQKAAQLAAHCLSRDPKAR 401
P E R L D G ++ + ++KA L L DPKAR
Sbjct: 215 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 265
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 238
E+ L L H ++K+ + + + +V E M G L N + + + +
Sbjct: 64 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
M +A+ +LHE +I+RD K N+LL + D K++DFG +K E T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 170
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ + GT Y APE ++ T D +S GV+L L+G
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSI------KGAQKAAQLAAHCLSRDPKAR 401
P E R L D G ++ + ++KA L L DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 111/296 (37%), Gaps = 62/296 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+R LLG+GGFG VF G T ++ + + L L EV L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 190 GDLV----HLNLVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALG 244
+ H +++L+ + + +LV E +P L ++ I K LG
Sbjct: 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDY-----------ITEKGPLG 137
Query: 245 AAKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYN-AKLSDFG---LAKDGPEGD 293
F + R V++RD K NIL+D AKL DFG L D P D
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
GT Y+ PE++ + + V+S G++L +M+ G ++++ E L
Sbjct: 198 FD-------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
HF + L CL+ P +RP + E++
Sbjct: 251 ------------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G + V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ D++S G ++ EM+ +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 20/178 (11%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
F ++L R +L EGGF V++ G+G A+K L + +
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQ---------DVGSGREYALKRLLSNEEEK 68
Query: 179 HKEWLAEVNFLGDLV-HLNLVKL-----IGYCIED--DQRLLVYEFMPRGSLENHLFRRS 230
++ + EV F+ L H N+V+ IG D L+ + +G L L +
Sbjct: 69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME 128
Query: 231 L--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
PL +KI + + +H + + P+I+RD K N+LL KL DFG A
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+G+G F V + VK TG A K +N L H++ E L H
Sbjct: 12 IGKGAFSVVRRC---------VKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V+L E+ LV++ + G L + R + + + L +
Sbjct: 63 SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLH 118
Query: 255 EAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+ V++RD K N+LL + KL+DFGLA + +GD+ GT GY +PE
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYLSPE 176
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ D+++ GV+L +L G
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVG 202
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 16 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 67 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 123
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 124 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 169
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 219
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 220 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++ G + +HL R R A +LH
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 209
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 34/220 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG GG G VF V VA+K + Q K L E+ + L H N
Sbjct: 19 LGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 197 LVKL--------------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+VK+ +G E + +V E+M L N L + L L R+
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPL-LEEHARL-FM 126
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAK--DGPEGDKTHVST 299
+GL ++H V++RD K +N+ ++ D K+ DFGLA+ D K H+S
Sbjct: 127 YQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 300 RVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
++ T Y +P +++ + T D+++ G + EMLTG+
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 48.5 bits (114), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++ G + +HL R R A +LH
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 209
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 23/214 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 70 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 123
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++ G + +HL R R A +LH
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 180
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 230
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+++ D ++ GV++ EM G ++P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 44 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 97
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++ G + +HL R R A +LH
Sbjct: 98 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 154
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 155 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 204
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAG 229
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 238
E+ L L H ++K+ + + + +V E M G L N + + + +
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
M +A+ +LHE +I+RD K N+LL + D K++DFG +K E T
Sbjct: 262 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 309
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ + GT Y APE ++ T D +S GV+L L+G
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 354
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSI------KGAQKAAQLAAHCLSRDPKAR 401
P E R L D G ++ + ++KA L L DPKAR
Sbjct: 355 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 405
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++ G + +HL R R A +LH
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 209
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 30 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 81 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 137
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 138 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 183
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 184 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 233
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 234 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 271
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 309
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 229
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 347
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 229
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 347
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+++D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 30 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 81 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 137
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 138 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 183
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 184 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 302
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 309
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 31 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 82 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 138
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 139 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 234
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 235 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 272
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 44 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 95 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 192
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 310
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 50/288 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 13 LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 122
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + + D K NI+L D N KL DFG+A G++ + GT
Sbjct: 123 YLHS---KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTP 175
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LGE ++
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETKQ 217
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ + + ++ A L +DPK R +++ +E
Sbjct: 218 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 43 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 94 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 302
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 15 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 66 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 122
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 123 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 168
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 169 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 218
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 219 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 31 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 82 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 138
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 139 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 50 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 157
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 158 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 203
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 204 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 253
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 254 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 291
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 192
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 310
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 44/286 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G+G F V + E G + + K + GL ++ E + L H
Sbjct: 31 VIGKGAFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFL 252
++V+L+ D +V+EFM L + +R+ ++ + L +
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 253 HEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
H+ +I+RD K N+LL + N+ KL DFG+A G+ V+ +GT + A
Sbjct: 147 HDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFMA 201
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE V DV+ GV+L +L+G P G + R +
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG------------------CLPFYGTKERLFEG 243
Query: 370 I-------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
I +PR H S + A L L DP R + E +
Sbjct: 244 IIKGKYKMNPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEAL 285
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 58 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 165
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 166 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 211
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 212 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 261
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 262 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 299
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 16 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 67 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 123
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 124 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 169
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 219
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 220 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 31 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 82 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 138
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 139 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 309
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LVKL + +D+ L +V E++ G + +HL R R A +LH
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLHS- 159
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEY 312
+IYRD K N+L+D +++DFG AK V R + GT Y APE
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEI 209
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+++ D ++ GV++ EM G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 190
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 308
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 58 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 165
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 166 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 211
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 212 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 309
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 309
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 185
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 303
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 16 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 67 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 123
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 124 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 169
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 219
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 220 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 11 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 118
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 119 VLEAVRHCHNXG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 164
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 215 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 252
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 185
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 303
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 43 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 94 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 44 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 95 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 50/288 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 20 LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 71 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 129
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + + D K NI+L D N KL DFG+A G++ + GT
Sbjct: 130 YLHS---KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTP 182
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LGE ++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETKQ 224
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ + + ++ A L +DPK R +++ +E
Sbjct: 225 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 272
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ +M G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 38 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 89 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 145
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 146 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 191
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 192 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 241
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 242 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 279
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 44 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 95 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 44 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 95 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 43 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 94 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 63 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 170
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 171 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 216
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 217 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V E G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 309
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 50/288 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 34 LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILR 84
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 85 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 143
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + + D K NI+L D N KL DFG+A G++ + GT
Sbjct: 144 YLHS---KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTP 196
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LGE ++
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETKQ 238
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ + + ++ A L +DPK R +++ +E
Sbjct: 239 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 286
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 43 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 94 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 48/296 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 25 IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 72
Query: 192 LVHLNLVKLIGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV++F G L N L + +L S +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 128
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHV 297
+ GL ++H +++RD K +N+L+ D KL+DFGLA+
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 298 STRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 355
RV+ T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 186 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 356 ---ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
P + Y L + +LE +KG ++ + RDP A L+ +++
Sbjct: 245 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 196
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ D++S G ++ EM+ +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 21/145 (14%)
Query: 208 DQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265
D+ LV+E M GS+ +H+ +R L S+ + A L FLH + + +RD
Sbjct: 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG---IAHRDL 137
Query: 266 KTSNILLDADYN---AKLSDFGLAKDGP-EGDKTHVSTRVM----GTYGYAAPEYV---- 313
K NIL + K+ DFGL GD + +ST + G+ Y APE V
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 314 -MTGHLTSRSDVYSFGVVLLEMLTG 337
R D++S GV+L +L+G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 48/296 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 26 IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 192 LVHLNLVKLIGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV++F G L N L + +L S +
Sbjct: 74 LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHV 297
+ GL ++H +++RD K +N+L+ D KL+DFGLA+
Sbjct: 130 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 298 STRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 355
RV+ T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 356 ---ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
P + Y L + +LE +KG ++ + RDP A L+ +++
Sbjct: 246 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL 297
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G + V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ D++S G ++ EM+ +
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 11 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 118
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 119 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 164
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 215 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 252
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 48/296 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 26 IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 192 LVHLNLVKLIGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV++F G L N L + +L S +
Sbjct: 74 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHV 297
+ GL ++H +++RD K +N+L+ D KL+DFGLA+
Sbjct: 130 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 298 STRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 355
RV+ T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 356 ---ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
P + Y L + +LE +KG ++ + RDP A L+ +++
Sbjct: 246 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL 297
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 185
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ D++S G ++ EM+ +
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYY 189
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ E++ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 14 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 65 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 121
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 122 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 167
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
V T GT Y+ PE++ RS V+S G++L +M+ G + +
Sbjct: 168 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 217
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E R + R+R + + L CL+ P RP E+
Sbjct: 218 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 255
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 41/234 (17%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGHKE 181
+++L +F ++G G FG V A VK T A+K LN + E
Sbjct: 84 EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTERIYAMKILNKWEMLKRAE 133
Query: 182 WLA-----EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW 235
+V GD + + Y +D+ L LV ++ G L L + LP
Sbjct: 134 TACFREERDVLVNGDC---QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPE 190
Query: 236 SI------RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289
+ M +A+ + L ++H RD K N+LLD + + +L+DFG
Sbjct: 191 DMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCLKM 241
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGR 338
+ D T S+ +GT Y +PE + G D +S GV + EML G
Sbjct: 242 ND-DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 124 LKLATRNFRPESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
+ L T N +S+ LG+G F V + VK G A K +N L
Sbjct: 11 VDLGTENLYFQSMYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAKIINTKKLS 61
Query: 178 G--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
H++ E L H N+V+L E+ L+++ + G L + R +
Sbjct: 62 ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----Y 117
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEG 292
+ + L + + V++RD K N+LL + KL+DFGLA + EG
Sbjct: 118 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE-VEG 176
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
++ GT GY +PE + D+++ GV+L +L G
Sbjct: 177 EQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 41/234 (17%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGHKE 181
+++L +F ++G G FG V A VK T A+K LN + E
Sbjct: 68 EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTERIYAMKILNKWEMLKRAE 117
Query: 182 WLA-----EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW 235
+V GD + + Y +D+ L LV ++ G L L + LP
Sbjct: 118 TACFREERDVLVNGDC---QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPE 174
Query: 236 SI------RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289
+ M +A+ + L ++H RD K N+LLD + + +L+DFG
Sbjct: 175 DMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCLKM 225
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGR 338
+ D T S+ +GT Y +PE + G D +S GV + EML G
Sbjct: 226 ND-DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LLG GGFG V+ G ++ L VA+K + D + E ++V L
Sbjct: 11 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 196 N--------LVKLIGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 236
+++L+ + D +L+ E RG+L+ L R W
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 118
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEG 292
+ + G V++RD K NIL+D + KL DFG L KD
Sbjct: 119 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 164
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
V T GT Y+ PE++ RS V+S G++L +M+ G
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT Y A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
P +++ D ++ GV++ EM G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L L H N+VKL+ + +D +V+E + +G + + PL
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYF 143
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KG+ +LH + +I+RD K SN+L+ D + K++DFG++ + D +T +
Sbjct: 144 QDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT--V 198
Query: 303 GTYGYAAPEYVM-TGHLTSRS--DVYSFGVVLLEMLTGR 338
GT + APE + T + S DV++ GV L + G+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 9/90 (10%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYG 306
GL LHE V++RD NILL + + + DF LA+ D + +KTH T
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RW 198
Query: 307 YAAPEYVMTGH-LTSRSDVYSFGVVLLEML 335
Y APE VM T D++S G V+ EM
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 9/90 (10%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYG 306
GL LHE V++RD NILL + + + DF LA+ D + +KTH T
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RW 198
Query: 307 YAAPEYVMTGH-LTSRSDVYSFGVVLLEML 335
Y APE VM T D++S G V+ EM
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G F V + +K TG A K +N L H++ E L H
Sbjct: 12 LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V+L E+ LV++ + G L + R + + + L ++
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCIQQILESVNH 118
Query: 255 EAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+++RD K N+LL + KL+DFGLA + +GD+ GT GY +PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYLSPE 176
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ D+++ GV+L +L G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 47/233 (20%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLV 193
L+G G +G V + + + VA+K + + L K L E+ L L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKR---------VVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 194 HLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
H ++VK++ I D + +V E S LFR + L + G
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS-------- 298
+ ++H +++RD K +N L++ D + K+ DFGLA+ D PE + +
Sbjct: 169 VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 299 ---------------TRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEML 335
T + T Y APE + + + T DV+S G + E+L
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G F V + +K TG A K +N L H++ E L H
Sbjct: 12 LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V+L E+ LV++ + G L + R + + + L ++
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCIQQILESVNH 118
Query: 255 EAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+++RD K N+LL + KL+DFGLA + +GD+ GT GY +PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYLSPE 176
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ D+++ GV+L +L G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 38/163 (23%), Positives = 73/163 (44%), Gaps = 31/163 (19%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+G+ +LH+ +++ D K NILL + Y + K+ DFG+++ + +MG
Sbjct: 142 EGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMG 195
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y APE + +T+ +D+++ G++ +LT P +GE
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH------------------TSPFVGED 237
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAA----HCLSRDPKARP 402
+ L ++ +S + +QLA L ++P+ RP
Sbjct: 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V +E+G VK + K L VNF
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF------ 102
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LVKL + +D+ L +V E++ G + +HL R S P +I L +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 309
H +IYRD K N+L+D +++DFG AK V R + GT A
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEALA 206
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE +++ D ++ GV++ EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 66/145 (45%), Gaps = 21/145 (14%)
Query: 208 DQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265
D+ LV+E M GS+ +H+ +R L S+ + A L FLH + + +RD
Sbjct: 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG---IAHRDL 137
Query: 266 KTSNILLDADYN---AKLSDFGLAKDGP-EGDKTHVSTRVM----GTYGYAAPEYV---- 313
K NIL + K+ DF L GD + +ST + G+ Y APE V
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 314 -MTGHLTSRSDVYSFGVVLLEMLTG 337
R D++S GV+L +L+G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK------EWLAEVNFLG 190
LG G F V K + TGL A K + + + E EV+ L
Sbjct: 20 LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++H N++ L +L+ E + G L + L ++ L G+
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 251 FLHEEAERPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + + + D K NI LLD + + KL DFGLA + +G + + GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPE 183
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE V L +D++S GV+ +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 24/155 (15%)
Query: 260 VIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
V++RD K N+L + + K+ DFG A+ P D + T T YAAPE +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAPELLNQN 184
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
D++S GV+L ML+G+ P H+ + ++ + G
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQ------VPFQSHDRSLTCTSAVEIMKKIKK-------G 231
Query: 377 HFSIKG------AQKAAQLAAHCLSRDPKARPLMS 405
FS +G +Q+A L L+ DP R MS
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++H N++ L +L+ E + G L + L ++ L G+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 251 FLHEEAERPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + + + D K NI LLD + + KL DFGLA + +G + + GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE V L +D++S GV+ +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 20/215 (9%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 185
T +++ LG+G F V + VK A K +N L H++ E
Sbjct: 30 TDDYQLFEELGKGAFSVVRRC---------VKKTPTQEYAAKIINTKKLSARDHQKLERE 80
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H N+V+L E+ LV++ + G L + R + +
Sbjct: 81 ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCI 136
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVM 302
+ L ++ + +++RD K N+LL + KL+DFGLA + +G++
Sbjct: 137 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGEQ-QAWFGFA 194
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT GY +PE + D+++ GV+L +L G
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++H N++ L +L+ E + G L + L ++ L G+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 251 FLHEEAERPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + + + D K NI LLD + + KL DFGLA + +G + + GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE V L +D++S GV+ +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 14/150 (9%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--MKIALGAAKGLAF 251
H N++ L + +V E M G L + + R+ +S R + K + +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEY 131
Query: 252 LHEEAERPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
LH + V++RD K SNIL +D N ++ DFG AK + ++ T +
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYTANF 186
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE + + D++S GV+L MLTG
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++H N++ L +L+ E + G L + L ++ L G+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 251 FLHEEAERPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + + + D K NI LLD + + KL DFGLA + +G + + GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE V L +D++S GV+ +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++H N++ L +L+ E + G L + L ++ L G+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 251 FLHEEAERPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + + + D K NI LLD + + KL DFGLA + +G + + GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE V L +D++S GV+ +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++H N++ L +L+ E + G L + L ++ L G+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 251 FLHEEAERPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + + + D K NI LLD + + KL DFGLA + +G + + GT
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE V L +D++S GV+ +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
pdb|2PZI|B Chain B, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
Length = 681
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 143 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLI 201
GC+ G + A + G V +K L H G + +AE FL ++VH ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 202 GYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+ D+ +V E++ SL+ + LP + + L L++LH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRS---KGQKLPVAEAIAYLLEILPALSYLHSIG 202
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
++Y D K NI+L + KL D G + + + GT G+ APE V TG
Sbjct: 203 ---LVYNDLKPENIML-TEEQLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRTG 252
Query: 317 HLTSRSDVYSFGVVLLEM 334
T +D+Y+ G L +
Sbjct: 253 P-TVATDIYTVGRTLAAL 269
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 62/261 (23%), Positives = 102/261 (39%), Gaps = 36/261 (13%)
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMP 218
G + V V + + +++ E L H N++ ++G C L+ + P
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 219 RGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD-FKTSNILLDADY 276
GSL N L + + S +K AL A+G AFLH P+I R + ++ +D D
Sbjct: 93 YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHALNSRSVXIDEDX 150
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSR--SDVYSFGVVLLE 333
A++S + + + + APE + T+R +D +SF V+L E
Sbjct: 151 TARISXADVKFSFQSPGRXYAP-------AWVAPEALQKKPEDTNRRSADXWSFAVLLWE 203
Query: 334 MLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 391
++T N G +E RP I P + H S +L
Sbjct: 204 LVTREVPFADLSNXEIGXKVALEGLRP----------TIPPGISPHVS--------KLXK 245
Query: 392 HCLSRDPKARPLMSEVVEALK 412
C + DP RP +V L+
Sbjct: 246 ICXNEDPAKRPKFDXIVPILE 266
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G F V + VK G A +N L H++ E L H
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V+L E+ L+++ + G L + R + + + L +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLH 125
Query: 255 EAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+ V++R+ K N+LL + KL+DFGLA + EG++ GT GY +PE
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQ-QAWFGFAGTPGYLSPE 183
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ D+++ GV+L +L G
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVG 209
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 64/288 (22%), Positives = 109/288 (37%), Gaps = 50/288 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 AFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ E + + A L +DPK R + + ++
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With
10z-Hymenialdisine
Length = 339
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 86/225 (38%), Gaps = 40/225 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-----DGLQGHKEWLAEVNFLGD 191
LGEG FG V + + G G VAVK + + + + + L +N
Sbjct: 22 LGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
V+++ + +V+E + + + LP K+A K + F
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 252 LHEEAERPVIYRDFKTSNIL-LDADY------------------NAKLSDFGLAKDGPEG 292
LH + + D K NIL + +DY + K+ DFG A E
Sbjct: 134 LHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
T VSTR Y APE ++ + DV+S G +L+E G
Sbjct: 191 HSTLVSTR-----HYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 31/83 (37%), Positives = 43/83 (51%), Gaps = 12/83 (14%)
Query: 260 VIYRDFKTSNILLDADY-NAKLSDFG---LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
V++RD K NIL+D + KL DFG L KD V T GT Y+ PE++
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRY 230
Query: 316 GHLTSRS-DVYSFGVVLLEMLTG 337
RS V+S G++L +M+ G
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCG 253
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 52/304 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 18 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 127
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 128 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 180
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 222
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 419
++ E + + A L +DPK R + + ++ +KP +
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
Query: 420 MASS 423
++S+
Sbjct: 283 LSSA 286
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 52/304 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGKFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 419
++ E + + A L +DPK R + + ++ +KP +
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
Query: 420 MASS 423
++S+
Sbjct: 284 LSSA 287
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 64/288 (22%), Positives = 109/288 (37%), Gaps = 50/288 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ E + + A L +DPK R + + ++
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2)
pdb|3NR9|B Chain B, Structure Of Human Cdc2-Like Kinase 2 (Clk2)
pdb|3NR9|C Chain C, Structure Of Human Cdc2-Like Kinase 2 (Clk2)
Length = 368
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 45/242 (18%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL---- 189
S LGEG FG V + G G VA+K + ++ +KE E+N L
Sbjct: 39 STLGEGTFGRVVQCVDHRRG--------GARVALKIIK--NVEKYKEAARLEINVLEKIN 88
Query: 190 -GDLVHLNL-VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
D + NL V++ + + +E + + + LP P +A +
Sbjct: 89 EKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 248 GLAFLHEEAERPVIYRDFKTSNIL-LDADYN------------------AKLSDFGLAKD 288
+ FLH+ + + D K NIL +++DY ++ DFG A
Sbjct: 149 AVKFLHDNK---LTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF 205
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
E T VSTR Y APE ++ + DV+S G ++ E G ++ + N
Sbjct: 206 DHEHHSTIVSTR-----HYRAPEVILELGWSQPCDVWSIGCIIFEYYVG-FTLFQTHDNR 259
Query: 349 EH 350
EH
Sbjct: 260 EH 261
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 52/304 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 419
++ E + + A L +DPK R + + ++ +KP +
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
Query: 420 MASS 423
++S+
Sbjct: 284 LSSA 287
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 52/304 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 18 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 127
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 128 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 180
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 222
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 419
++ E + + A L +DPK R + + ++ +KP +
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
Query: 420 MASS 423
++S+
Sbjct: 283 LSSA 286
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 64/288 (22%), Positives = 109/288 (37%), Gaps = 50/288 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ E + + A L +DPK R + + ++
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
++ E + + A L +DPK R
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
++ E + + A L +DPK R
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 37/228 (16%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK--IALGAAKGLAF 251
H N++ L + LV E M G L + + R+ +S R + K + +
Sbjct: 80 HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVEY 136
Query: 252 LHEEAERPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
LH + V++RD K SNIL +D N ++ DFG AK + ++ T +
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANF 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + D++S G++L ML G NG + E +G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIG------ 241
Query: 368 RLIDPRLEGHFSIKG------AQKAAQLAAHCLSRDPKARPLMSEVVE 409
G F++ G ++ A L + L DP R +V++
Sbjct: 242 -------SGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
++ E + + A L +DPK R
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 52/304 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGVFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 419
++ E + + A L +DPK R + + ++ +KP +
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
Query: 420 MASS 423
++S+
Sbjct: 284 LSSA 287
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
++ E + + A L +DPK R
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
++ E + + A L +DPK R
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 37/228 (16%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK--IALGAAKGLAF 251
H N++ L + LV E M G L + + R+ +S R + K + +
Sbjct: 80 HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVEY 136
Query: 252 LHEEAERPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
LH + V++RD K SNIL +D N ++ DFG AK + ++ T +
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANF 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + D++S G++L ML G NG + E +G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIG------ 241
Query: 368 RLIDPRLEGHFSIKG------AQKAAQLAAHCLSRDPKARPLMSEVVE 409
G F++ G ++ A L + L DP R +V++
Sbjct: 242 -------SGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 65/286 (22%), Positives = 109/286 (38%), Gaps = 44/286 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G+G F V + E G + + K + GL ++ E + L H
Sbjct: 33 VIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHP 88
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFL 252
++V+L+ D +V+EFM L + +R+ ++ + L +
Sbjct: 89 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 253 HEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
H+ +I+RD K +LL + N+ KL FG+A G+ V+ +GT + A
Sbjct: 149 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMA 203
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE V DV+ GV+L +L+G P G + R +
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSG------------------CLPFYGTKERLFEG 245
Query: 370 I-------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
I +PR H S + A L L DP R + E +
Sbjct: 246 IIKGKYKMNPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEAL 287
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 52/304 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
++ H N++ L +L+ E + G L + L + L + G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + + D K NI+L D N K+ DFGLA G++ + GT
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTP 181
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V L +D++S GV+ +L+G A P LG+ ++
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTKQ 223
Query: 366 ----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 419
++ E + + A L +DPK R + + ++ +KP +
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
Query: 420 MASS 423
++S+
Sbjct: 284 LSSA 287
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 65/286 (22%), Positives = 109/286 (38%), Gaps = 44/286 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G+G F V + E G + + K + GL ++ E + L H
Sbjct: 31 VIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFL 252
++V+L+ D +V+EFM L + +R+ ++ + L +
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 253 HEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
H+ +I+RD K +LL + N+ KL FG+A G+ V+ +GT + A
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMA 201
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE V DV+ GV+L +L+G P G + R +
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG------------------CLPFYGTKERLFEG 243
Query: 370 I-------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
I +PR H S + A L L DP R + E +
Sbjct: 244 IIKGKYKMNPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEAL 285
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 20/169 (11%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRS-------LPLPW 235
E+ L +L H N++ L + D + L++++ F R+ + LP
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DG 289
+ + G+ +LH V++RD K +NIL+ + K++D G A+ +
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 337
P + V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 185 PLKPLADLDP-VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 10/101 (9%)
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTH 296
+I + FLH + +RD K N+L + D KL+DFG AK E +
Sbjct: 113 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 166
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ T Y Y APE + D++S GV++ +L G
Sbjct: 167 LQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG- 316
+ +I+RD K NI++ D+ KL DFG A G + GT Y APE +M
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPEVLMGNP 205
Query: 317 HLTSRSDVYSFGVVLLEML 335
+ +++S GV L ++
Sbjct: 206 YRGPELEMWSLGVTLYTLV 224
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 10/101 (9%)
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTH 296
+I + FLH + +RD K N+L + D KL+DFG AK E +
Sbjct: 132 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 185
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ T Y Y APE + D++S GV++ +L G
Sbjct: 186 LQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 7/86 (8%)
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
LA LH + +++ D K +NI L KL DFGL + V G Y
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYM 223
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEM 334
APE ++ G + +DV+S G+ +LE+
Sbjct: 224 APE-LLQGSYGTAADVFSLGLTILEV 248
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.136 0.413
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 13,699,467
Number of Sequences: 62578
Number of extensions: 559599
Number of successful extensions: 3927
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 832
Number of HSP's successfully gapped in prelim test: 218
Number of HSP's that attempted gapping in prelim test: 1463
Number of HSP's gapped (non-prelim): 1116
length of query: 486
length of database: 14,973,337
effective HSP length: 103
effective length of query: 383
effective length of database: 8,527,803
effective search space: 3266148549
effective search space used: 3266148549
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 53 (25.0 bits)